Pdf study (directory)

S10000-TRUST CRT 2009.pdf

S10001-à effacer(NCT00403767) -NCT00403767.pdf

S10002-rivaroxaban japan phase 3 DOUBLON -NCT00494871.pdf

S10003-ATLAS ACS 2 - TIMI 51 (2.5mg) 2011-NCT00809965.pdf

S10004-MAGELLAN 2011-NCT00571649.pdf

S10005-Einstein-DVT Evaluation 2010-NCT00440193.pdf

S10006-Einstein-PE Evaluation 2012-NCT00439777.pdf

S10008-CHILLAS .pdf

S10009-Astrup (NN8022-1807 ) 2009-NCT00422058.pdf

S10010-OB 301 (mid-dose) 0.pdf

S10011-BLOSSOM (10mg bid) 2009-NCT00603902.pdf

S10012-OB 302 (low-dose) 0.pdf

S10013-BARRIT 1960.pdf

S10014-STAMINA (Amoxicillin) 2002.pdf

S10015-ARBITER-HALTS 6 2010.pdf

S10019-Borer (CL2-009) 5mg 2003.pdf

S10021-Nishimura 2009.pdf

S10022-ESPRIM 1994.pdf

S10023-ISIS-4 1995.pdf

S10024-GISSI-3 1994.pdf

S10025-Hildebrandt 1992.pdf

S10026-Beaufils 1988.pdf

S10027-Charvat 1990.pdf

S10028-Zharov 1991.pdf

S10029-Hargreaves 1992.pdf

S10030-Jugdutt 1988.pdf

S10031-Fitzgerald 1990.pdf

S10032-SPACE 2 0.pdf

S10033-Bussmann 1992.pdf

S10034-Wagner 2002.pdf

S10035-Di Pasquale 1994.pdf

S10036-Di Pasquale 1997.pdf

S10037-Galcera 1993.pdf

S10038-Hargreaves 1992.pdf

S10051-Oxford Niaspan Study 2009-NCT00232531.pdf

S10052-GOPCABE -NCT00719667.pdf

S10053-PHS (diabetics sub group) 1989.pdf

S10054-ETDRS à effacer 1992.pdf

S10055-PPP (diabetics sub group) 2003.pdf

S10056-WHS (diabetics sub group) 2005.pdf

S10057-ARBITER 2 2009.pdf

S10058-HATS 2001.pdf

S10059-ARBITER 6-HALTS (niacin vs ezetimibe) 2009-NCT00397657.pdf

S10060-Nouvel essai .pdf

S10062-REDEEM 2009-NCT00621855.pdf

S10063.pdf

S10064-Nouvel essai .pdf

S10065-RESPOND .pdf

S10066-JCHF 2.5mg 2009.pdf

S10067-NIA DOUBLON avec Oxford Niaspan Study, 2009 .pdf

S10068-FAIR-HF (Anker) 2009.pdf

S10069-Nouvel essai .pdf

S10072-JCHF 5mg 2009.pdf

S10073-HeartMate II 2009-NCT00121485.pdf

S10074-REMATCH 2001.pdf

S10075-NOBLE 2016.pdf

S10076-OCTOPUS (idem octostent) 2009.pdf

S10077-CLARITY-TIMI 28 2005.pdf

S10078-RE-COVER 2009-NCT00291330.pdf

S10079-Nouvel essai .pdf

S10080-Baker 2001.pdf

S10081-Lee 2003.pdf

S10082-Vedin 2006.pdf

S10083-SCOUT 2010-NCT00234832.pdf

S10085-Czerny 2000.pdf

S10086-Czerny b 2001.pdf

S10087-Dorman 2004.pdf

S10088-Gasz 2004.pdf

S10089-Guler 2001.pdf

S10090-Muneretto 2003.pdf

S10091-Parolari 2003.pdf

S10092-Parolari b 2003.pdf

S10093-Puskas 2004.pdf

S10094-Sahlman 2003.pdf

S10096-Syed 2004.pdf

S10097-Tang 2002.pdf

S10098-Velisaris 2003.pdf

S10099-Vural 1995.pdf

S10100-Wan 2004.pdf

S10101-Wandschneider 2000.pdf

S10102-EINSTEIN-extension 2009-NCT00439725.pdf

S10103-PROTECT 2009-NCT00351390.pdf

S10104-STARS-BNP 2007.pdf

S10105-ESCAPE 2005.pdf

S10106-RABBIT -NCT00206856.pdf

S10107-BATTLESCARRED 2009-ANZCTR12605000735651.pdf

S10108-STARBRITE 2007-NCT00484770.pdf

S10109-Troughton 2000.pdf

S10110-INSTEAD 2009-NCT00525356.pdf

S10111-DORADO-AC .pdf

S10112-DORADO 2009-NCT00330369.pdf

S10114-ERASE-MI 2009.pdf

S10115-INNOVATE -NCT00751231.pdf

S10153-NAPLES (Tavano) 2009.pdf

S10157-VanGogh PE 2007-NCT00062803.pdf

S10158-Aschner 2006-NCT00087516.pdf

S10159-Goldstein 2007-NCT00103857.pdf

S10160-Hanefeld 2007.pdf

S10161-Nonaka 2008-NCT00371007.pdf

S10162-Raz 2006.pdf

S10163.pdf

S10164-Goldstein (sit vs met) 2007.pdf

S10165.pdf

S10166-Charbonnel 2006-NCT0086515.pdf

S10167-Goldstein (sit+met vs met) 2007.pdf

S10168-Hermansen 2007.pdf

S10169-Nauck 2007-NCT00094770.pdf

S10170-Rosenstock (sit on top pio vs pbo) 2006-NCT00086502.pdf

S10171.pdf

S10172-Dejager [1] 2007-NCT00099905.pdf

S10173-Mimori 2006.pdf

S10174-Pi-Sunyer 2007-NCT00120536.pdf

S10175-Pratley 2006.pdf

S10176-Ristic 2005.pdf

S10177-Scherbaum [2] 2008-NCT00101712.pdf

S10178.pdf

S10179.pdf

S10180-Schweizer 2007-NCT00099866.pdf

S10181-Ahren 2004.pdf

S10182-Bolli 2008-NCT00237237.pdf

S10183-Bosi 2007-NCT00099892.pdf

S10184-Fonseca 2007-NCT00099931.pdf

S10185-Garber 2007-NCT00099853.pdf

S10186.pdf

S10187-Madsbad (vs Glimepiride) 2004.pdf

S10188-Vilsboll 2008.pdf

S10189-Seino 2008-NCT00154414.pdf

S10190-Feinglos 2005.pdf

S10191-LEAD-3 mono 1.2mg (Garber) 2009-NCT00294723.pdf

S10192-LEAD-2 (Nauck) (1.2mg vs placebo) 2009-NCT00318461.pdf

S10193-LEAD-1 SU (1.2 mg vs placebo) 2009-NCT00318422.pdf

S10194-LEAD-4 (1.2mg) 2009-NCT00333151.pdf

S10195-LEAD-5 (vs placebo) 2009-NCT00331851.pdf

S10196-Davis 2007-NCT00099333.pdf

S10197-Barnett 2007-NCT00099619.pdf

S10198-Nauck 2007-NCT00082407.pdf

S10199-Heine 2005.pdf

S10204-Kadowaki (trial 8683) 2009.pdf

S10206-Kim 2007-NCT00103935.pdf

S10207-Moretto (DOUBLONS avec druker) 2008-NCT00381342.pdf

S10208-Madsbad (vs placebo) 2004.pdf

S10209-LEAD-2 (Nauck) (1.2 mg vs glimepiride) 2009-NCT00318461.pdf

S10210-LEAD-5 (vs Glargine) 2009-NCT00331851.pdf

S10313-VTACH 2009-NCT00919373.pdf

S10315-SMASH-VT 2007-ISRCTN62488166.pdf

S10316-SALTIRE 2005.pdf

S10317-ASTRONOMER 2010-ISRCTN 32424163.pdf

S10318-SEAS 2008-NCT00092677.pdf

S10325-Hare 2009.pdf

S10326-SPIRIT III (small vessel subgroup) 2009.pdf

S10327-PREPARE 2009.pdf

S10328-AMPLIFY 2013-NCT00643201.pdf

S10329-AMPLIFY-EXT 2.5mg 2012-NCT00633893.pdf

S10330-ADOPT doublon autre MA 2011-NCT00457002.pdf

S10331-ADVANCE 1 (Lassen) DOUBLON 2009-NCT00371683.pdf

S10332-ADVANCE 3 2010-NCT00423319.pdf

S10333-ADVANCE 2 2010-NCT00452530.pdf

S10334-CV185-027 -NCT00320255.pdf

S10335-PLATO invasive subgroup 2010.pdf

S10336-Nouvel essai .pdf

S10338-APPRAISE 2 2011-NCT00831441.pdf

S10339-ARISTOTLE 2011-NCT00412984.pdf

S10340-AVERROES 2011-NCT00496769.pdf

S10341-phase 2 apixaban 0-NCT00787150.pdf

S10342-SEPIA PCI .pdf

S10345-CALISTO 2010-NCT00443053.pdf

S10347-Sasaki 2010.pdf

S10348-CABANA -NCT00911508)..pdf

S10349-Nouvel essai .pdf

S10350-Nouvel essai .pdf

S10352-ACCORD lipid 2010-NCT00000620.pdf

S10353-ACCORD blood pressure 2010-NCT00000620.pdf

S10355-RACE II 2010-NCT00392613.pdf

S10356-phase 2 betrixaban Ezekowitz -NCT00742859.pdf

S10357-CILON-T 2010.pdf

S10359-ARTS 2 2010.pdf

S10360-EXCEL 2016.pdf

S10364-CAMELOT (amlodipine vs enalapril) 2004.pdf

S10365-SUVIMAX 2005.pdf

S10366-Nouvel essai .pdf

S10367-Nouvel essai .pdf

S10369-DECLARE-DIABETES 2010.pdf

S10370- RE-LY 150mg (2nd prevention subgroup) .pdf

S10371- RE-LY 110mg (2nd prevention subgroup) 2010.pdf

S10372-MICHELANGELO OASIS-6 2006-NCT00064428.pdf

S10376-BRiEF -NCT00521885.pdf

S10377-FONDACAST -NCT00843492.pdf

S10378-NCT00333021 -NCT00333021.pdf

S10382-SWITCH III -NCT00464087.pdf

S10385-NCT00320398 0-NCT00320398.pdf

S10386-Nouvel essai .pdf

S10387-Nouvel essai .pdf

S10389-NAVIGATOR valsartan 2010-NCT00097786.pdf

S10391-NAVIGATOR nateglinide 2010-NCT00097786.pdf

S10393-L8541 0.pdf

S10395-L8635 0.pdf

S10396-DRI4757 0.pdf

S10400-Hot cafe (rate vs rythm control) 2004.pdf

S10401-RACE (rate vs rythm control) 2002.pdf

S10402-STAF (rate vs rythm control) 2003.pdf

S10403-AFFIRM (rate vs rythm control) 2002-NCT00000556.pdf

S10404-PIAF (rate vs rythm control) 2000.pdf

S10405-AF-CHF (rate vs rythm control) 2002-NCT00597077.pdf

S10407-EXPLORE-Xa DOUBLON 2010-NCT00742859.pdf

S10409-DES-LATE 2010-NCT00484926.pdf

S10410-Nouvel essai .pdf

S10411-DES-LATE 2010-NCT00484926.pdf

S10412-Nouvel essai .pdf

S10413-OPTIMIZED .pdf

S10414-MATISSE PE 2003.pdf

S10415-GRAVITAS 2011-NCT00645918.pdf

S10416-ARTIC adjusted .pdf

S10417-ARTIC (extended dual antiplatelet) 0-NCT00827411.pdf

S10418-PLATINUM 2011-NCT00823212.pdf

S10419-VA CABG 2010-NCT00054847.pdf

S10420-Steinbauer 2008.pdf

S10421-JETSTENT 2010.pdf

S10422-Ruilope 2010.pdf

S10423-Nouvel essai .pdf

S10424-RAS -NCT00475488.pdf

S10425-Gaudino (RITA) 2005.pdf

S10429-CLOTS 2009.pdf

S10431-Schirai 1985.pdf

S10433-Fisher 1995.pdf

S10434-Hull II 1990.pdf

S10435-Knudson 1994.pdf

S10436-Kosir 1996.pdf

S10437-Turple II 1979.pdf

S10438-Bachmann 1976.pdf

S10439-Butson 1981.pdf

S10440-Bynke 1987.pdf

S10441-Clark 1974.pdf

S10442-Clarke-Pearson I 1984.pdf

S10443-Clarke-Pearson II 1984.pdf

S10444-Coe 1978.pdf

S10445-Gallus 1983.pdf

S10446-Hills 1972.pdf

S10447-Hull I 1979.pdf

S10448-Skillman 1978.pdf

S10449-Turpie I 1977.pdf

S10450-Weitz 1986.pdf

S10451-Lieberman (A) 1994.pdf

S10452-Siragusa (H) 1994.pdf

S10453-Smith (D) 1978.pdf

S10454-Scurr 1981.pdf

S10455-Wilson 1992.pdf

S10456-Stannard (vs UFH+asp) 1996.pdf

S10457-Muir 2000.pdf

S10458-Rosengarten 1970.pdf

S10460-Kalodiki (GCS+LMWH vs LMWH) 1996.pdf

S10461-Kierkegaard 1993.pdf

S10462-McKenna 1980.pdf

S10463-Prasad 1982.pdf

S10464-Turpie 1989.pdf

S10465-Killewich 1997.pdf

S10466-Soderdahl 1997.pdf

S10467-Hansberry 1991.pdf

S10468-Blanchard 1999.pdf

S10470-Clarke Pearson 1993.pdf

S10471-Coe (vs UFH) 1978.pdf

S10472-Kosir 1998.pdf

S10473-Hansberry (vs UFH) 1991.pdf

S10474-Chandhoke 1992.pdf

S10475-paiement 1987.pdf

S10476-Kaempffe 1991.pdf

S10477-HAAS I 1990.pdf

S10478-HAAS II 1990.pdf

S10479-McKenna (vs aspirin) 1980.pdf

S10480-Niolaides 1983.pdf

S10481-Santori 1994.pdf

S10484-Fordyce 1992.pdf

S10485-Caprini 1983.pdf

S10486-Turpie 1989.pdf

S10487-Wautrecht 1996.pdf

S10488-Rokito 1996.pdf

S10489-Lacut 2005.pdf

S10490-Pambianco 1995.pdf

S10491-Ramos 1996.pdf

S10492-Hull (+asp) 1979.pdf

S10493-Hull 2 (+asp) 1979.pdf

S10494-Dickinson 1998.pdf

S10495-Goldhaber 1995.pdf

S10496-Nodari 2010.pdf

S10497-Mellbring 1986.pdf

S10498-Turpie (IPD or GCS) 1989.pdf

S10499-Camporese 2008.pdf

S10500-Rasmussen (GCS vs UFH) 1998.pdf

S10501-Fasting 1985.pdf

S10502-Hansberry (vs UFH) 1991.pdf

S10503-Mellbring 1986.pdf

S10504-Torngren 1980.pdf

S10520-TROPHY 2006-NCT00227318.pdf

S10521-KANT (7 days) 2008.pdf

S10522-KANT (14 days) 2008.pdf

S10569-STATIN STEMI 2010.pdf

S10570-ARMYDA-ACS 2007.pdf

S10572-Wohrle 2010.pdf

S10573-JPPP -NCT00225849.pdf

S10574-ENACT-AMI .pdf

S10575-ACAPULCO .pdf

S10576-Kujath 1993.pdf

S10577-Kock 1995.pdf

S10578-Jorgensen 2002.pdf

S10579-Lapidus 2007.pdf

S10580-Lassen 2002.pdf

S10581-Lapidus 2007.pdf

S10582-ABCD 2010.pdf

S10583-Revive .pdf

S10584-D-KAf (Selby) 2007-NCT00187408.pdf

S10585-Handley (low dose) 1972.pdf

S10586-Handley 1972.pdf

S10587-Gallus 1973.pdf

S10588-Emerson 1973.pdf

S10589-Zawilska 1989.pdf

S10590-Warlow 1973.pdf

S10591-Pitt 1980.pdf

S10592-Scala 1990.pdf

S10594-Bergmann 1996.pdf

S10595-Harenberg 1990.pdf

S10596-Bergmann and Neuhart 1996.pdf

S10597-Harenberg 1996.pdf

S10598-Lechler 1996.pdf

S10599-Kleber 2003.pdf

S10603-British Bifurcation Coronary Study DOUBLON 2010.pdf

S10608-ZETELD 2010.pdf

S10609-Nouvel essai .pdf

S10610-DIRECT-Carotid (Shai) 2010.pdf

S10611-DeFronzo 2009-NCT00121667.pdf

S10612-Ferrannini 2009-NCT00106340.pdf

S10613-Goodman 2009.pdf

S10614-Nauck 2009-NCT00286442.pdf

S10615-Ristic 2006.pdf

S10616-Marre 2002.pdf

S10617-Moses 1999.pdf

S10628-LEAD-2 (Nauck) Sulf vs pbo 2009-NCT00318461.pdf

S10629-LEAD-2 (Nauck) (vs GLP-1 analog) 2009.pdf

S10630-Khanolkar 2008.pdf

S10631-Hamann 2008.pdf

S10632-Nauck 2007.pdf

S10633-Garber 2006.pdf

S10634-Ristic 2006.pdf

S10635-Feinglos 2005.pdf

S10637-Charpentier 2001.pdf

S10638-Matthews 2005.pdf

S10642-Li 2009.pdf

S10643-Li 2007.pdf

S10644-Lund 2007.pdf

S10646-Colwell 2010.pdf

S10651-ARMYDA-4 RELOAD 2010.pdf

S10653-Pratley 1.2mg 2010-NCT00700817.pdf

S10654-LEADER 2016-NCT01179048.pdf

S10718-Baker 1964.pdf

S10719-Bradshaw 1975.pdf

S10720-Enger 1965.pdf

S10721-Howard 1963.pdf

S10722-LHSPS 1999.pdf

S10724-McDevitt 1959.pdf

S10725-Nat-Coop 1962.pdf

S10726-SWAT 1998.pdf

S10727-Thygesen 1964.pdf

S10728-VA Study 1961.pdf

S10729-Wallace 1964.pdf

S10730-BBC ONE 2008-NCT00351260.pdf

S10731-CACTUS 2009.pdf

S10732-Colombo 2004.pdf

S10733-Ferenc 2008.pdf

S10734-NORDIC 2006.pdf

S10735-Pan 2004.pdf

S10736-Macdonald 2010.pdf

S10738-LIFE (diabetic subgroup) 2002.pdf

S10739-ALLHAT (lisi vs chlor, diabetic subgroup) 2002.pdf

S10740-ALLHAT (amlodipine vs chlor, diabetic subgroup) 2002.pdf

S10741-STOP-2 (ACEI vs CCB) (diabetic subgroup) 2000.pdf

S10748-Baillargeon 2004.pdf

S10749-Bridger 2006.pdf

S10750-Charles 1998.pdf

S10751-Charles 2000.pdf

S10752-Choux 2003.pdf

S10753-Crave 1995.pdf

S10754-Fleming 2002.pdf

S10755-Freemark 2001.pdf

S10756-Gambineri 2004.pdf

S10757-Giugliano 1993.pdf

S10758-Hoeger 2004.pdf

S10759-James 2005.pdf

S10760-Kay 2001.pdf

S10761-Kelly 2002.pdf

S10763-Kocak 2002.pdf

S10764-Lehtovirta 2001.pdf

S10765-Li 1999.pdf

S10766-Moghetti 2000.pdf

S10767-Morel 1999.pdf

S10768-Ng 2001.pdf

S10769-Orchard 2005.pdf

S10770-Pasquali 2000.pdf

S10771-Ramachandran 2006.pdf

S10772-Rodriguez 2004.pdf

S10773-Rodriguez-Moctezuma 2004.pdf

S10774-Sirtori 1984.pdf

S10775-Srinivasan 2006.pdf

S10776-Stakos 2005.pdf

S10777-Sturrock 2002.pdf

S10778-Tang 2006.pdf

S10779-Vitale 2005.pdf

S10780-Hanefeld 1991.pdf

S10781-LOCAT 1997.pdf

S10782-Emmerich 2009.pdf

S10783-ACCORD lipid (DOUBLON ) 2010.pdf

S10784-CREST 2010.pdf

S10792-UMPIRE -NCT01057537.pdf

S10793-GAP -ACTRN12608000583347.pdf

S10794-IMPACT -ACTRN12606000067572.pdf

S10795-TIPS 2009-NCT00443794.pdf

S10796-NCT00567307 -NCT00567307.pdf

S10797-NCT00603590 -NCT00603590.pdf

S10798-TIPS 2 .pdf

S10804-RESOLUTE All comers 2010-NCT00617084.).pdf

S10805-Nouvel essai .pdf

S10825.pdf

S10828-VISP (Toole) 2004.pdf

S10829-Lonn 2006.pdf

S10830-Bonaa 2006.pdf

S10831-Zoungas 2006.pdf

S10832-Wrone 2004.pdf

S10833-Righetti 2006.pdf

S10834-Mark (Linxian) 1996.pdf

S10836-Liem 2003.pdf

S10837-Boudriot 2008.pdf

S10838-SYNTAX (unprotected left main sub group) 2009.pdf

S10839-SCANDSTENT (subgroup) 2006.pdf

S10840-SPEED (Phase B) 2000.pdf

S10841-SPEED (Phase B) importé 2000.pdf

S10842-SPEED (Phase A) importé 2000.pdf

S10843-SURVIVE 2007-NCT00348504.pdf

S10844-REVIVE-I 2003.pdf

S10845-CASINO 0.pdf

S10846-RUSSLAN 2002.pdf

S10847-LIDO 2002.pdf

S10848-CUPID 2011.pdf

S10850-Kim 2010.pdf

S10851-DART (Burr) 1989.pdf

S10853-Finnish Mental Hospital (Turpeinen) 1979.pdf

S10854-Nouvel essai 0.pdf

S10855-Nouvel essai 0.pdf

S10856-Tweddel 1981.pdf

S10857-Jenkins 1982.pdf

S10858-Strauss 1984.pdf

S10859-Frishman 1985.pdf

S10860-Strauss 1985.pdf

S10861-O'Keefe (5mg) 1987.pdf

S10862-Akhras 1991.pdf

S10863-Foale 1993.pdf

S10864-Meyer 1993.pdf

S10865-Madjlessi-Simon 1995.pdf

S10866-Dunselman 1998.pdf

S10867-Donaldson (nifedipine) 1993.pdf

S10868-IMAGE (Savonitto) 1996.pdf

S10869-Hung 1983.pdf

S10870-Kenny .pdf

S10871-Humen 1986.pdf

S10872-Uusitato 1986.pdf

S10873-El-Tamimi 1992.pdf

S10874-Parameshwar 1993.pdf

S10875-TIBET (Fox) 1996.pdf

S10876-Dunselman 1997.pdf

S10877-Emanuelsson 1999.pdf

S10878-Ruzyllo (CL3-023) 15mg 2007.pdf

S10879-INITIATIVE (CL3-017, Tardif) 20mg 2005.pdf

S10880-BEAUTIFUL 2008-NCT00143507.pdf

S10881-ASSOCIATE (Tardif) 2009-NCT00202566.pdf

S10882-CL3-018 15mg 3000.pdf

S10883-CL3-018 10mg 3000.pdf

S10884-phase II 10mg importé 0.pdf

S10885-phase II 15mg importé 0.pdf

S10886-Borer (CL2-009) 10mg 2003.pdf

S10887-Borer (CL2-009) 20mg 2003.pdf

S10888-REDUCTION .pdf

S10889-ASSOCIATE (Tardif) 2009-NCT00202566.pdf

S10892-INITIATIVE (Tardif) 20mg 2005.pdf

S10893-INITIATIVE (CL3-017, Tardif) 15mg 2005.pdf

S10894-CL3-023 (15mg) 0.pdf

S10895-CL3-023 (20mg) 0.pdf

S10896-Ruzyllo (CL3-023) 20mg 2007.pdf

S10897-CANOE 2010-NCT00116932.pdf

S10899-Nouvel essai .pdf

S10900-Nouvel essai .pdf

S10942-Nouvel essai .pdf

S10943-INVEST (CAD subgroup) 2003.pdf

S10944-ALLHAT (CAD sub group) 2006.pdf

S10945-JMIC-B (CAD subgroup) 2004.pdf

S10946-Destors 1989.pdf

S10947-Egstrup 1988.pdf

S10948-Rae 1985.pdf

S10949-Logan 1986.pdf

S10950-Bowles 1983.pdf

S10951-Hauf-Zachariou 1997.pdf

S10952-Khurmi 1987.pdf

S10953-Riley 1992.pdf

S10954-Romano 1986.pdf

S10955-Cocco 1979.pdf

S10956-Shapiro 1989.pdf

S10957-de Vries 1996.pdf

S10958-Johnston 1983.pdf

S10959-Di Somma 1996.pdf

S10960-Wallace 1994.pdf

S10961-Ardissino 1995.pdf

S10962-Ardissino 1991.pdf

S10963-Johnston 1984.pdf

S10964-Higginbotham 1989.pdf

S10965-Vliegen 1993.pdf

S10966-van der Does 1992.pdf

S10967-TIBBS (von Arnim) 1995.pdf

S10968-Waysbort 1991.pdf

S10969-Krepp 1991.pdf

S10970-Aubert 1970.pdf

S10971-Binak 1974.pdf

S10972-Goldbarg 1969.pdf

S10973-Alderman A EFFACER .pdf

S10974-Akhras 1989.pdf

S10975-Ankier 1989.pdf

S10976-Liang 1985.pdf

S10977-Connelly 1995.pdf

S10978-Eldridge 1987.pdf

S10979-Emanuelsson 1989.pdf

S10980-von Arnim 1988.pdf

S10981-Steffensen 0.pdf

S10982-Schneider 0.pdf

S10983-Friedensohn 0.pdf

S10984-Carboni 0.pdf

S10985-van de Ven à effacer 0.pdf

S10986-IMAGE (Savonitto) 1996.pdf

S10987-Johnson 1981.pdf

S10988-Lynch 1980.pdf

S10989-Kawanishi 1992.pdf

S10990-Pflugfelder 1987.pdf

S10991-McGill 1986.pdf

S10992-Humen 1991.pdf

S10993-Frishman 1982.pdf

S10994-Nadazdin SANS REF 1994.pdf

S10995-De Divitiis 1987.pdf

S10996-Crake 1988.pdf

S10997-Southall 1982.pdf

S10998-Wheatley 1985.pdf

S10999-Steffensen 1993.pdf

S11000-Bjerle 1986.pdf

S11001-Findlay 1983.pdf

S11002-Findlay 1986.pdf

S11003-Findlay 1987.pdf

S11004.pdf

S11005-Frishman 1992.pdf

S11006-van Dijk 1194.pdf

S11007-Kenny 1985.pdf

S11008-Arnman 1982.pdf

S11009-Ahuja 1993.pdf

S11010-Parameshwar 1993.pdf

S11011-Sadick 1982.pdf

S11012-Hung 1983.pdf

S11013-Egstrup 1993.pdf

S11014-Lai 1992.pdf

S11015-Bowles REF MANQUANTE 1981.pdf

S11016-Parker SANS ref 1986.pdf

S11017-Hopkinson 1991.pdf

S11018-Romano 1988.pdf

S11019-Catipovic-Veselica 1993.pdf

S11020-Johnston 1984.pdf

S11021-Rousseau 1986.pdf

S11023-Lessem 1984.pdf

S11024-Blake 1991.pdf

S11025-Miller 1976.pdf

S11026-Hill 1991.pdf

S11027-Meyer 1991.pdf

S11028-Singh 1993.pdf

S11029-O’Hara 1984.pdf

S11030-Brouwer 1995.pdf

S11031-Sigurd 1984.pdf

S11032-Kenmure 1979.pdf

S11033-Lai 1988.pdf

S11034-Hetzel 1994.pdf

S11035-Wieshammer 1991.pdf

S11036-de Vries 1994.pdf

S11037-Steffensen (ass vs B-) 1993.pdf

S11038-Humen (ass 240 mg) 1991.pdf

S11039-Di Somma 1986.pdf

S11040-Kawanishi (ass) 1992.pdf

S11041-Lynch (high dose) 1980.pdf

S11042-Friedensohn (ass) 0.pdf

S11043-Zhu 2007.pdf

S11044-Edwards 2005.pdf

S11045-Raftery 1993.pdf

S11046-Guermonprez 1993.pdf

S11047-Di 1993.pdf

S11048-Ulvenstam 1992.pdf

S11049-Meeter 1992.pdf

S11050-Lai 1991.pdf

S11051-Hughes 1990.pdf

S11052-Meany 1989.pdf

S11054-Kato 1987.pdf

S11055-Hayata 1986.pdf

S11056-Wieshammer (ass) 1991.pdf

S11057-Hill (ass) 1991.pdf

S11058-### Miller (ass) 1976.pdf

S11059-Lessem (ass) 1984.pdf

S11060-ROADMAP 2010-NCT00185159.pdf

S11061-ORIENT -NCT00141453.pdf

S11062-Parameshwar (ass) 1993.pdf

S11063.pdf

S11064.pdf

S11065-Findlay (ass) 1983.pdf

S11066-Steffensen (ass) BOUBLON 1993.pdf

S11067-Egstrup (ass) 1988.pdf

S11068-Rae (vs BB) 1985.pdf

S11069.pdf

S11070.pdf

S11071-Liang 1985.pdf

S11072-Connelly 1995.pdf

S11073-Eldridge 1987.pdf

S11074-Emanuelsson 1989.pdf

S11075-von Arnim 1988.pdf

S11076-Steffensen 1997.pdf

S11077-Schneider 1988.pdf

S11078-Friedensohn 1991.pdf

S11079-Carboni 1992.pdf

S11080-van de Venn 1995.pdf

S11081-Waysbort 1991.pdf

S11082-Krepp 1991.pdf

S11083.pdf

S11084-Binak 1974.pdf

S11085-Goldbarg 1969.pdf

S11086-Alderman 1997.pdf

S11087-de Vries 1994.pdf

S11088-Schneider (vs PBO) 1988.pdf

S11089-Krepp (ass) 1991.pdf

S11090-Waysbort (ass) 1991.pdf

S11091-Krepp (ass) à effacer 1991.pdf

S11095-AMIHOT II 2000-NCT00175058.pdf

S11096-AMIHOT 2007.pdf

S11097-Rawles 1976.pdf

S11098-Ukholkina 2005.pdf

S11099-Wilson 1997.pdf

S11100-Dekleva 2004.pdf

S11101-Sharifi 2004.pdf

S11102-Swift 1992.pdf

S11103-Thurston 1973.pdf

S11104-Hot MI 1997.pdf

S11105-Kerr 1975.pdf

S11106-HEMOPURE 2005.pdf

S11107-HOT MI pilot 1997.pdf

S11110-Lai (vs PBO) 1991.pdf

S11111-Di (20mg) 1993.pdf

S11112-Akhras (SR) 1989.pdf

S11113-RE-NOVATE 2 0-NCT00657150.pdf

S11137-Butina (ass) 2002.pdf

S11138-CLOSURE I 2010-NCT00201461.pdf

S11139-RESPECT PFO -NCT00465270.pdf

S11140-PC-Trial -NCT00166257.pdf

S11141-REDUCE -NCT00738894.pdf

S11142-CLOSE -NCT00562289.pdf

S11143-CryptoCard -NCT01018355.pdf

S11144-RAN080 (vs atenolol) 2005.pdf

S11145-Destors 1989.pdf

S11146-Dorow 1990.pdf

S11147-Frishman 1979.pdf

S11148-van der Does 1999.pdf

S11149-Narahara 1990.pdf

S11150-Frishman 1989.pdf

S11151-Chieffo 1986.pdf

S11152-Grant 1966.pdf

S11153-Idrisova 2004.pdf

S11154-Weiss 1998.pdf

S11155-Chrysant 1994.pdf

S11156-Lee 1989.pdf

S11157-Pesciatini 1989.pdf

S11158-Quyyumi 1985.pdf

S11159-Harston 1982.pdf

S11160-Lee 1982.pdf

S11161-Aronow 1980.pdf

S11162-Lang 1979.pdf

S11163-Keyriläinen 1976.pdf

S11164-Uusitalo 1987.pdf

S11168-SIRTAX II .pdf

S11169-Sansa 2005.pdf

S11170-TINOX 2005.pdf

S11171-Mauer 2009.pdf

S11172-DIRECT 1-3 2009.pdf

S11175-Zanolla 1997.pdf

S11176-Toal (90mg) 1995.pdf

S11177-Walker 1996.pdf

S11178-Lagioia 1995.pdf

S11179-IMAGE (Savonitto) (ass) 1996.pdf

S11180-Hung (ass) 1983.pdf

S11181-Mueller 1981.pdf

S11182-Sherman 1983.pdf

S11183-Van de Wall 1983.pdf

S11184-Dargie 1981.pdf

S11185-De Buitler (atenolol) 1984.pdf

S11186-de Buitleir à effacer 1984.pdf

S11187-Kenmure 1979.pdf

S11188-Keyriläinen 1984.pdf

S11189-Bailey 1982.pdf

S11190-###Rousseau 1987.pdf

S11191-Lehmann 1993.pdf

S11192-Davies (CASIS) 1995.pdf

S11193-Woodmansey 1993.pdf

S11194-Siu (Nifedipine) 1993.pdf

S11196-Kenedi 1987.pdf

S11197-Uusitalo 1988.pdf

S11198-Glasser 1997.pdf

S11199-Svenden 1989.pdf

S11200-Eteiba (Ismo retard) 1991.pdf

S11201-Steele 1978.pdf

S11202-DePonti 1981.pdf

S11203-Pfisterer 1982.pdf

S11204-### Mitrovic 1989.pdf

S11205-SATURN -NCT00620542.pdf

S11206-Bailey (MB102014) 2010-NCT00528879.pdf

S11207-DURATION-3 (Diamant) 2010-NCT00641056.pdf

S11209-Akhras à effacer 1990.pdf

S11210-Challenor 1989.pdf

S11211-El-Tamini 1991.pdf

S11212-Crake (nifedipine) 1987.pdf

S11213-Dargie0voir 1988.pdf

S11214-Allen 1984.pdf

S11215-Strauss DOUBLON 1984.pdf

S11216-Kenny 1984.pdf

S11217-### Johnson 1983.pdf

S11218-Crake (nifedipine SR) 1987.pdf

S11219-Toal (60mg) 1995.pdf

S11220-Toal (30mg) 1995.pdf

S11221-ACCORD (sub group, Eye study) 2010-NCT00000620.pdf

S11222-ACCORD lipid (subgroup Eye study) 2010-NCT00000620.pdf

S11223.pdf

S11224-O'Keefe (10mg) 1987.pdf

S11225-Donaldson (nisoldipine) 1993.pdf

S11226-DiBianco 1992.pdf

S11229-SECURE 2001.pdf

S11232-Humen (ass 360 mg) 1991.pdf

S11233-PROMISS (Uva) 2010.pdf

S11234-TRIMAG (Szwed) 2001.pdf

S11235-TIBET (Fox) nifedipine 1996.pdf

S11237-TRAFFIC (Emanuelsson) 1999.pdf

S11238-WHS vitamin E 2005-NCT00000479.pdf

S11239-BLOOM 2010-NCT00395135.pdf

S11240-Tepel 2003.pdf

S11241-HOPE renal insufficiency subgroup 2004.pdf

S11242-ASAP 2000.pdf

S11243-MASI 2000.pdf

S11244-ATBC 2nd prev subgroup (vitamin E) 1998.pdf

S11245-HATS 2001.pdf

S11246-MVP 1997.pdf

S11247-### Strauss 1984.pdf

S11250-ALLHAT (women subgroup) 2002.pdf

S11251-ASCOT (women subgroup) 2003.pdf

S11252-MEGA (women subgroup) 2006.pdf

S11253-HPS (women subgroup) 2002.pdf

S11254-JUPITER (women subgroup) 2008.pdf

S11255-Wing study 1 1988.pdf

S11256-Wing study 2 .pdf

S11280-Eteiba 1991.pdf

S11281-Crake (pooling) 1987.pdf

S11282-Humen (pooling) 1991.pdf

S11283-O'Keefe (pooling) 1987.pdf

S11284-Toal (pooling) 1995.pdf

S11285-OPTIMA 2009-ISRCTN80874637.pdf

S11286-Brandjes 1997.pdf

S11287-Ginsberg 2001.pdf

S11288-Partsch 2004.pdf

S11289-Prandoni 2004.pdf

S11291-Aschwanden 2008.pdf

S11294-ACCOMPLISH (diabetic subgroup) 2010-NCT00170950.pdf

S11295.pdf

S11296-HDFP (diabetic subgroup) 1986.pdf

S11297-PART2 (diabetic subgroup) 2000.pdf

S11298-PROGRESS (diabetic subgroup) 2001.pdf

S11299-SCAT (diabetic subgroup) 2000.pdf

S11300-NICOLE (diabetic subgroup) 2001.pdf

S11301-PREVENT (diabetic subgroup) 2000.pdf

S11302-SCOPE (diabetic subgroup) 2003.pdf

S11303-AASK (diabetic subgroup) 2002.pdf

S11304-ANBP2 (diabetic subgroup) 2003.pdf

S11305-CONVINCE (diabetic subgroups) 2003.pdf

S11306-ELSA (diabetic subgroup) 2002.pdf

S11307-NICS-EH (diabetic subgroup) 1999.pdf

S11308-VHAS (diabetic subgroup) 1995.pdf

S11310-JMIC-B (diabetic subgroup) 2004.pdf

S11313-Rea 2010-NCT00219687.pdf

S11314-Svensson 2010-CT20080012.pdf

S11315-Hallstrom 2000.pdf

S11316-Hallstrom + preliminary study .pdf

S11318-FAVORIT -NCT00064753.pdf

S11319-CSPPT 2015-NCT00794885.pdf

S11320-SU.FOL.OM3 -ISRCTN41926726.pdf

S11321-DURATION-2 (Bergenstal) (vs sitagliptin) 2010-NCT00637273.pdf

S11322-DURATION-3 (copie de 11207) 2010.pdf

S11323-DURATION-2 (Bergenstal) (vs pioglitazone) 2010-NCT00637273.pdf

S11332-ASSOCIATE (symptomatic subgroup) 0.pdf

S11333-BEAUTIFUL (angina subgroup) .pdf

S11336-TIBET (ass vs BB or CaB) 1996.pdf

S11337-EXCLAIM 2010-NCT00077753.pdf

S11356-ATBC 2nd prev subgroup (b carotene) 1998.pdf

S11357-TOHP (weight) 1997.pdf

S11358-Stevens 1993.pdf

S11364-Lyon .pdf

S11365-Soya bean (DOUBLON, A EFFACER) 0.pdf

S11366-Kurnanyika (A DEPLACER) 0.pdf

S11367-Kumanyika 1993.pdf

S11368-Hypertension Prevention Trial DOUBLON A EFFACER .pdf

S11369-DISH 1985.pdf

S11370-Marra 1985.pdf

S11373.pdf

S11374.pdf

S11375.pdf

S11376.pdf

S11377.pdf

S11378.pdf

S11379-ORAR III .pdf

S11380-EPAT 2001.pdf

S11381-EVTET 2000.pdf

S11382-Hall 1998.pdf

S11383-HERS II 2002.pdf

S11384-ESPRIT 2002.pdf

S11385-WEST 2001.pdf

S11386-WHI 2002.pdf

S11387-ESPRIT-UK DOUBLON A EFFACER .pdf

S11389-PHASE .pdf

S11390-WHISP 2006.pdf

S11391-WISDOM 2007-ISRCTN63718836.pdf

S11392-ERA (estrogen plus medroxyprogesterone) 2000-NCT00000549.pdf

S11393-WELL-HART (estrogen-progestin) 2003-NCT00000559.pdf

S11394-PARTNER 2010-NCT00530894.pdf

S11395-LANCELOT ACS .pdf

S11397-BLAST .pdf

S11398-ISAR TEST 5 -NCT00598533.pdf

S11399-CRISTAL .pdf

S11400-BIOFREEDOM -NCT01172119.pdf

S11401-EXCELLENT .pdf

S11402-Schulman (NHLBI) (estrogen-progestogen) 2002-NCT00000601.pdf

S11409-DEFINE 2010-NCT00685776.pdf

S11412-ALPHA OMEGA (EPA DHA) 2010-NCT00127452.pdf

S11413-HEBE III 2010.pdf

S11414-ALPHA OMEGA (ALA) 2010-NCT00127452.pdf

S11415-INNOVATE PCI -NCT00751231.pdf

S11416-ISAR REACT 3A 2010.pdf

S11417-J-LANCELOT 2010.pdf

S11418-ATOLL 2010.pdf

S11420-CURRENT-OASIS 7 clopidogrel PCI subgroup 2010-NCT00335452.pdf

S11421-ART 2010-ISRCTN46552265.pdf

S11449-TRITOM TIMI 38 (PCI subgroup) 2009.pdf

S11450-ISAR-TEST 4 (EES vs SES) .pdf

S11451-ESSENCE diabetes -NCT00997763.pdf

S11453-OPAL-2 -NCT00938730.pdf

S11454-phase 2 YM150 0-NCT00448214.pdf

S11455-phase 2 edoxaban 0-NCT00829933.pdf

S11456-NCT00806624 0-NCT00806624.pdf

S11458-phase 2 edoxaban 0-NCT00806624.pdf

S11459-Lip (phase 2 AZD0837) 2009-NCT00684307.pdf

S11460-phase 2 AZD0837 0-NCT00623779.pdf

S11461-phase 2 dabigatran 0-NCT01136408.pdf

S11462-ADDITION 2010-NCT00237549.pdf

S11719-CIBELES .pdf

S11720-MAR-Tyn .pdf

S11721-Rischio and Prevenzione study DOUBLON .pdf

S11739-PROTECT 2010-NCT00328692.pdf

S11740-Chicago 1982.pdf

S11741.pdf

S11742.pdf

S11743.pdf

S11744.pdf

S11745.pdf

S11746.pdf

S11747.pdf

S11748-Frankfurt 1981.pdf

S11787-Pokushalov (DOUBLON DIB) 2010.pdf

S11807-PALLAS 2011-NCT01151137.pdf

S11808-ARTEMIS AF -NCT01199081.pdf

S11811-BLOOM-DM (10mg bid) -NCT00603291.pdf

S11812-CONQUER (mid-dose) (OB 303) -NCT00553787.pdf

S11813-RAFT 2010-NCT00251251.pdf

S11816-BASKET-PROVE (SES) 2010-ISRCTN72444640.pdf

S11817-BASKET-PROVE (EES) 2010-ISRCTN72444640.pdf

S11818-Verifrenchy -NCT00753753.pdf

S11822-REVEAL -NCT00378352.pdf

S11823-REVIVAL-3 -NCT00390832.pdf

S11824-TELE-HF 2010.pdf

S11825-TIM-HF -NCT00543881.pdf

S11826-REVEAL HPS-3 TIMI-55 -NCT01252953.pdf

S11827-APPRAISE japan -NCT00852397.pdf

S11828.pdf

S11829.pdf

S11830.pdf

S11831.pdf

S11832-CLGB 9840 (Seidman) 2008.pdf

S11833.pdf

S11834.pdf

S11835.pdf

S11836.pdf

S11837.pdf

S11838.pdf

S11839-E2100 (Miller) 2007-NCT00028990.pdf

S11840-AVADO (Miles) 15mg 2009.pdf

S11841-RIBBON-I (Robert) on top capecitabine 2009.pdf

S11842-RIBBON-I (Robert) on top Tax or anthra 2009.pdf

S11843-AVF2119g (Miller) cape 2005.pdf

S11844-Burstein 2005.pdf

S11845-GeparQuattro 2010-NCT00288002.pdf

S11846-Mavroudis 2010.pdf

S11847-Joensuu 2009-NCT00114816.pdf

S11848-Muss 2009-NCT00024102.pdf

S11849-Reed 2009.pdf

S11850-GeparTrio 2008.pdf

S11851-EORTC 10001 (Pajk) 2008.pdf

S11852-Lee 2008.pdf

S11853-Verma 2005.pdf

S11854-GEPARTRIO pilot 2005.pdf

S11855-Miles 2004.pdf

S11856-O'Shaughnessy 2002.pdf

S11857-Talbot 2002.pdf

S11858-Oshaughnessy 2001.pdf

S11859-Hori 0.pdf

S11860-Moiseenko 2000.pdf

S11861-Sparano 2010.pdf

S11865-Thomas 2007.pdf

S11870-STARS J-V 0-NCT01181167.pdf

S11871-GetGoal-M-As 0-NCT01169779.pdf

S11872-ELIXA (EFC11319) 0-NCT01147250.pdf

S11873-GetGoal Duo1 0-NCT00975286.pdf

S11874-EFC10780 2010-NCT00976937.pdf

S11876-RESTORE 0-NCT00931372.pdf

S11877-PDY10931 0-NCT01175473.pdf

S11878-BP21844 0-NCT00811460.pdf

S11879-BC21893 0-NCT00909597.pdf

S11880-NC25113 0-NCT01018173.pdf

S11881-BC21625 0-NCT00717457.pdf

S11882-BC22092 0-NCT00823992.pdf

S11883-BC20750 0-NCT00744926.pdf

S11884-BC21713 (vs placebo) 0-NCT00754988.pdf

S11885-BC20963 0-NCT00744367.pdf

S11886-ZC22565 0-NCT01051011.pdf

S11887-BC20965 0-NCT00755287.pdf

S11888-LEAD-6 2009-NCT00518882.pdf

S11889-SU.FOL.OM3 2010-ISRCTN41926726.pdf

S11893-Poizot-Martin .pdf

S11894-Moulin 2006.pdf

S11895-DelPrato 2003.pdf

S11896-Roger .pdf

S11897-Leutenegger 1998.pdf

S11898-Pontiroli 1996.pdf

S11899-Stucci .pdf

S11900-Velussi 1996.pdf

S11901-Cavallo-Perin 1991.pdf

S11902-Ranquin 1987.pdf

S11923-CERTIFY 2010.pdf

S11926-phase II (Perez) 0.pdf

S11927-Roché 2007.pdf

S11928-Thomas phase 2 .pdf

S11929-Denduluri .pdf

S11930-Low .pdf

S11931-Denduluri .pdf

S11951-phase 2 (O'Shaughnessy) 2010-NCT00540358.pdf

S11952-APROPOS à effacer 0.pdf

S11962-Rosenstock 1993.pdf

S11963-Birkeland 1994.pdf

S11964-Draeger 1996.pdf

S11965-Dills 1996.pdf

S11966-Inukai 2005.pdf

S11967-Horton 2000.pdf

S11968-Hanefeld 1990.pdf

S11969-Saloranta 2002.pdf

S11970-Mari 2005.pdf

S11971-Goldberg 1998.pdf

S11972-Jovanovic 2000.pdf

S11973-Bech 2003.pdf

S11974-Moses 2001.pdf

S11975-Garber 2002.pdf

S11976-Birkeland 1994.pdf

S11977-Simonson 1997.pdf

S11978-Vray 1995.pdf

S11979-Testa 1998.pdf

S11980-Cefalu 1998.pdf

S11981-Study 201 (Goldberg) 1996.pdf

S11982-Schade 1998.pdf

S11983-Rosenstock 1996.pdf

S11984-Luis Bautista 2003.pdf

S11986-Garber 2002.pdf

S11987-Charpentier 2001.pdf

S11988-Willms 1999.pdf

S11989-Manzella 2004.pdf

S11990-Del Prato 2003.pdf

S11991-Grant 1996.pdf

S11992-Schneider 1991.pdf

S11993-Garber 1997.pdf

S11994-Lee 1998.pdf

S11995-Dornan 1991.pdf

S11996-Hermann 1991.pdf

S11997-Hermann 1994.pdf

S11998-DeFronzo 1995.pdf

S11999-Erle 1999.pdf

S12000-Charpentier 2001.pdf

S12001-Garber 2002.pdf

S12002-Marre (ass) 2002.pdf

S12003-Blonde 2002.pdf

S12004-Goldstein .pdf

S12005-Tosi 2003.pdf

S12006-Garber 2003.pdf

S12007-Marre (ass) (ass vs glyburide) 2002.pdf

S12008-Blonde (vs metformin) 2002.pdf

S12009-Garber 2003.pdf

S12010-Bolinder 2012-NCT00855166.pdf

S12011-Ferrannini (MB102013) 2010-NCT00528372.pdf

S12012-Wilding (MB102009) 2009-NCT00357370.pdf

S12013-add on to Glimepiride .pdf

S12014-Nauck (vs glipizide) -NCT00660907.pdf

S12015-Phase 2b dose-ranging study .pdf

S12016-Taskinen 0-NCT00601250.pdf

S12017-Lewin 2010-NCT00819091.pdf

S12018-Owens 0-NCT00602472.pdf

S12019-Del Prato 0-NCT00621140.pdf

S12048-TRA-2P TIMI 50 2012-NCT00526474.pdf

S12051-Buse 2011-NCT00765817.pdf

S12052-CAROLINA 2012-NCT01243424.pdf

S12053-linagliptine 1218.52 0-NCT00915772.pdf

S12054-linagliptin 1218.61 0-NCT00996658.pdf

S12055-linagliptin 1218.65 0-NCT01215097.pdf

S12056-linagliptin 1218.62 0-NCT01012037.pdf

S12057-linagliptine 1218.50 0-NCT00740051.pdf

S12059-A EFFACER 0-NCT00309608.pdf

S12060-linagliptin1218.5 0-NCT00328172.pdf

S12062-Gallwitz 2012-NCT00622284.pdf

S12063-linagliptin 1264.3 0-NCT01183013.pdf

S12065-linagliptin 1218.46 0-NCT00798161.pdf

S12066-CoreValve US pivotal trial -NCT01240902.pdf

S12067-PARTNER cohort A 2011-NCT00530894.pdf

S12068-Protocol 311 .pdf

S12069-Clark (301) 1997.pdf

S12070-Kaneko 1993.pdf

S12071-Study 202 .pdf

S12072-Sonnenberg 1997.pdf

S12073-Charpentier (301F) .pdf

S12074-Riddle 1994.pdf

S12075-Labor 1990.pdf

S12076-Nagi 1993.pdf

S12077-Johnson 1993.pdf

S12078-Tessari 1994.pdf

S12079-Grant 1996.pdf

S12080-Rains 1988.pdf

S12081-Collier 1989.pdf

S12082-Josephkutty 1990.pdf

S12083-Hermann 1991.pdf

S12084-Noury 1991.pdf

S12085-Boyd 1992.pdf

S12086-Hermann 1994.pdf

S12087-Campbell 1994.pdf

S12088-Chuang 1999.pdf

S12089-RE-COVER II 2011-NCT00680186.pdf

S12090-RE-MEDY 2011-NCT00329238.pdf

S12091-RE-SONATE 2011-NCT00558259.pdf

S12092-Edoxaban Hokusai VTE 2013-NCT00986154.pdf

S12093-RELY - ABLE -NCT00808067.pdf

S12094-Landgraf 1999.pdf

S12095-Marbury 1999.pdf

S12096-Wolffenbuttel 1999.pdf

S12097-Madsbad 2001.pdf

S12098-Raskin 2000.pdf

S12099-Raskin 2001.pdf

S12100-Raskin 2001.pdf

S12101-Landin-Olsson 1999.pdf

S12102-Goldberg 1998.pdf

S12103-Jovanovic 2000.pdf

S12104-Gao 0-NCT00461617.pdf

S12105-Kaku 2009.pdf

S12106-Kumashiro 2007.pdf

S12146-AVADO (Miles) all group together 2010.pdf

S12147-RIBBON-2 (Brufsky) 2009.pdf

S12240-ROCKET J -NCT00494871.pdf

S12241-GetGoal-X 0-NCT00707031.pdf

S12263-Blum 1999.pdf

S12264-Jones 1995.pdf

S12265-Stewart 1997.pdf

S12266-Namer 2001.pdf

S12267-French Epirubicin Study 1988.pdf

S12268-Italian Study 1988.pdf

S12269-EORTC 10808 (Engelsman) 1991.pdf

S12270-Smalley 1983.pdf

S12271-ECOG E3186 (Sledge) 2000.pdf

S12272-Ross A EFFACER 1985.pdf

S12299-Nicholls 2011-NCT01058018.pdf

S12301-NORDIET .pdf

S12303-Van Gogh (subgroup) 2011.pdf

S12304-Jost 2010.pdf

S12305-Baker 2008.pdf

S12306-Jacobs 2005.pdf

S12307-Wik 2003.pdf

S12309-Lead-3 (Bode) A EFFACER 2010.pdf

S12310-Hermansen (LEAD 2) A EFFACER 2010.pdf

S12311-LEAD-6 ext (Buse) 2010-NCT00518882.pdf

S12312-Seino 2010-NCT00393718.pdf

S12314-Astrup 2009-NCT00422058.pdf

S12315-Chatterjee 2009.pdf

S12316-Nauck ANALYSE CONJOINTE 2009.pdf

S12318-Irie 2008.pdf

S12321-Vilsbøll Wolpert DOUBLONS A EFFACER 2007-NCT00154401.pdf

S12322-Nauck (LI+MET vs MET) 2006.pdf

S12323-Harder 2004.pdf

S12324-Degn 2004.pdf

S12325-Nauck (LI vs MET) 2006.pdf

S12326-LEAD 3 extension 0-NCT00853359.pdf

S12327-H8O-MC-GWDE 0-NCT01029886.pdf

S12328-HARMONY 7 (114179) 0-NCT01128894.pdf

S12329-NN2211-3533 0-NCT00761540.pdf

S12330-LIBRA 0-NCT01270789.pdf

S12331-NN2211-1800 0-NCT00943501.pdf

S12334-EAGLE 0-NCT01117350.pdf

S12335-NCT00978393 0-NCT00978393.pdf

S12336-LEAD-2 (vs MET) A VERIFIER 2009-NCT00318461.pdf

S12337-NN2211-1571 (Vilsbøll) 2007-NCT00154401.pdf

S12339-NN2211-1799 0-NCT00620282.pdf

S12340-NN2211-1796 0-NCT00614120.pdf

S12341-NN2211-1701 0-NCT00395746.pdf

S12342-NCT01234649 0-NCT01234649.pdf

S12343-NN2211-3534 0-NCT00993304.pdf

S12344-NN2211-3619 0-NCT01206101.pdf

S12345-NN8022-1923 0-NCT00781937.pdf

S12346-NN8022-1922 0-NCT01272232.pdf

S12347-MK-0431-403 0-NCT01296412.pdf

S12388-Gao 2009-NCT00324363.pdf

S12419-Ogihara 2010-NCT00151229.pdf

S12420-CASE-J 2008.pdf

S12433-TAC-HFT 2014-NCT00768066.pdf

S12434-EMMA 1998.pdf

S12435-SNRASCG 1998.pdf

S12436-DRASTIC 2000.pdf

S12437-ASTRAL 2009.pdf

S12438-STAR 2009.pdf

S12439-NITER 2009.pdf

S12472-PROTECT 2011-NCT00182143.pdf

S12473-STARS E-3 0-NCT01181102.pdf

S12474-Takeshi Fuji 0-NCT01203098.pdf

S12475-DU176b-B-J302 0-NCT01181102.pdf

S12476-DU176b-B-J303 0-NCT01181141.pdf

S12477-DU176b-B-J304 0-NCT01181167.pdf

S12478-DU176b-04 0-NCT01203072.pdf

S12484-DECLARE-LONG II 2011.pdf

S12486-STICH (vs med) 2011-NCT00023595.pdf

S12487-PRECOMBAT 2011-NCT00422968.pdf

S12488-ISAR-CABG 2011-NCT00611910.pdf

S12489-OSCAR 2011-NCT00134160.pdf

S12490-NAGOYA HEART -NCT00129233.pdf

S12491-EXCELLENT 2011-NCT00698607.pdf

S12492-Camporese = KANT DOUBLON 2008.pdf

S12493-Marlovits 2007.pdf

S12505-NAGOYA HEART 2011-NCT00129233.pdf

S12507-SEASIDE -NCT00963781.pdf

S12508-FINESSE .pdf

S12509-Brieger .pdf

S12510-ARMYDA BIVALVE .pdf

S12511-DEDICA .pdf

S12543-IMPACT-DCM 2014-NCT00765518.pdf

S12544-ANCHOR .pdf

S12545-MARINE -NCT01047683.pdf

S12575-ALPINE 2003.pdf

S12576-DETAIL 2004.pdf

S12577-E-COST 2005.pdf

S12578-E-COST-R 2005.pdf

S12579-HIJ-CREATE 2009.pdf

S12580-IRMA 2 2001.pdf

S12581-JIKEI 2007.pdf

S12582-Suzuki 2008.pdf

S12583-Takahashi 2006.pdf

S12593-Pratley 1.8mg 2010-NCT00700817.pdf

S12624-LEAD-3 mono 1.8mg (Garber) 2009-NCT00294723.pdf

S12625-LEAD-4 (1.8mg) 2009-NCT00333151.pdf

S12626-LEAD-1 SU (1.8 mg vs placebo) 2009-NCT00318422.pdf

S12627-LEAD-1 SU (1.8 vs rosiglitazone) 2009-NCT00318422.pdf

S12628-LEAD-2 (Nauck) (1.8 mg vs glimepiride) 2009-NCT00318461.pdf

S12629-LEAD-2 (Nauck) (1.8mg vs placebo) 2009-NCT00318461.pdf

S12630-BASE-ACS .pdf

S12631-XAMI .pdf

S12632-RECLOSE 2 ACS A EFFACER -NCT01231035.pdf

S12645-R --- 2010.pdf

S12646-SIRTAX-LATE .pdf

S12648-AVADO (Miles) 7.5mg 2010.pdf

S12684-Chang 2006.pdf

S12685-HPT 1990.pdf

S12686-Morgan 1978.pdf

S12687-Paterna 2008.pdf

S12688-TOHP I 1992.pdf

S12689-TOHP II 1997.pdf

S12690-TONE 1998.pdf

S12692-CHIBA .pdf

S12708-Alli 1992.pdf

S12709-Arroll 1995.pdf

S12710-Costa 1981.pdf

S12711-Morgan DOUBLON A EFFACER 1978.pdf

S12712-Morgan 1987.pdf

S12713-Silman 1993.pdf

S12714-TOHP I DOUBLON A EFFACER .pdf

S12715-TOHP II DOUBLON A EFFACER .pdf

S12716-TONE DOUBLON A EFFACER .pdf

S12717-Thaler 1982.pdf

S12718-Thaler women A EFFACER 1982.pdf

S12768-HOME 2009-NCT00375388.pdf

S12769-OTPE (Aujesky) 2011-NCT00425542.pdf

S12770-Otero 2010-NCT00214929.pdf

S12771-ATLANTIS 2000.pdf

S12772-ADVANCE 2007-NCT00145925.pdf

S12773-DETAIL 2004.pdf

S12774-ABCD normotensives 1993.pdf

S12775-DIABHYCAR 2004.pdf

S12776-ACTION 1998.pdf

S12777-EUROPA (PERSUADE substudy) 2005.pdf

S12778-MERIT-HF 2005.pdf

S12779-ASCOT (subgroup) 2008.pdf

S12780-INVEST (subgroup) 2003.pdf

S12781-MOSES 2006.pdf

S12782-PROFESS 2008.pdf

S12783-DREAM 2008.pdf

S12784-SOLVD (subgroup) 1996.pdf

S12785-CAPPP (subgroup) 2001.pdf

S12786-GEMINI 2004.pdf

S12787-Zhang 2010.pdf

S12788-Komoroski (MB102007) 2009-NCT00162305.pdf

S12789-List (MB102008) 2009-NCT00263276.pdf

S12790-ISCHEMIA .pdf

S12791-KOhan 0-NCT00736879.pdf

S12792-Wilding 2012-NCT00673231.pdf

S12793-Nauck 2011-NCT00660907.pdf

S12794-Kohan 0-NCT00663260.pdf

S12795-Kohan 0-NCT00643851.pdf

S12796-Strojek 2011-NCT00680745.pdf

S12797-MB102022 A EFFACER DOUBLON 0-NCT00660907.pdf

S12798-Rosenstock 2012-NCT00683878.pdf

S12799-MB102034 2016-NCT00859898.pdf

S12829-dal-VESSEL 2011.pdf

S12830-dal-OUTCOMES 2012-NCT00658515.pdf

S12831-Dargie 2007.pdf

S12845-Ruby-1 2011-NCT00994292.pdf

S12853-RESET 2011-NCT01035450.pdf

S12854-PRODIGY -NCT00611286.pdf

S12855-PRODIGY 2011.pdf

S12856-PRODIGY 2011-NCT00611286.pdf

S12857-REAL-LATE, ZEST-LATE 2010-NCT00484926.pdf

S12858-UGDP (Tolb or Phen) 1975.pdf

S12859-UGDP (insulin) 1982.pdf

S12860-Nishio 2006.pdf

S12861-Takagi 2003.pdf

S12862-Giles 2008-NCT00521820.pdf

S12864-SAMMPRIS 2011-NCT00576693.pdf

S12865- ROCKET (2nd prevention subgroup) 2011.pdf

S12908-Kohan -NCT00972244.pdf

S12909-D1690C00005 A EFFACEr DOUBLON -NCT00680745.pdf

S12910.pdf

S12951-UGDP phenformin 1975.pdf

S12952-UGDP tolbutamide 1975.pdf

S12953-UKPDS 33+34 1998.pdf

S12954-PERISCOPE 2008-NCT00225277.pdf

S12979-ADOPT 2006-NCT00279045.pdf

S12980-TWENTE 2012-NCT01066650.pdf

S12981-ATLAS ACS 2 - TIMI 51 (5mg) 2011-NCT00809965.pdf

S13072-BOLERO-2 2011-NCT00863655.pdf

S13115-LIFENOX 2011-NCT00622648.pdf

S13124.pdf

S13125-Di Leo 2008-NCT00075270.pdf

S13126.pdf

S13127.pdf

S13128-EGF104353 .pdf

S13129.pdf

S13130-EGF20002 -NCT00044330.pdf

S13131-EGF20008 -NCT00062686.pdf

S13132-EGF104900 DOUBLON .pdf

S13133-EGF104900 -NCT00320385.pdf

S13134-NCI-CTEP 6969 .pdf

S13135-EGF103900 .pdf

S13136-EGF102580 -NCT00111787.pdf

S13137-TEACH -NCT00374322.pdf

S13138-ALTTO -NCT00490139.pdf

S13178-TRA 2P TIMI 50 -NCT00526474.pdf

S13193-CASSIOPEA 2012-NCT00345618.pdf

S13247-TRA-2P TIMI 50 (no prior stroke sub group) 2012.pdf

S13248-TRA-2P TIMI 50 (MI subgroup) 2012-NCT00526474.pdf

S13249-FOCUS-CCTRN 2012-NCT00824005.pdf

S13250-FOCUS-HF 2011-NCT00203203..pdf

S13251-RESET -NCT01145079.pdf

S13277-MOPETT 2012.pdf

S13278-PEITHO -NCT00639743.pdf

S13295-CLEOPATRA 2012-NCT00567190.pdf

S13296-ATLAS ACS-TIMI 46 (5mg) 2009-NCT00402597.pdf

S13297-ATLAS ACS-TIMI 46 (2.5mg) 2009-NCT00402597.pdf

S13298-ESTEEM 2003.pdf

S13299-ARBITER-3 2006.pdf

S13300-Nielsen 2011.pdf

S13301-Brufsky 2011.pdf

S13302-Seidman 2011.pdf

S13303-Papadimitriou 2009.pdf

S13304-Chan 2009.pdf

S13305-Albain 2008.pdf

S13306-Martín 2007.pdf

S13307-Feher 2005.pdf

S13312-ESH-CHL-SHOT -NCT01563731.pdf

S13315-MB102035 -NCT00976495.pdf

S13316-MB102061 -NCT00984867.pdf

S13317-Cefalu 2015-NCT01031680.pdf

S13318-Leiter 2016-NCT01042977.pdf

S13319-MB102073 -NCT01137474.pdf

S13320-Weber -NCT01195662.pdf

S13321-Schumm-Draeger 2015-NCT01217892.pdf

S13322-FAME II 2012-NCT01132495.pdf

S13325-WARFASA 2012-NCT00222677.pdf

S13326-neoSphere (Group B) 2012-NCT00545688.pdf

S13327-Phase 2 2010.pdf

S13328-TRYPHAENA .pdf

S13329-APHINITY (BIG 04-11) -NCT01358877.pdf

S13330-BO25126 A EFFACER 0-NCT01358877.pdf

S13331-PHEREXA 0-NCT01026142.pdf

S13332-MO27775 0-NCT01491737.pdf

S13333-TRYPHAENA 2013-NCT00976989.pdf

S13336-SAVE-HIP1 2012-NCT00697099.pdf

S13337-SAVE-KNEE 2012-NCT00718224.pdf

S13338-SAVE-HIP 2 2012-NCT00721760.pdf

S13354-Forst 2010-NCT00309608.pdf

S13389-UGDP .pdf

S13390-UKPDS 33 .pdf

S13440-BC22140 0-NCT01042769.pdf

S13441-BC20265 0-NCT00461058.pdf

S13442-SYNCHRONY 2009-NCT00388518.pdf

S13443-Rubin 2009.pdf

S13444-Rubin 2009-NCT00162175.pdf

S13445-Rubin 2008-NCT00095030.pdf

S13446-Ratner 2007.pdf

S13447-Göke 2007.pdf

S13448-Wilding 2007.pdf

S13449-Bays 2007.pdf

S13450-Goldstein 2006-NCT00280865.pdf

S13451-Kendall 2006.pdf

S13452-Buse 2005.pdf

S13453-GALLANT 9 -NCT00242372.pdf

S13454-GALLANT 7 -NCT00251940.pdf

S13455-GALLANT 8 -NCT00251953.pdf

S13456-GALLANT 6 -NCT00214565.pdf

S13457-D6160C00028 -NCT00255541.pdf

S13458-D6160C00026 -NCT00252772.pdf

S13459-GALLANT 14 -NCT00261352.pdf

S13460-D6160C00055 -NCT00252837.pdf

S13461-D6160C00040 -NCT00229684.pdf

S13462-D6160C00029 0-NCT00214591.pdf

S13467-APD356-004 2009.pdf

S13499-CONQUER (high-dose) (OB 303) 0-NCT00553787.pdf

S13500-OB 302 (high-dose) 0.pdf

S13501-OB 301 (high-dose) 0.pdf

S13535-Diamicron MR Study 2000.pdf

S13562-ADOPT 2010.pdf

S13563-Chien 2007.pdf

S13565-Garber (ass vs MET) 2003.pdf

S13566-Chien (ass) 2007.pdf

S1357-Kassis 1990.pdf

S1358-Littler 1995.pdf

S1359-DiDi 1996.pdf

S1360-V-HeFT III 1997.pdf

S1361-PRAISE 1998.pdf

S1362-Liao 1998.pdf

S1363-MACH-1 2000.pdf

S1364-PRAISE II 2000.pdf

S1365- 0.pdf

S13767-TRA 2P TIMI 50 (MI subgroup) DOUBLON 2012-NCT00526474.pdf

S13768-IABP SHOCK II 2012-NCT00491036.pdf

S13770-GRACE - ORIGIN (glargine) 2012.pdf

S13771-GRACE - ORIGIN (n-3 fatty acid) .pdf

S13773-WOEST -NCT00769938.pdf

S13856-ADAPT DES -NCT00638794.pdf

S13861-ASPIRE 2012-ACTRN12605000004662.pdf

S13862-SCIPIO 2011-NCT00474461.pdf

S13863-CARRESS-HF .pdf

S13867-POSEIDON 2012-NCT01087996.pdf

S13954-CHAMPION PHOENIX 2013-NCT01156571.pdf

S14054-GLOBAL LEADERS .pdf

S14073-TROPHI .pdf

S14074-MUSTELLA .pdf

S14132-Bonneterre 2000.pdf

S14194-PREDIMED (olive oil) 2013-ISRCTN35739639.pdf

S14195-PREDIMED (nuts) 2013-ISRCTN35739639.pdf

S14196-BARON .pdf

S14197-HPT .pdf

S14198-Kumanyika .pdf

S14199-TAIM .pdf

S14200-DISH .pdf

S14278-Goldenberg 1975.pdf

S14279-Clavel 1982.pdf

S1428-Barbizza 1993.pdf

S1429- 0.pdf

S1430-WASH 1999.pdf

S1431-Mortalité 0.pdf

S1432-IDM 0.pdf

S1433-AVC 0.pdf

S1434-Hémorragie majeure 0.pdf

S1435-Hospitalisations 0.pdf

S14360-NCIC-IND163 2009.pdf

S14361-Baselga 2009.pdf

S14486-Risk and Prevention Study 2013-NCT00317707.).pdf

S14762-CANTATA-D 0-NCT01106677.pdf

S14763.pdf

S14764.pdf

S14765.pdf

S14766.pdf

S14767.pdf

S14768.pdf

S14769.pdf

S15343-ALECARDIO -NCT01042769.pdf

S15344-ALEPREVENT -EUDRACT201200067116.pdf

S15356-TASTE (Fröbert) 2013-NCT01093404.pdf

S15360-PIOcard -NCT00479986.pdf

S15361-DECLARE TIMI 58 -NCT01730534.pdf

S15362-EXSCEL -NCT01144338.pdf

S15364-CARMELINA -NCT01897532.pdf

S15365-TECOS 2015-NCT00790205.pdf

S15366-CANVAS -NCT01032629.pdf

S15367-NCT01018173 -NCT01018173.pdf

S15371-EMPA-REG MONO DOUBLON -NCT01177813.pdf

S15382-AMPLIFY-EXT 5mg 2012-NCT00633893.pdf

S1542-ASCOT (diabetics sub group) 2003.pdf

S15423-STABILITY -NCT00799903.pdf

S15424-IBIS .pdf

S15425-VISTA-16 -NCT01130246.pdf

S15426-SOLID-TIMI 52 2014-NCT01000727.pdf

S1543-HPS (sub group) 2002.pdf

S1544-PROSPER (sub group) 2002.pdf

S1545-LIPID (sub group) 1998.pdf

S1546-CARE (sub group) 1998.pdf

S15464-Guan -NCT00281658..pdf

S1547-WOSCOPS (sub group) 1996.pdf

S15470-RELAX-AHF 2013-NCT00520806.pdf

S15473-ALECARDIO 2014-NCT01042769.pdf

S1548-4S (sub group) 1999.pdf

S15486-ODYSSEY Long-Term 2015-NCT01507831.pdf

S15487-ODYSSEY Alternative -NCT01709513.pdf

S15488-CHOICE II -NCT02023879.pdf

S15489- CHOICE I -NCT01926782.pdf

S15490-ODYSSEY OUTCOMES -NCT01663402.pdf

S15491-ODYSSEY MONO -NCT01644474.pdf

S15492-ODYSSEY FH 1 -NCT01623115.pdf

S15493-ODYSSEY FH 2 -NCT01709500.pdf

S15494-ODYSSEY HIGH FH -NCT01617655.pdf

S15495-ODYSSEY OPTIONS I .pdf

S15496-ODYSSEY OPTIONS II .pdf

S15497-ODYSSEY COMBO -NCT01644175.pdf

S15498-ODYSSEY COMBO II -NCT01644188.pdf

S15499-NCT01288469 -NCT01288469.pdf

S15500-MENDEl 2 -NCT01763827.pdf

S15501-DESCARTES 2014-NCT01516879.pdf

S15509-PARADIGM-HF 2014-NCT01035255.pdf

S15511-SIGNIFY 2014-ISRCTN61576291.pdf

S15515-TH3RESA 2014-NCT01419197.pdf

S15535-Socinski .pdf

S15536-Giaccone .pdf

S15537-Gatzemeier .pdf

S15538-Rossel .pdf

S15539-Schiller .pdf

S15540-Chen 2006.pdf

S15541-Sweeney 2001.pdf

S15542-Yan 2001.pdf

S15543-PEGASUS 60mg 2015-NCT01225562.pdf

S15544-ITALIC -NCT01476020.pdf

S15545-DAPT A EFFACER .pdf

S15546-Ikeda et al. A EFFACER .pdf

S15559-Hodi 2010-NCT00094653.pdf

S15560-Robert (Ipilimumab) 2011-NCT00324155.pdf

S15561-KEYNOTE-001 2014-NCT01295827.pdf

S15562-Hamid 2013-NCT01295827.pdf

S15563-Wolchok 2013.pdf

S15564-CheckMate 067 (nivo + ipi) 2015-NCT01844505.pdf

S15566-BRIM 3 2011-NCT01006980.pdf

S15567-Larkin 2014-NCT01689519.pdf

S15568-Hauschild 2012-NCT01227889.pdf

S15569-Long 2014-NCT01584648.pdf

S15570-Flaherty 2012-NCT01072175.pdf

S15582-CheckMate 066 (Robert) 2015-NCT01721772.pdf

S15583-CheckMate 037 (Weber) 2015-NCT01721746.pdf

S15584-Falkson 1991.pdf

S15585-Falkson 1995.pdf

S15586-Falkson 1998.pdf

S15587-Gough 1978.pdf

S15588-Kongoniia 1981.pdf

S15589-Lopez 1984.pdf

S15590-Luikart 1984.pdf

S15591-Middleton 2000.pdf

S15592-Moon 1975.pdf

S15593-Ringborg 1989.pdf

S15637-ACCENTUATE 2016-NCT02227784.pdf

S15642-OSLER 1 and 2 2015-NCT01854918.pdf

S15643-Mendel 1 2012-NCT01375777.pdf

S15644-LAPLACE-TIMI 57 -NCT01380730.pdf

S15645-GAUSS 1 2012-NCT01375764.pdf

S15646-RUTHERFORD-1 -NCT01375751.pdf

S15647-YUKAWA-1 2014.pdf

S15648-LAPLACE 2 2014-NCT01763866.pdf

S15649-GAUSS 2 -NCT01763905.pdf

S1565-PQRST 1994.pdf

S15650-RUTHERFORD-2 2015-NCT01763918.pdf

S15651-THOMAS 1 -NCT01849497.pdf

S15652-THOMAS 2 -NCT01879319.pdf

S15653-SPIRE-1 0-NCT01975376.pdf

S15654-SPIRE-2 0-NCT01975389.pdf

S15655-SPIRE-SI 0-NCT02135029.pdf

S15656-SPIRE-HR 0-NCT01968954.pdf

S15657-SPIRE-LDL 0-NCT01968967.pdf

S15658-SPIRE-FH 0-NCT01968980.pdf

S15659-SPIRE-LL 0-NCT02100514.pdf

S1566-CLAS 1987-NCT00000599.pdf

S15660-VITATOPS 2010-NCT00097669.pdf

S15661-FOURIER -NCT01764633.pdf

S15662-NeoPembroMel A EFFACER 0-NCT02306850.pdf

S15663-KEYNOTE-006 (every 2W) 2015-NCT01866319.pdf

S15664-KEYNOTE-054 -NCT02362594.pdf

S15665-CheckMate 057 2015-NCT01673867.pdf

S15666-PEGASUS 90mg 2015-NCT01225562.pdf

S15668-Ciszewski 2011.pdf

S15669-Liistro 2009.pdf

S15670-INFUSE AMI 2013.pdf

S15671-Chao 2008.pdf

S15672-Lipiecki 2009.pdf

S15675-CUPID 2b 2016-NCT01643330.pdf

S15690.pdf

S15691-Keynote 042 -NCT02220894.pdf

S15692-POPLAR Phase 2 atezolizumab 2016-NCT01903993.pdf

S15693-Checkmate 063 .pdf

S15695-CheckMate 153 -NCT02066636.pdf

S15696-CheckMate 026 2016-NCT02041533.pdf

S15697-CheckMate 017 2015-NCT01642004.pdf

S15698-CheckMate 238 0-NCT02388906.pdf

S15699-Ahmad Tarhini 0-NCT01274338.pdf

S15700-CA184-169 0-NCT01515189.pdf

S15701-EORTC Melanoma Group 0-NCT00636168.pdf

S15709.pdf

S15710-REALIZE 2015-NCT01524289.pdf

S15711-ELOQUENT 2 2015-NCT01239797.pdf

S15712-ENDEAVOR 0-NCT01568866.pdf

S15713-ARROW -NCT02412878.pdf

S15714-ASPIRE study 009 DOUBLON -NCT01080391.pdf

S15715-FOCUS -NCT01302392.pdf

S15716-CLARION -NCT01818752.pdf

S15717-NCT01863550 -NCT01863550.pdf

S15718-GIMEMA -NCT00232934.pdf

S15719-HOVON 49 -ISRCTN90692740 .pdf

S15720-NMSG .pdf

S15721-TMSG -NCT00934154 .pdf

S15722.pdf

S15723.pdf

S15724-NCT01274403 -NCT01274403.pdf

S15725-VISTA -NCT00111319 .pdf

S15726-FIRST -NCT00689936 .pdf

S15727-MM-015 -NCT00405756 .pdf

S15728-MRC Myeloma IX -ISRCTN68454111 .pdf

S15729-NR 1997 .pdf

S15730-NR 2010 .pdf

S15731-NCT00911859 -NCT00911859 .pdf

S15732-EIA06 (NCT00602641) 0-NCT00602641.pdf

S15733-NR 2013 .pdf

S15737-NALA 0-NCT01808573.pdf

S15738-ExteNET 0-NCT00878709.pdf

S15739-EGF104535 0-NCT00281658.pdf

S15740-EGF105485 0-NCT00374322.pdf

S15741-Lisa Carey 0-NCT00770809.pdf

S15742-NCI-2009-00475 0-NCT00390455.pdf

S15743-NSABP B-41 0-NCT00486668.pdf

S15744-100151 0-NCT00078572.pdf

S15745-ICORG 11-10 0-NCT01526369.pdf

S15746-DETECT III 0-NCT01619111.pdf

S15747-111438 0-NCT00820222.pdf

S15748-112515 0-NCT00968968.pdf

S15749-114299 0-NCT01160211.pdf

S15750-114299 0-NCT01160211.pdf

S15751-NCT01160211 0-NCT01160211.pdf

S15752-CDR0000596572 0-NCT00688194.pdf

S15753-1200.75 0-NCT01125566.pdf

S15754-1200.32 0-NCT00949650.pdf

S15755-1200.34 0-NCT01121393.pdf

S15756-1200.42 0-NCT01085136.pdf

S15757-LUX-LUNG 1 0-NCT00656136.pdf

S15758-LUX-LUNG 8 0-NCT01523587.pdf

S15759-A011106 0-NCT01953588.pdf

S15760-EFECT (Chia) 0-NCT00065325.pdf

S15761-D6997L00021 3000-NCT01300351.pdf

S15762-CONFIRM (Di Leo) 2010-NCT00099437.pdf

S15763-Xu et al. 2011-NCT00327769.pdf

S15764-0021 (Osborne) 2002-NCT00635713.pdf

S15765.pdf

S15766-CDR0000349337 0-NCT00075764.pdf

S15767-FALCON 0-NCT01602380.pdf

S15768-DOUBLONS certainement 3000-NCT00253422.pdf

S15769-FUMANCE 0-NCT02383030.pdf

S15771.pdf

S15772.pdf

S15773-GO29058 0-NCT02340221.pdf

S15774-SOLAR-1 0-NCT02437318.pdf

S15777-MONALEESA-3 0-NCT02422615.pdf

S15787-Agawarla 1999.pdf

S15788-Ahmann 1972.pdf

S15789-Atkins 2008.pdf

S15790-Atzpodien 2002.pdf

S15791-Bedikian 2006.pdf

S15792-Carter 1976.pdf

S15793-Chiarion 2001.pdf

S15794-Constanza 1977.pdf

S15795-Dorval 1999.pdf

S15796-Eton 2002.pdf

S15797-Glover 2003.pdf

S15798-Hauschild 2009.pdf

S15799-Hill 1979.pdf

S15800-Johnston 1998.pdf

S15801-Keilholz 1997.pdf

S15802-Luikart 1984.pdf

S15803-Maio 2010.pdf

S15804-McDermott 2008.pdf

S15805-Mornex 2003.pdf

S15806-O'Day 2009.pdf

S15807-Rosenberg 1999.pdf

S15808-Rusthoven 1996.pdf

S15809-Zimpfer 2003.pdf

S15820-Postow 2015-NCT01927419.pdf

S15867-Keynote 024 2015-NCT02142738.pdf

S15868-SWOG S1404 .pdf

S15869-SWOG S1404 .pdf

S15871-E4512 0-NCT02201992.pdf

S15872-A8081029 0-NCT01639001.pdf

S15873-Shaw 2013-NCT00932893.pdf

S15874-PROFILE 1014 2014-NCT01154140.pdf

S15875-ELOQUENT - 2 0-NCT01239797.pdf

S15876-ELOQUENT - 1 0-NCT01335399.pdf

S15878-PEARL 0-NCT02028507.pdf

S15879-PALOMA-4 0-NCT02297438.pdf

S15880-PALOMA-2 0-NCT01740427.pdf

S15881-PALOMA 3 2015-NCT01942135.pdf

S15882-PENELOPE-B 0-NCT01864746.pdf

S15883-CheckMate 067 (nivo vs ipi) 2015-NCT01844505.pdf

S15884-CheckMate 067 (nivo + ipi vs nivo) 2015-NCT01844505.pdf

S15885-GO29432 0-NCT02409355.pdf

S15886-IMpower 110 0-NCT02409342.pdf

S15887-OAK 2016-NCT02008227.pdf

S15888-IMpower 150 0-NCT02366143.pdf

S15889-PACIFIC 0-NCT02125461.pdf

S15890-ARCTIC 0-NCT02352948.pdf

S15891-MYSTIC 0-NCT02453282.pdf

S15892-NCT02273375 0-NCT02273375.pdf

S15893-CAURAL 0-NCT02454933.pdf

S15894-Beelen 2014.pdf

S15895-Beex 2006.pdf

S15896-Sawka 1997.pdf

S15897-Kuss 1997.pdf

S15898-Stuart 1996.pdf

S15899-Willsher 1996.pdf

S15900-Muss 1994.pdf

S15901-Gill 1993.pdf

S15902-Castiglione-Gertsch 1993.pdf

S15903-Spooner 1991.pdf

S15904-De Lena 1990.pdf

S15905-Takatsuka 1989.pdf

S15906-Kellokumpu-Lehtinen 1987.pdf

S15907-Ettinger 1986.pdf

S15908-Gockerman 1986.pdf

S15909-Buchanan 1986.pdf

S15910-van 1986.pdf

S15911-Ingle 1986.pdf

S15912-Mauriac 1986.pdf

S15913-Viladiu 1985.pdf

S15914-Mouridsen 1985.pdf

S15915-Perry 1985.pdf

S15920-Martin (motesanib) 2011-NCT00356681.pdf

S15921-Blackwell 2010.pdf

S15922-Gasparini 2006.pdf

S15923-Huober 2012.pdf

S15924-TAnDEM (Kaufman) 2009.pdf

S15925-Marty 2005-M77001.pdf

S15926-Slamon 2001.pdf

S15927-von Minckwitz 2009.pdf

S15929-ISTANA (Lee) 2010.pdf

S15930-V-15-32 (Maruyama) 2008.pdf

S15931-INTEREST (Kim) 2008.pdf

S15932-SIGN (Cufer) 2006.pdf

S15933-IPASS .pdf

S15934-West Japan .pdf

S15935-Northeast Japan .pdf

S15936-First Signal .pdf

S15937-Kris 2003.pdf

S15938-INTACT 1. .pdf

S15939-INTACT 2 2004.pdf

S15940-CTONG0806 (Yang) 2013.pdf

S15941-NCIC CTG BR19 (Goss) 2013.pdf

S15942-NEJ002 2013.pdf

S15943-INFORM; C-TONG 0804 2012-NCT00770588.pdf

S15944.pdf

S15945-Maemondo 2010-UMIN-CTR C000000376.pdf

S15946-IFCT-0301 study (Morère) 2010.pdf

S15947-WJTOG0203 (Takeda) 2010.pdf

S15948-WJTOG3405 (Mitsudomi) 2010.pdf

S15949-IPASS (Mok) 2009-NCT00322452.pdf

S15950-Goss 2009.pdf

S15951-INVITE (Crinò) 2008-NCT00256711.pdf

S15952-SWOG S0023 (Kelly) 2008.pdf

S15953-ISEL 2006.pdf

S15954-Tsuboi 2005.pdf

S15955-LUX-LUNG 3 2015.pdf

S15956-LUX-LUNG 6 2015.pdf

S15957-ZODIAC 2014-NCT00312377.pdf

S15958-Gridelli 2014.pdf

S15959-Ahn 2013.pdf

S15960-PrE0501 2013.pdf

S15961-Leboulleux 2012.pdf

S15962-ZEPHYR 2012.pdf

S15963-Natale 2011-NCT00364351.pdf

S15964-de Boer 2011.pdf

S15965-Natale 2009.pdf

S15966-BR.20 (Arnold) 2007.pdf

S15967-Heymach 2007.pdf

S15968.pdf

S15969-0020 (Howell) 2002.pdf

S15970-FINDER 1 (Ohno) 2010.pdf

S15972-FINDER 2 2010-NCT00313170.pdf

S15973-0025 (Howell) 2004.pdf

S15974-FIRST (Robertson) 2010-NCT00274469.pdf

S15975-SoFEa (Johnston) combination 2012-NCT00253422.pdf

S15976-FACT (Bergh) 2012-NCT00256698.pdf

S15977-Mehta(SWOG-S0226) 2012-NCT00075764.pdf

S15978-Bonneterre 2000.pdf

S15982-BOLERO-3 2014-NCT01007942.pdf

S15983-HORIZON 2013-NCT00083993.pdf

S15984-BOLERO-1 -NCT00876395.pdf

S15985-ENGAGE-AF TIMI 48 Low dose 2013-NCT00781391.pdf

S15989-CECOG BM1 2005.pdf

S15990-Rugo 0.pdf

S15991-Blohmer 2010.pdf

S15992-Bonneterre 2004.pdf

S15993-HERNATA 2011.pdf

S15994-UKCCCR AB01 1997.pdf

S15995-Yardley 2009.pdf

S15996-JCOG 2005.pdf

S15997-AGO 1998.pdf

S15998-Lyman 0.pdf

S15999-TRAVIOTA 0.pdf

S16000-EU-1 2004.pdf

S16001-Meier 2008.pdf

S16003-ODYSSEY Alternative (vs atorvastatin) 0.pdf

S16004-Boccardo 1985.pdf

S16005-Abe 1995.pdf

S16006-Mouridsen 1985.pdf

S16007-Tominaga 1994.pdf

S16008-Viladiu 1985.pdf

S16009-Gundersen 1992.pdf

S16010-ANZBC 1986.pdf

S16011-Falkson 1995.pdf

S16012-Kiang 1985.pdf

S16013-CLKGB 8081 (Perry) 1987.pdf

S16014-Edimburg 1979.pdf

S16015-ECOG E3186 (Sledge) 2000.pdf

S16016-Kiang 1985.pdf

S16017-Ahmann 1982.pdf

S16018-Rossof 1982.pdf

S16019-Bezwoda 1982.pdf

S16020-ANZBC 1986.pdf

S16021-Abe 1995.pdf

S16022-Falkson 1979.pdf

S16026-Coates 1987.pdf

S16027-Harris 1990.pdf

S16028-Muss 1991.pdf

S16029-Ejlertsen 1993.pdf

S16030-Gregory 1997.pdf

S16031-Falkson 1998.pdf

S16032-French Epirubicin Study Group 2000.pdf

S16033-Nooij 2003.pdf

S16034-Gennari 2006.pdf

S16035-Mayordomo 2009.pdf

S16036-Alba 2010.pdf

S16039-RESILIENCE 2013.pdf

S16040-Schwartzberg 2013-NCT00493636.pdf

S16041-Gradishar 2013.pdf

S16042-Baselga 2012.pdf

S16043-BOLERO-4 -NCT01698918.pdf

S16044-BOLERO-6 (combination) -NCT01783444.pdf

S16045-DOUBLON TAMRAD .pdf

S16046-BELLE-2 -NCT01610284.pdf

S16047-BELLE-3 -NCT01633060.pdf

S16048-BELLE-4 -NCT01572727.pdf

S16049-B-YOND -NCT02058381.pdf

S16050-MANTA -NCT02216786.pdf

S16051-BEECH -NCT01625286.pdf

S16052-ENCORE 301 2013-NCT00676663.pdf

S16053-NCT02115282 -NCT02115282.pdf

S16054-NCT02115594 -NCT02115594.pdf

S16055-MONALEESA-2 2016-NCT01958021.pdf

S16056-MONALEESA-7 -NCT02278120.pdf

S16057-Monarch3 -NCT02246621.pdf

S16058-SOPHIA -NCT02492711.pdf

S16059-MAIN-A -NCT02511639.pdf

S16060-NCT02311933 -NCT02311933.pdf

S16061-NCT01327781 -NCT01327781.pdf

S16062-Trial 301 (Kaufman) 2015-NCT00337103.pdf

S16063-Vahdat 2013-NCT00879086.pdf

S16064-EMBRACE (Cortes) 2011-NCT00388726.pdf

S16065-A EFFACER Twelves 2010.pdf

S16066-NCT02037529 -NCT02037529.pdf

S16067-Gradishar 2009-NCT00274456.pdf

S16068-A EFFACER DOUBLONS Phase 2 Gradishar 2012.pdf

S16069-tnAcity -NCT01881230.pdf

S16070-Roy 2008-NCT00110084.pdf

S16078-Meier 2008.pdf

S16079-Martin 2007.pdf

S16080-Kim 2006.pdf

S16081-Norris 2000.pdf

S16082-Ejlertsen 2004.pdf

S16083-Pajk 2007.pdf

S16084-Venturino 2000.pdf

S16085-Frasci 2000.pdf

S16086-Verma 2007.pdf

S16087.pdf

S16088-SoFEa (Johnston) fluvestrant alone 2012-NCT00253422.pdf

S16089-BOLERO-6 (alone) 0-NCT01783444.pdf

S16116-Badwe 2015.pdf

S16117-KEYNOTE-006 (every 3W) 2015-NCT01866319.pdf

S16118-EMPA-REG OUTCOME 2015-NCT01131676.pdf

S16119-EXAMINE 2013-NCT00968708.pdf

S16120-SAVOR TIMI 2013-NCT01107886.pdf

S16121-ELIXA -NCT01147250.pdf

S16122-REWIND -NCT01394952.pdf

S16123-SPRINT 2015-NCT01206062.pdf

S16124-SUSTAIN 6 2016-NCT01720446.pdf

S16125-PROACTIVE -NCT00174993.pdf

S16126-CheckMate 025 2015-NCT01668784.pdf

S16127-METEOR 2015-NCT01865747.pdf

S16128-ASPIRE 2015-NCT01080391.pdf

S16137-AVOID HF -NCT01474200.pdf

S16138-UNLOAD .pdf

S16148-CLEOPATRA .pdf

S16152-CA204-009 0-NCT01478048.pdf

S16153-Tourmaline-MM1 0-NCT01564537.pdf

S16154-MC1181 0-NCT01415882.pdf

S16155-OlympiAD 2017-NCT02000622.pdf

S16156-NCT02163694 -NCT02163694.pdf

S16157-EMBRACA -NCT01945775.pdf

S16158-BRAVO -NCT01905592.pdf

S16161-UKPDS-HDS 1998.pdf

S16162-JATOS 2008.pdf

S16163-VANLISH 2010.pdf

S16164-HOMED-BP 2012.pdf

S16165-SPS3 2013-NCT00059306..pdf

S16166-Wei 2013.pdf

S16167-PAST-BP 2015.pdf

S16188-Keynote 001 2015.pdf

S16189-Reck 2010.pdf

S16190-Sandler 2006.pdf

S16191-Johnson 2004.pdf

S16192-Nishio 2009.pdf

S16193-Herbst 2007.pdf

S16194-Herbst 2011.pdf

S16195-Lynch 2010.pdf

S16196-FLEX (Pirker) 2009-NCT00148798.pdf

S16197-Rosell 2008.pdf

S16198-Butts 2007.pdf

S16199.pdf

S16200-EUTRAC - NCT00446225.pdf

S16201-TITAN - NCT00556322.pdf

S16202-De Boer 2011.pdf

S16203-Smit 2009.pdf

S16204-Chiappori 2010.pdf

S16205-Schiller 2010.pdf

S16206-Scagliotti 2010.pdf

S16207.pdf

S16208.pdf

S16209.pdf

S16210.pdf

S16211.pdf

S16212.pdf

S16213.pdf

S16214.pdf

S16215-Esteban 2003.pdf

S16216-Hanna 2004.pdf

S16217-TRIBUTE (Herbst) .pdf

S16218.pdf

S16219.pdf

S16220-SATURN (Cappuzzo) - NCT00556712.pdf

S16221- Boutsikou .pdf

S16222.pdf

S16223-Stinchcombe .pdf

S16224.pdf

S16225-RECORD-1 2008-NCT00410124.pdf

S16226-ARCC (Hudes) temsirolimus alone 2007-NCT00065468.pdf

S16227-Escudier 2009.pdf

S16228-Motzer 2007-NCT00083889.pdf

S16229-Sternberg 2010.pdf

S16230-AXIS (Rini) 2011-NCT00678392.pdf

S16231-TARGET 2007-NCT00073307.pdf

S16232-Ratain 2006.pdf

S16233-CheckMate 214 0-NCT02231749.pdf

S16234-TIVO-1 2013-NCT01030783.pdf

S16235-Qin 2012.pdf

S16236-Disruptor-1 .pdf

S16237-GOLD -NCT01223027.pdf

S16238-VEG105192 2010-NCT00334282.pdf

S16239-Powles 2014.pdf

S16240-Motzer 2015-NCT01136733.pdf

S16241-SWITCH -NCT00732914.pdf

S16242-RECORD 3 2014-NCT00903175.pdf

S16243-INTORSECT 2014-NCT00474786.pdf

S16244-PISCES 2014-NCT01064310.pdf

S16245-COMPARZ 2013-NCT00720941.pdf

S16246-STAR 2012-ISRCTN06473203.pdf

S16247-Motzer 2012.pdf

S16248-Castellano 2009.pdf

S16249-BEST 2015-NCT00378703.pdf

S16250-TORAVA 2011-NCT00619268.pdf

S16251-CALGB 90206 2010.pdf

S16252-AVOREN 2007.pdf

S16253-DOUBLON Escudier 2007.pdf

S16254-Yang 2003.pdf

S16293-Keynote 010 2mg 2015-NCT01905657.pdf

S16299-Keynote 010 10mg 2015-NCT01905657.pdf

S16417.pdf

S16418.pdf

S16419.pdf

S16420.pdf

S16421.pdf

S16422-Takeda .pdf

S16423.pdf

S16424.pdf

S16425.pdf

S16426.pdf

S16427-Chen 2008.pdf

S16428-Hanna 2004.pdf

S16429-Jose 2011.pdf

S16430-Li 2012.pdf

S16431-Socinski 2010.pdf

S16432-Sun 2013-NCT00391274.pdf

S16460-Scagliotti (pemetrexed vs bortezomib) 2010.pdf

S16466-1276.1 (bitherapy MET) 0-NCT01719003.pdf

S16467-1275.13 0-NCT02489968.pdf

S16468-1245.35 2015-NCT01947855.pdf

S16469-EASE-2 0-NCT02414958.pdf

S16470-1245.23 DOUBLON 0-NCT01159600.pdf

S16471-1245.22 0-NCT01984606.pdf

S16472-1275.9 0-NCT01734785.pdf

S16473-EMPA-REG OUTCOME 0-NCT01131676.pdf

S16474-Barnett 2014-NCT01164501.pdf

S16475-Tikkanen DOUBLON 2015-NCT01370005.pdf

S16476-Kovacs DOUBLON 2015-NCT01210001.pdf

S16477-Araki 2015-NCT01368081.pdf

S16478-Rosenstock (1245.49) 2014-NCT01306214.pdf

S16479-Ridderstrale 2014-NCT01167881.pdf

S16480-1245.29 0-NCT02182830.pdf

S16481-99050 0-NCT01257334.pdf

S16482-CRC2014EMPA 0-NCT02471963.pdf

S16483-1275.10 0-NCT01778049.pdf

S16484-1275.19 0-NCT02453555.pdf

S16485-DeFronzo 2015-NCT01422876.pdf

S16486-EASE-3 0-NCT02580591.pdf

S16487-1969 0-NCT02518945.pdf

S16488-DERIVE 0-NCT02413398.pdf

S16489-D1690C00017 0-NCT02725593.pdf

S16490-D1683C00005 0-NCT02681094.pdf

S16491-D1695C00001 0-NCT02582814.pdf

S16492-D5553C00003 0-NCT02229396.pdf

S16493-0431-838 0-NCT02532855.pdf

S16494-Rosenstock 2015-NCT01606007.pdf

S16495-DEPICT 1 0-NCT02268214.pdf

S16496-MB102-137 0-NCT02096705.pdf

S16497-MB102-054 0-NCT01095653.pdf

S16498-Yang 2015-NCT01095666.pdf

S16499-MB102-210 0-NCT02383238.pdf

S16500-CV181-363 0-NCT02284893.pdf

S16501-Depict 2 0-NCT02460978.pdf

S16502-Matthaei 2015-NCT01392677.pdf

S16503-DECLARE-TIMI 58 0-NCT01730534.pdf

S16504-Mathieu 2015-NCT01646320.pdf

S16505-CV181-365 0-NCT02419612.pdf

S16506-Kaku 2014-NCT01294423.pdf

S16507-NCT02592421 0-NCT02592421.pdf

S16508-CV181-369 0-NCT02551874.pdf

S16509-D1693C00002 0-NCT01257412.pdf

S16510-DAPA-GDM 0-NCT02338193.pdf

S16511-CV181-168 0-NCT01619059.pdf

S16512-D1690C00023 0-NCT02547935.pdf

S16513-EMPA-REG MONO DOUBLON 3000-NCT01177813.pdf

S16514-Lewin 2015-NCT01422876.pdf

S16515-Ferrannini 2013-NCT00789035.pdf

S16516-Haring DOUBLON 2013-NCT01159600.pdf

S16517-Kadowaki 2013.pdf

S16518-EMPA-REG PIO (Kovacs) 2013-NCT01210001.pdf

S16519-EMPA-REG MONO (Roden) vs placebo 2013-NCT01177813.pdf

S16520-Rosenstock 2013-NCT00749190 .pdf

S16521.pdf

S16522-Tikkanen 2013.pdf

S16523-Kadowaki 2015-NCT01193218.pdf

S16524-Ross 2015-e2012-000905-53.pdf

S16525-Kadowaki 2014.pdf

S16526-EMPA-REG MET (Haring) 2014-NCT01159600.pdf

S16527-Ferrannini 2013-NCT00881530.pdf

S16528-1276.1 (monotherapy) 0-NCT01719003.pdf

S16529-EMPA-REG MONO (Roden) vs sitagliptin 2013-NCT01177813.pdf

S16531-E7389-C086-304 0-NCT02225470.pdf

S16532-SCRI BRE 197 0-NCT01527487.pdf

S16533-2014-0857 0-NCT02263495.pdf

S16534-Cortes 2010.pdf

S16536-IRIS 2016-NCT00091949.pdf

S16540-HOPE 3 2016-NCT00468923.pdf

S16545-ALLIANCE 2004.pdf

S16546-Vascular basis 2005.pdf

S16547-SQUIRE -NCT00981058.pdf

S16548-INSPIRE -NCT00982111.pdf

S16549-INSPIRE -NCT00982111.pdf

S16550-APEX 2016-NCT01583218.pdf

S16551- .pdf

S16552- .pdf

S16553- .pdf

S16565-RELAX REPEAT -NCT01982292.pdf

S16566-RELAX-AHF-2 -NCT01870778.pdf

S16567-VERITAS 1 0-NCT00525707.pdf

S16568-VERITAS 2 0-NCT00524433.pdf

S16569-COMPOSE EARLY 0-NCT01064037.pdf

S16570-COMPOSE 1 0-NCT01065077.pdf

S16571-COMPOSE 2 0-NCT01067859.pdf

S16572-NCT00559650 0-NCT00559650.pdf

S16573-REACH UP 0-NCT00443690.pdf

S16574-PROTECT-2 0-NCT00354458.pdf

S16575-PROTECT-1 0-NCT00328692.pdf

S16576-7418-503 0-NCT00729222.pdf

S16577-CKI-203 0-NCT00159614.pdf

S16578-2007_806 0-NCT00652782.pdf

S16579-Debio 0614-202 0-NCT00838253.pdf

S16580-HORIZON-HF 0-NCT00616161.pdf

S16581-CVie2015002 0-NCT02617446.pdf

S16582-BALANCE 0-NCT00578695.pdf

S16583-TRUE-AHF 0-NCT01661634.pdf

S16584-Mitrovic 2005.pdf

S16585-Mitrovic 2006.pdf

S16586-CONVERT-H 0-NCT00843986.pdf

S16587-087-CL-071 0-NCT00057356.pdf

S16588-BLAST-AHF 0-NCT01966601.pdf

S16589-Reno-Defend 1 0-NCT00744341.pdf

S16590-S320.2.002 0-NCT00160134.pdf

S16591-TRIDENT-1 0-NCT00709865.pdf

S16592-POSEIDON 0-NCT00745316.pdf

S16593-05-025 0-NCT00283361.pdf

S16594-PARSiFAL 0-NCT02040233.pdf

S16595-PRONTO 0-NCT00803634.pdf

S16598-ixCELL-DCM 2016-NCT01670981.pdf

S16599-CAuSMIC 2005.pdf

S16600-SEISMIC 2011.pdf

S16601-MAGIC 2001.pdf

S16602-MARVEL 2011-NCT00526253 .pdf

S16603-Catheter-DCM 2014-NCT01020968.pdf

S16604.pdf

S16605-ESCAPE 0-NCT00841958.pdf

S16606.pdf

S16607-REMEDIUM 0-NCT02248532.pdf

S16608-BC-14-001-02 0-NCT02438306.pdf

S16609-CHART-1 0-NCT01768702.pdf

S16610-C CURE 2013-NCT00810238.pdf

S16611-TOPCARE-CHD 2006- NCT00289822.pdf

S16612-Hendrikx 2006.pdf

S16613-Yao 2008.pdf

S16614-Ang 2008.pdf

S16615-Patel 2005.pdf

S16616-Manginas 2007.pdf

S16617-Vrtovec 2011-NCT00629018.pdf

S16618-Vrtovec 2013-NCT01350310.pdf

S16619-Perin 2012.pdf

S16620-CADUCEUS 2012-NCT00893360.pdf

S16640-Checkmate 032 -NCT01928394.pdf

S16652-NEPTUNE -NCT02542293.pdf

S16653-JAVELIN Lung 200 -NCT02395172.pdf

S16654-JAVELIN Lung 100 -NCT02576574.pdf

S16655-AURA 3 -NCT02151981.pdf

S16656-WJOG 5108L .pdf

S16680-NCT01082068 -NCT01082068.pdf

S16681-NCT01437566 -NCT01437566.pdf

S16682-NCT01277757 -NCT01277757.pdf

S16683-NCT02049957 -NCT02049957.pdf

S16684-[34] .pdf

S16685-NCT00616967 .pdf

S16686-NCT01709370 -NCT01709370.pdf

S16687-FINESSE -NCT02053636.pdf

S16688-NCT00958971 -NCT00958971.pdf

S16689-NCT01528345 -NCT01528345.pdf

S16690-NCT01791985 -NCT01791985.pdf

S16691-ADOPT 2011-NCT00457002.pdf

S16692-MARINER -NCT02111564.pdf

S16694-VOYAGER PAD -NCT02504216.pdf

S16696-COMPASS (rivaroxaban alone) -NCT01776424.pdf

S16697-COMPASS (rivaroxaban + aspirin) 0-NCT01776424.pdf

S16698-PARAMOUNT 2012-NCT00887588.pdf

S16699-Edlemann 2013.pdf

S16700-TOPCAT 2014-NCT00094302.pdf

S16701-TOPCAT .pdf

S16702-PARAGON-HF -NCT01920711.pdf

S16710-Atrasentan .pdf

S16711-canagliflozin) .pdf

S16712-FIDELIO-DKD 0-NCT02540993.pdf

S16713-FIGARO-DKD 0-NCT02545049.pdf

S16715-SONAR 0-NCT01858532.pdf

S16716-CREDENCE 0-NCT02065791.pdf

S16717-VA NEPHRON-D 0-NCT00555217.pdf

S16718-EINSTEIN CHOICE (20mg) 2017-NCT02064439.pdf

S16733-NCT02614833 -NCT02614833.pdf

S16736-KEYNOTE-045 -NCT02256436.pdf

S16737-IMvigor211 -NCT02302807.pdf

S16738-IMvigor130 -NCT02807636.pdf

S16739-CheckMate 274 -NCT02632409.pdf

S16742-ASCEND-4 2017-NCT01828099.pdf

S16743-ALEX 0-NCT02075840.pdf

S16744-YO29449 0-NCT02838420.pdf

S16745-MO29750 0-NCT02604342.pdf

S16746-CLDK378A2303 0-NCT01828112.pdf

S16747-ALTA-1L 0-NCT02737501.pdf

S16748-B7461006 0-NCT03052608.pdf

S16749-X396-CLI-301 0-NCT02767804.pdf

S1676-Corsi 1985.pdf

S1677-Davis 1975.pdf

S16770-IMvigor010 -NCT02450331.pdf

S16803-IMvigor210 -NCT02951767.pdf

S16805-LEA .pdf

S16806-De Jong .pdf

S16807-Hyams -NCT00454805.pdf

S16824-Eribulin phase 3 (Schöffski ) 2016.pdf

S16825-Demetri 2016-NCT01343277.pdf

S16827-TSAR -NCT02672527 .pdf

S16828-CR017269 -NCT01692678.pdf

S16829-phase 2 ET743-STS-201 -NCT00060944 .pdf

S16830-Spanish Group for Research on Sarcomas 2011.pdf

S16839-Ledermann 2012- NCT00753545.pdf

S16840.pdf

S16841-XXX veliparib -NCT02163694 .pdf

S16842- .pdf

S16843-DURAC II 1997.pdf

S16844-LAFIT 1999.pdf

S16845-WODIT DVT 2001.pdf

S16846-ELATE 2003.pdf

S16847-PREVENT 2003.pdf

S16848-REMEDY 2013.pdf

S16849-RESONATE 2013.pdf

S1685-Gans 1990.pdf

S16850-THRIVE 3 2003.pdf

S16851-EISNTEIN EXT 2010.pdf

S16852-AMPLIFY EXT 2.5mg 2013.pdf

S16853-WARFASA 2012.pdf

S16854-ASPIRE 2012.pdf

S16855-WODIT PE 2003.pdf

S16856-Pini 1994.pdf

S16857-Das 1996.pdf

S16858-Gonzalez-Fajardo .pdf

S16859-Lopaciuk 1999.pdf

S16860-Veiga 2000.pdf

S16861-Lopez-Beret 2001.pdf

S16862-Meyer 2002.pdf

S16863-Hull .pdf

S16864-Deitcher 2003.pdf

S16865-Kakkar .pdf

S16866-Lee 2003.pdf

S16867-PADIS-PE (Couturaud) 2015-NCT00740883.pdf

S16868-Kearon LAFIT DOUBLON 1999.pdf

S16869-Vitotec 2009.pdf

S16870-AUREC FVII 2009.pdf

S16871-Van Gogh 2007-NCT00071279.pdf

S16872-WODIT DVT .pdf

S16873-DACUS (Siragusa) 2008-NCT00438230.pdf

S16874-EINSTEIN CHOICE (10mg) 2017-NCT02064439.pdf

S16875-SOFAST 2004.pdf

S16876-British Thoracic Society 1992.pdf

S16877-PROLONG (Palarati) 2006-NCT00264277.pdf

S16878-Levine 1995.pdf

S16879-DDOAT2006 -NCT00895505.pdf

S16886-CANTOS 2017-NCT01327846.pdf

S16887-AMPLIFY EXT 5mg 2013.pdf

S1691-Nye 1973.pdf

S1702- 1983.pdf

S1703-St Thomas 1983.pdf

S1704-HPS 2002.pdf

S1718-LEADER trial 2000.pdf

S1782-Mondillo 2003.pdf

S1784-Blann 2001.pdf

S1787-Mohler III 2003.pdf

S1816-Castano 2003.pdf

S1827-St Thomas 1983.pdf

S1851-Schumer W 1963.pdf

S1852-Hutchinson K 1983.pdf

S1875-Leng GC 1995.pdf

S1905-Aronow 2003.pdf

S1936-Amburgey CF 0.pdf

S2085- 1983.pdf

S2086-St Thomas 1983.pdf

S2087-PQRST 1994.pdf

S2088-CLAS 1987.pdf

S2089-Corsi 1985.pdf

S2090-Davis 1975.pdf

S2091-Gans 1990.pdf

S2092-Nye 1973.pdf

S2093-HPS (sub group) 2002.pdf

S2094-LEADER trial 2000.pdf

S2095-Mondillo 2003.pdf

S2096-Blann 2001.pdf

S2097-Mohler III 2003.pdf

S2098-Castano 2003.pdf

S2099-St Thomas 1983.pdf

S2100-Schumer W 1963.pdf

S2101-Hutchinson K 1983.pdf

S2102-Leng GC 1995.pdf

S2103-Aronow 2003.pdf

S2104-Amburgey CF 0.pdf

S2132-APIC 1989.pdf

S2133-De Smit 1987.pdf

S2134-Deutschinoff 1987.pdf

S2135-Calabro 1993.pdf

S2136-Mannarino 1991.pdf

S2137-Allegra 1994.pdf

S2138-Antonicelli 1999.pdf

S2139-Tesi 1989.pdf

S2140-Andreozzi 1993.pdf

S2141-Serrao 1991.pdf

S2142-Simoni 1993.pdf

S2143-Cina 1996.pdf

S2144-Montesi 1991.pdf

S2145-Schweizer 2001.pdf

S2146-Palmieri 1988.pdf

S2147-EMATAP 1993.pdf

S2148-Katsumara 1982.pdf

S2149-Aukland 1982.pdf

S2150-Stiegler 1984.pdf

S2151-Ellis 1986.pdf

S2152-Cloarec 1986.pdf

S2153-Arcan 1988.pdf

S2154-Balsano 1989.pdf

S2155-PACK 1996.pdf

S2156-Walden 1991.pdf

S2157-Thulesius 1987.pdf

S2158-Hess (2) 1985.pdf

S2159-Schoop (2) 1983.pdf

S2160-VA study 1986.pdf

S2161-ADEP 1993.pdf

S2162-Neirotti 1994.pdf

S2163-Coto 1989.pdf

S2164-Adriaensen 1976.pdf

S2165-Verhaeghe 1981.pdf

S2166-Jones 1982.pdf

S2167-Holm 1984.pdf

S2168-Schoop 1983.pdf

S2169-Hess 1985.pdf

S2170-STIMS 1990.pdf

S2171-Munich A 1975.pdf

S2172-Munich B 1975.pdf

S2173-Hurlow 1980.pdf

S2174-Krause 1980.pdf

S2175-Bounameaux 1985.pdf

S2176-Cameron 1987.pdf

S2177-Clément 1989.pdf

S2178-De Crée 1984.pdf

S2179-CRAMPS 2000.pdf

S2180-CAPRIE 1996.pdf

S2181-Brittenden J 0.pdf

S2182-Brittenden J (2) 0.pdf

S2183-Fowkes FGR 0.pdf

S2184-Belcaro 1991.pdf

S2185-McCollum CN 0.pdf

S2186-Goldman 1984.pdf

S2187-Raithel 1987.pdf

S2188-Clyne 1987.pdf

S2189-Donaldson 1985.pdf

S2190-Green 1982.pdf

S2191-Kohler 1984.pdf

S2192-McCollum 1991.pdf

S2193-Lucas 1984.pdf

S2194-BOA 2000.pdf

S2195-Edmondson 1994.pdf

S2196-Becquemin 1997.pdf

S2197-Daddato 1992.pdf

S2198-Shionoya S 1990.pdf

S2199-DeWeese JA 1971.pdf

S2200-Harjola PT 1981.pdf

S2201-Satiani B 1985.pdf

S2202-Rosenthal D 1987.pdf

S2203-Lassila R 1991.pdf

S2204-Gruss JD 1991.pdf

S2205-Arfvidsson 1990.pdf

S2206-Johnson 2002.pdf

S2207-Kretschmer 1992.pdf

S2208-Sarac 1998.pdf

S2209-Jivegard 1990.pdf

S2225-Johnson WC (PTFE vs veine saphène ) 2000.pdf

S2226-Aalders GJ 1992.pdf

S2227-Abbot WM 1997.pdf

S2228-Eickhoff JH 1987.pdf

S2229-Eickhoff JH 1983.pdf

S2230-Harris PL 1987.pdf

S2231-Moody AP 1992.pdf

S2232-Stonebridge PA 1997.pdf

S2233-Tilanus HW 1985.pdf

S2234-Bergan JJ 1982.pdf

S2235-Veith FJ 1986.pdf

S2236-Veterans Study Group 141 1988.pdf

S2237-Watelet J 1986.pdf

S2238-Watelet J 1997.pdf

S2239-Bennion RS 1985.pdf

S2240-Zilla P 1994.pdf

S2241-Schulman ML 1986.pdf

S2242-Gupta SK 1991.pdf

S2243-Flectcher JP 1995.pdf

S2244-McCollum C 1991.pdf

S2245-Schulman ML 1987.pdf

S2246-Devine C 2001.pdf

S2247-Becquemin JP 2003.pdf

S2248-Gong J 0.pdf

S2249-Post S 2001.pdf

S2250-Kreienberg PB 2002.pdf

S2251-Robinson BI 1999.pdf

S2252-Robinson BI 2003.pdf

S2253-Klinkert P 2003.pdf

S2254-Prager MR 2003.pdf

S2255-Kreienberg PB 2000.pdf

S2256-Burger DHC 2000.pdf

S2257-Kansal N 1999.pdf

S2258-Johnson WC 1999.pdf

S2259-Johnson WC (PTFE vs HUV) 2000.pdf

S2260-Green RM 2000.pdf

S2261-Archie Jr. JP 0.pdf

S2262-DeWeese JA 1971.pdf

S2295-Lear PA 0.pdf

S2296-Gelin 2001.pdf

S2297-Fitzgerald DE 1971.pdf

S2298-Ericsson B 1970.pdf

S2299-Mannarino E 1989.pdf

S2300-Mannarino E 1991.pdf

S2301-Dahllof AG 1974.pdf

S2302-Hiatt WR 1990.pdf

S2303-Hiatt WR 1994.pdf

S2304-Larsen OA 1966.pdf

S2305-Tisi PV 1997.pdf

S2306-Ernest EW 1987.pdf

S2307-Creasy TS 1990.pdf

S2308-Regensteiner JG 1996.pdf

S2309-Taft 2001.pdf

S2310-Holm J 1973.pdf

S2311-Lundgren F 1989.pdf

S2312-Fowler 2002.pdf

S2313-Pockley G 0.pdf

S2314-Stewart A 0.pdf

S2315-McCloskey B 0.pdf

S2316-Jayatunga AP 0.pdf

S2317-Gardner 2001.pdf

S2318-Savage P 2001.pdf

S2319-Dahllof AG 1976.pdf

S2320-NIQOL germany 1999.pdf

S2321-Clyne 1980.pdf

S2322-Beebe 1999.pdf

S2323-Dawson 1998.pdf

S2324-Money 1998.pdf

S2325-Dawson (pentoxifylline) 2000.pdf

S2326-APIC 1989.pdf

S2327-Donaldson 1984.pdf

S2328-Porter 1982.pdf

S2329-LIMB 2008.pdf

S2330-Trubestein 1984.pdf

S2331-Meehan 1982.pdf

S2332-Diamantopoulos 2001.pdf

S2333-Farquhar JW 0.pdf

S2334-Cornu C 0.pdf

S2335-Boccalon 2001.pdf

S2336-NIQOL belgium 2001.pdf

S2337-NCIS 2001.pdf

S2338-Bisler 1983.pdf

S2339-Bauer 1984.pdf

S2340-De Sanctis 2002.pdf

S2341-Belcaro 2002.pdf

S2342-Cesarone 2002.pdf

S2343-Elam 1998.pdf

S2344-Strandness 2002.pdf

S2345-Scandinavian study 1989.pdf

S2346-Karnik 1988.pdf

S2347-Ernst 1992.pdf

S2348-Waters 1980.pdf

S2349-Adhoute 1990.pdf

S2350-Bollinger 1977.pdf

S2351-Kriessmann 1988.pdf

S2352-Di Perri 1983.pdf

S2353-Roekaerts 1984.pdf

S2354-Kellner 1983.pdf

S2355-Reilly 1987.pdf

S2356-Rudofsky 1989.pdf

S2357-Chacon-Quevedo 1994.pdf

S2358-Trubestein (naftidrofuryl) 1984.pdf

S2359-Accetto 1982.pdf

S2360-Moody 1994.pdf

S2361-Vowden P 0.pdf

S2362-TRAFFIC 0.pdf

S2363-Fonseca 1988.pdf

S2364-Dawson (cilostazol) 2000.pdf

S2365-Blume 1998.pdf

S2366-Drabaek 1996.pdf

S2367-Rudofsky 1987.pdf

S2368-Thomson 1990.pdf

S2369-Blume 1996.pdf

S2370-Peters 1998.pdf

S2371-Mouren 1994.pdf

S2372-Dormandy Etude A 2000.pdf

S2373-Dormandy Etude B 2000.pdf

S2374-BERCI-2 2000.pdf

S2375-ICAI 1999.pdf

S2376-Cronenwett 1986.pdf

S2377-Nizankowski 1985.pdf

S2378-Schuler 1984.pdf

S2379-Telles 1984.pdf

S2380-Belch 1997.pdf

S2381-Ciprostene study 1991.pdf

S2382-Bliss 1991.pdf

S2383-Brock 1990.pdf

S2384-Diehm 1989.pdf

S2385-Norgren 1990.pdf

S2386-Guilmot 1991.pdf

S2387-Balzer 1991.pdf

S2388-Eklund 1982.pdf

S2389-Diehm 1987.pdf

S2390-Tonnesen 1978.pdf

S2391-Lowe 1982.pdf

S2392-Belch 1983.pdf

S2393-Mohler 2002.pdf

S2394-Cachovan 2001.pdf

S2395-Lievre 1996.pdf

S2396-Soranson JA 0.pdf

S2397-Soranson JA (2) 0.pdf

S2398-Wolfe JHN 0.pdf

S2399-Virgolini 1990.pdf

S2400-Rudofsky 1987.pdf

S2401-Hay 1987.pdf

S2402-Virgolini 1989.pdf

S2403-Mangiafico 2000.pdf

S2404-Horsch 1998.pdf

S2405-Karnik 1986.pdf

S2406-Meehan 1982.pdf

S2407-Negus 1987.pdf

S2408-Testart 1994.pdf

S2409-Greenhalgh RM 1981.pdf

S2410-Wong AL 1980.pdf

S2411-Taggart I 1989.pdf

S2412-Meehan SE 1982.pdf

S2413-Fellman N 1989.pdf

S2414-Mustapha NM 1984.pdf

S2415-D'Hooge D 2001.pdf

S2416-Van der Stricht 1977.pdf

S2417-Barnes RW 1977.pdf

S2418-Satiani B 1982.pdf

S2419-Fyfe T 1975.pdf

S2420-Shanik GD 1976.pdf

S2421-Cross FW 1985.pdf

S2557-MAAS 1994.pdf

S2559-REVERSAL 2004.pdf

S2560-CLAS 1987.pdf

S2561-CARDS 2004-NCT00327418.pdf

S2562-ASCOT 2003.pdf

S2563-PROSPER 2002.pdf

S2564-ALLHAT 2002-NCT00000542.pdf

S2565-LIPS 2002.pdf

S2566-NHLBI (Brensike) 1984-NCT00000594.pdf

S2567-PQRST 1994.pdf

S2568-PLAC I 1995.pdf

S2569-PLAC II 1995.pdf

S2570-PROVE-IT 2004.pdf

S2571-FIELD 2005-ISRCTN64783481.pdf

S2572-CCAIT 1994.pdf

S2573-PACT 2004.pdf

S2574-AVERT 1999.pdf

S2575-MIRACL 2001.pdf

S2576-MARS 1993-NCT00116870.pdf

S2577-FATS 1990-NCT00000512.pdf

S2578-SCOR 1990.pdf

S2580-BECAIT 1996.pdf

S2581-KAPS 1995.pdf

S2583-HPS 2002.pdf

S2584-BIP 2000.pdf

S2585-VA-HIT 1999-NCT00283335.pdf

S2586.pdf

S2587-LIPID 1998.pdf

S2588-CARE 1996.pdf

S2589-WOSCOPS 1995.pdf

S2590-4S 1994.pdf

S2591-Helsinki (HHS) 1987.pdf

S2592-LRC 1984.pdf

S2593-UCS (Dorr) 1978.pdf

S2594-WHO clofibrate 1978.pdf

S2595-Carlson (Stockholm) 1977.pdf

S2596-CDP Clofibrate 1975.pdf

S2597-CDP niacin 1975.pdf

S2598-Scottish 1971.pdf

S2599-Newcastle 1971.pdf

S2600-Veterans Ad. (Dayton) 1969.pdf

S2601-MRC Soya 1968.pdf

S2602-Woodhill 1966.pdf

S2603-Oslo Diet Heart Study (Leren) 1966.pdf

S2604-Rose 1965.pdf

S2605-MRC low fat 1965.pdf

S2606-HOPE 2000.pdf

S2607-EUROPA 2003.pdf

S2608-PEACE 2004-NCT00000558.pdf

S2609-QUIET 2001.pdf

S2616-PATAF (vs coumadin low dose) 1999.pdf

S2617-AFASAK II (aspirin vs warfarin low dose) 1998.pdf

S2618-PATAF (coumadin low dose vs coumadin standard dose) 1999.pdf

S2619-AFASAK II (warfarin low dose vs warfarin standard dose) 1998.pdf

S2620-AFASAK II (warfarin low dose+aspirin vs warfarin standard dose) 1998.pdf

S2621-SPAF III 1996.pdf

S2622-AFASAK1 1989.pdf

S2623.pdf

S2624-AFASAK II (aspirin vs warfarin standard dose) 1998.pdf

S2625-PATAF (vs coumadin standard dose) 1999.pdf

S2626.pdf

S2627-AFASAK (aspirin vs placebo) 1989.pdf

S2628-SPAF I (preliminary report) importé 1990.pdf

S2629-LASAF(aspirin vs no treatment) 1999.pdf

S2630-SPAF (aspirin,warfarin ineligible arm) 1991.pdf

S2631-CAFA 1991.pdf

S2632-AFASAK (warfarin standard dose vs control) 1989.pdf

S2633-BAATAF (warfarin vs no treatment) 1990-NCT00000517.pdf

S2634-SPAF (warfarin standard dose) 1991.pdf

S2635-SPINAF (warfarin vs placebo) 1992.pdf

S2636-SPORTIF II (ximelagatran vs warfarin standard dose) 2002.pdf

S2637-SPORTIF III 2003.pdf

S2638-SPORTIF V 2005.pdf

S2639-EAFT 1993.pdf

S2640-SPINAF 1992.pdf

S2641-EAFT 1993.pdf

S2642-UK-TIA(high dose) 1991.pdf

S2643-UK-TIA(low dose) 1991.pdf

S2644-ESPS II 1996.pdf

S2645-SIFA 1997-NCT00244426.pdf

S2646-EAFT 1993.pdf

S2647-MWNAF 1998.pdf

S2648-NASPEAF (triflusal + coumadin medium dose vs coumadin standard dose) 2004.pdf

S2650-SAFT(warfarin low dose + aspirin vs no treatment) 2003.pdf

S2651-NASPEAF 2004.pdf

S2652-NASPEAF (triflusal vs coumadin standard dose)) 2004.pdf

S2653-NASPEAF (triflusal+coumadin medium dose vs triflusal) 2004.pdf

S2654-AFASAK (aspirin vs warfarin standard dose) 1989.pdf

S2655-CAMELOT (enalapril) 2004.pdf

S2658-FFAACS 2001.pdf

S2659-CLAAF(aspirin + clopidogrel vs warfarin standard dose) 2004.pdf

S2660-BAFTA (aspirin vs warfarin standard dose) 0.pdf

S2661-ACTIVE(aspirin + clopidogrel vs warfarin) 0.pdf

S2662-SPAF (aspirin , warfarin eligible arm) 1991.pdf

S2678-ALERT 2003.pdf

S2679-Deutsche Diabetes Dialyse Studie (4D) 2005.pdf

S293-Zwolle 1994.pdf

S302-Ribeiro 1993.pdf

S303-Grinfeld 1996.pdf

S304-Zijlstra 1997.pdf

S305-DeWood 1989.pdf

S306-PAMI 1993.pdf

S307-Gibbons 1993.pdf

S308-Ribichini 1996.pdf

S309-Garcia 1997.pdf

S310-GUSTO 2B 1997.pdf

S311-CDPA 1976.pdf

S312-Cardiff I 1974.pdf

S313-Cardiff II 1979.pdf

S314-Vogel 1979.pdf

S315-AMIS 1980-NCT00000491.pdf

S316-GAMIS 1980.pdf

S317-PARIS 1980.pdf

S318-JAMIS 1999.pdf

S319-CAPRIE 1996.pdf

S320-PARIS 1980.pdf

S321-PARIS-II 1986.pdf

S322-PARIS 1980.pdf

S3437-NORVIT (folic acid + B12) (Bonaa) 2006-NCT00266487.pdf

S3438-SEARCH 2007-NCT00124072.pdf

S3443-COMMIT 2005-NCT00222573.pdf

S3448-A to Z 2004.pdf

S3449-PROVE IT - TIMI 22 2004.pdf

S3450-Avert 1999.pdf

S3453-REVERSAL 2004.pdf

S3455-MIRACL 2001.pdf

S3462-MRC I (vs placebo) 1985.pdf

S3463-MRC I (vs diuretics) 1985.pdf

S3465-IPPPSH 1985.pdf

S3466-Coope 1986.pdf

S3467-Berglund 1986.pdf

S3468-HAPPHY 1988.pdf

S3469-MRC old (vs placebo) 1992.pdf

S3470-MRC old (vs diuretics) 1992.pdf

S3471-Yurenev 1992.pdf

S3472-Dutch TIA 1993.pdf

S3475-TEST 1995.pdf

S3476-UKPDS 1998.pdf

S3477-LIFE 2002.pdf

S3478-ELSA 2002.pdf

S3479-INVEST 2003-NCT00133692.pdf

S3480-ASCOT-BPLA 2005.pdf

S3481-NORDIL 2000.pdf

S3482-STOP 1991.pdf

S3486-HOPE 2000.pdf

S3487-PART2 2000.pdf

S3488-QUIET 1999.pdf

S3489-SCAT 2000.pdf

S3490-PREVENT 2000.pdf

S3491-SYST-EUR 1997.pdf

S3492-INSIGHT 2000.pdf

S3493-NICS-EH 1999.pdf

S3494-STOP 2 (vs diurectic or beta-blocker) 1999.pdf

S3495-NORDIL 2000.pdf

S3496-VHAS 1998.pdf

S3497-ABCD (H) 1998.pdf

S3498-STOP-2 (vs felodipine or isradipine) 1999.pdf

S3499-STOP 2 (vs conventional drugs) 1999.pdf

S3500-UKPDS-HDS 1998.pdf

S3501-CAPPP 1999.pdf

S3502-CASTEL (vs clonidine) 0.pdf

S3503-CASTEL (vs betablocker + diuretic) 0.pdf

S3504-MIDAS 1996.pdf

S3616-PATS 1995.pdf

S3617-Carter 1970.pdf

S3618-HSCS 1974.pdf

S3619-VA-I 1967.pdf

S3620-VA II 1970.pdf

S3621.pdf

S3622-USPHS 1977.pdf

S3623-Barraclough 1973.pdf

S3624-Kuramoto 1981.pdf

S3625-EWPHE 1985.pdf

S3627-SHEP 1991-NCT00000514.pdf

S3628-SHEP-pilot 1989.pdf

S3636-SYNERGY 2005-NCT00043784.pdf

S3637-RIO europe 20mg 2005.pdf

S3638-Rio-lipid 20 mg 2005.pdf

S3639-Wadden 2005.pdf

S3651-PEP hip-fracture 2000.pdf

S3652-MRC 1972.pdf

S3653-Parodi I 1973.pdf

S3654-Parodi II 1973.pdf

S3655-Loew DVT 1974.pdf

S3656-Zekert-III 1977.pdf

S3657-Clagett 1975.pdf

S3658-Australian I 1975.pdf

S3659-Australian II 1976.pdf

S3660-Encke IA 1976.pdf

S3661-Encke IB 1976.pdf

S3662-Toulouse I 1979.pdf

S3663-Erfurt-A 1979.pdf

S3664-Zekert V 1980.pdf

S3665-Vinazzer I 1980.pdf

S3666-Vinazzer II 1977.pdf

S3667-Zekert VI 1982.pdf

S3668-Harjola DVT 1982.pdf

S3669-Lasierra 1982.pdf

S3670-Athens 1981.pdf

S3671-Turpie 1985.pdf

S3672-Veth 1985.pdf

S3673-Carter IA 1971.pdf

S3674-Carter IB 1971.pdf

S3675-Carter II 1974.pdf

S3676-Walker 1974.pdf

S3677-Weiss 1977.pdf

S3678-New York 1977.pdf

S3679-Vermont 1975.pdf

S3680-PEP elective arthroplasty 2000.pdf

S3681-ASCOT-BPLA 2005.pdf

S3682-CAMELOT 2005.pdf

S3696-ATBC beta carotene 1994.pdf

S3697-CARET beta carotene 1996.pdf

S3698-HPS antioxidant 2002.pdf

S3699-SCP beta carotene 1990.pdf

S3700-AREDS DOUBLONS 2001.pdf

S3701-NSCP (Green) beta carotene 1999.pdf

S3702-PHS beta carotene 1996.pdf

S3703-WHS beta carotene 1999-NCT00000479.pdf

S3704-ATBC vitamin E 1994.pdf

S3705-CHAOS 1996.pdf

S3706-GISSI 1999.pdf

S3707-HOPE 2000.pdf

S3708-HPS A EFFACER 2002.pdf

S3709-AREDS 2001.pdf

S3710-PPP 2001.pdf

S3711-ACCORD à effacer 0.pdf

S3712-SPACE 2000.pdf

S3713-WAVE (Waters) 2002.pdf

S3714-ACME 2 (Folland) 1997.pdf

S3715-AVERT 1995.pdf

S3721-Moer 2001.pdf

S3722-Doucet 2001.pdf

S3723-Koning 2001.pdf

S3724-Park 2000.pdf

S3725-Lotan 2000.pdf

S3726-Weaver 2000.pdf

S3727-Dangas 2000.pdf

S3728-Fluck 2000.pdf

S3729-Lafont 2000.pdf

S3730-Witkowski 2000.pdf

S3731-Kastrati 2000.pdf

S3732-Di Marlo 2000.pdf

S3733-Serruys 2000.pdf

S3734-Lincoff (EPISTENT) 1999-NCT00271401.pdf

S3735-Buller 1999.pdf

S3736-Betriu 1999.pdf

S3737-Hoher 1999.pdf

S3738-Sievert 1999.pdf

S3739-Eeckout 1996.pdf

S3740-Sirnes 1996.pdf

S3741-Savage 1998.pdf

S3742-Erbel 1998.pdf

S3743-Rubartelli 1998.pdf

S3744-Hancock 1998.pdf

S3745-Rodriguez 1998.pdf

S3746-Rapport 1998.pdf

S3747-ISAR-2 2000.pdf

S3748-ADMIRAL 2001.pdf

S3749-CADILLAC 2002.pdf

S3750-Petronio 2002.pdf

S3751-Zoman 2002.pdf

S3752-ACE 2003.pdf

S3753-Petronio 2003.pdf

S3754-ASSENT III 2001.pdf

S3755-ENTIRE-TIMI23 2002.pdf

S3756-GUSTO V 2002.pdf

S3807-Azancot 1982.pdf

S3808-Balcon 1966.pdf

S3809-Barber 1976.pdf

S3810-Campbell 1984.pdf

S3811-Clausen 1966.pdf

S3812-CPRG 1981.pdf

S3813-Curtis 1991.pdf

S3814-Dotremont 1968.pdf

S3815-Evemy 1978.pdf

S3816-Federman 1984.pdf

S3817-Fuccella 1968.pdf

S3818-Gupta 1982.pdf

S3819-Gupta 1984.pdf

S3820-Heber 1987.pdf

S3821-Hutton 1979.pdf

S3822-ICSG 1984.pdf

S3823-ISIS1 Collaborative Group 1986.pdf

S3824-Johansson 1980.pdf

S3825-Kahler 1968.pdf

S3826-Ledwich 1968.pdf

S3827-Lloyd 1988.pdf

S3828-Lombardo 1979.pdf

S3829-Macleod 1980.pdf

S3830-McMurray 1991.pdf

S3831-MIAMI Trial Research Group 1985.pdf

S3832-Mueller 1980.pdf

S3833-Multicentre 1966.pdf

S3834-Nigam 1983.pdf

S3835-Norris 1968.pdf

S3836-Norris 1978.pdf

S3837-Norris 1984.pdf

S3838-Owensby 1984.pdf

S3839-Peter 1978.pdf

S3840-Pitt 1976.pdf

S3841-Ranganathan 1988.pdf

S3842-Roberts 1984.pdf

S3843-Singh 1985.pdf

S3844-Sloman 1967.pdf

S3845-Snow 1980.pdf

S3846-Thompson 1979.pdf

S3847-Tonkin 1981.pdf

S3848-UKCSG 1983.pdf

S3849-Van de Werf 1993.pdf

S3850-Von Essen 1982.pdf

S3851-Waagstein 1975.pdf

S3852-Wilcox 1980.pdf

S3853-Yang 1987.pdf

S3854-Yusuf 1980.pdf

S3855-TIMI IIB 1989.pdf

S3856-Ahlmark 1974.pdf

S3857-Andersen 1979.pdf

S3858-APSI 1990.pdf

S3859-Aronow 1997.pdf

S3860-Australian and Swedish study 1983.pdf

S3861-Baber 1980.pdf

S3862-Barber 1967.pdf

S3863-Basu 1997.pdf

S3864-BHAT 1982-NCT00000492.pdf

S3865-Darasz 1995.pdf

S3866-EIS 1984.pdf

S3867-Hansteen 1982.pdf

S3868-Hjalmarson 1981.pdf

S3869-Julian 1982.pdf

S3870-Kaul 1988.pdf

S3871-LIT Research Group 1987.pdf

S3872-Manger Cats 1983.pdf

S3873-Mazur 1984.pdf

S3874-Multicentre international 1975.pdf

S3875-Norwegian Multicentre Study Group 1981.pdf

S3876-Rehnqvist 1980.pdf

S3877-Rehnqvist 1983.pdf

S3878-Reynolds 1972.pdf

S3879-TIARA (Roqué) 1987.pdf

S3880-Salathia 1985.pdf

S3881-Schwartz (high risk and low risk) 1992.pdf

S3882-SSSD 1993.pdf

S3883-Taylor 1982.pdf

S3884-Wilcox 1980.pdf

S3885-Wilhelmsson 1974.pdf

S3886-Yusuf 1979.pdf

S3984-NSGET (efficacy trial) 2000.pdf

S3985-VMAC (24h) 2002-NCT00083772.pdf

S3986-PROACTION 2003.pdf

S3987-PRISM 1998.pdf

S3988- PRISM-PLUS Low-dose+heparin 1998.pdf

S3989- PRISM-PLUS High-dose 1998.pdf

S3990- PARAGON-A Low-dose (no heparin) 1998.pdf

S3991- PARAGON-A Low-dose lamifiban + heparin 1998.pdf

S3992- PARAGON-A High-dose lamifiban (no heparin) 1998.pdf

S3993- PARAGON-A High-dose lamifiban + heparin 1998.pdf

S3994- PURSUIT low dose 1998.pdf

S3995-PURSUIT 1998.pdf

S3996- PARAGON-B 2002.pdf

S3997- GUSTO-IV ACS Abciximab 24 h 2001.pdf

S3998- GUSTO-IV ACS Abciximab 48 h 2001.pdf

S4001-OPUS 2000.pdf

S4002-SYMPHONY 2000.pdf

S4003-SYMPHONY 2 2001.pdf

S4004-Theroux et al. 1995.pdf

S4005-Schulman et al (Hopkins study) Low dose 1995.pdf

S4006-Schulman et al (Hopkins study) high dose 1995.pdf

S4007-MATE 1998.pdf

S4008-TACTICS-TIMI 18 2001.pdf

S4009-VINO 2002.pdf

S4010-RITA 3 2002-ISRCTN07752711r.pdf

S4023-VA-pilot 0.pdf

S4024-VA-main 1983.pdf

S4025-Canadian (Aspirin + sulfinpyrazone) 1985.pdf

S4026-RISC 1990.pdf

S4027-ALDUSA-pilot 0.pdf

S4028-STAI 1990.pdf

S4029-Prandoni 1991.pdf

S4030-Théroux 1988.pdf

S4031-Florida UA 0.pdf

S4032-ATACS-pilot 1990.pdf

S4033-Plaza 1993.pdf

S4034-Modena 0.pdf

S4035-CONVINCE 2003.pdf

S4036-INVEST (Pepine) 2003-NCT00133692.pdf

S4037-COMMIT 2005-NCT00222573.pdf

S4039- ADEPT 2001.pdf

S4040- ARCH-J 2003.pdf

S4041- CHARM-Added 2003.pdf

S4042- CHARM-Alternative 2003.pdf

S4043- Crozier et al. 1995.pdf

S4044- Dickstein et al. 1995.pdf

S4045- ELITE 1997.pdf

S4046- ELITE II 2000.pdf

S4047- Hamroff et al. 1999.pdf

S4048- HEAVEN 2002.pdf

S4049- Lang et al. 1997.pdf

S4050-Mazayev et al. (vs placebo) 1998.pdf

S4051- Mitrovic et al. 2003.pdf

S4052- OPTIMAAL 2002.pdf

S4053-Losartan Phase III International 1996.pdf

S4054-Losartan Phase III U.S. 1995.pdf

S4055- REPLACE 2001.pdf

S4056-RESOLVD (candesartan alone) 1999.pdf

S4057- RESOLVD association 1999.pdf

S4058-SPICE 2000.pdf

S4059- STRETCH 1999.pdf

S4060- Tonkon et al. 2000.pdf

S4061- V-HeFT 1999.pdf

S4062-Val-HeFT 2001.pdf

S4063- VALIANT (valsartan alone) 2003.pdf

S4064- VALIANT (valsartan+capropril) 2003.pdf

S4065-RESOLVD 2000.pdf

S4066-DCCT (no retinopathy) 1993.pdf

S4068-Mazayev et al. (vs lisinopril 1998.pdf

S4069-SAVE 0.pdf

S4070-AIRE 0.pdf

S4071-TRACE 1995.pdf

S4072-CONSENSUS 2 0.pdf

S4073-GISSI 3 0.pdf

S4074-ISIS-4 0.pdf

S4075-CCS-1 0.pdf

S4076-Colfer 1992.pdf

S4077-McGany 1991.pdf

S4078-Magnani 1986.pdf

S4079-Bussmann 1987.pdf

S4080-Captopril Digoxin Multicenter Research Group 1988.pdf

S4082-Barabino 1991.pdf

S4083-Munich MHFT (Kleber) 1992.pdf

S4084-Drexler 1989.pdf

S4085-Cleland 1985.pdf

S4086-Rucinska-b (enalapril) 1991.pdf

S4087-CONSENSUS 1987.pdf

S4088-Enalapril CHF investigators 1987.pdf

S4089-Dickstein 1991.pdf

S4091-Rucinska-a (enalapril) 1991.pdf

S4092-Zwehl 1990.pdf

S4093-Giles 1990.pdf

S4094-Rucinska-c (lisinopril) 1000.pdf

S4095-Gilbert 1993.pdf

S4096-Lechat 1993.pdf

S4097-Riegger 1990.pdf

S4098-Northridge 1991.pdf

S4099-Uprichard-a 1994.pdf

S4100-Uprichard-b 1994.pdf

S4101-Uprichard-c 1994.pdf

S4102-Swedberg 1991.pdf

S4103-Maass-a 1991.pdf

S4104-Gordon 1991.pdf

S4105-Maass-b 1991.pdf

S4106-Maass-c 1991.pdf

S4107-Lemarie 1992.pdf

S4108-SMILE 1995.pdf

S4109-Bratt et al 1985.pdf

S4110-Holm et al 1986.pdf

S4111-Faivre et al 1988.pdf

S4112-Notarbartolo et al 1988.pdf

S4113-Zanghi 1988.pdf

S4114-Etude Multicentrique 1989.pdf

S4115-Albada et al 1989.pdf

S4116-Bratt et al 1990.pdf

S4117-Harenberg et al 1990.pdf

S4118-Collaborative European Multicentre 1991.pdf

S4119-Prandoni et al 1992.pdf

S4120-Lopaciuk et al 1992.pdf

S4121-Hull et al 1992.pdf

S4122-Simonneau et al 1993.pdf

S4123-Tedoldi et al 1993.pdf

S4124-Lindmarker et al 1993.pdf

S4155-LeGagneux 1987.pdf

S4156-Ockelford 1989.pdf

S4157-Pezzuoli 1989.pdf

S4158-Valle 1988.pdf

S4185-Turpie 1986.pdf

S4186-Leclerc 1991.pdf

S4187-Jorgensen 1989.pdf

S4188-Torholm 1991.pdf

S4189-Lassen 1991.pdf

S4190-DES Group 1991.pdf

S4191-Eriksson 1988.pdf

S4192-Matzsch 1988.pdf

S4193-Matzsch 1991.pdf

S4194-Planes 1988.pdf

S4195-Levine 1991.pdf

S4196-Chiapuzzo 1988.pdf

S4197-Pini 1989.pdf

S4198-Haas 1985.pdf

S4199-Binsack 1986.pdf

S4200-Barre 1987.pdf

S4201-Dechavanne 1989.pdf

S4202-Eriksson 1989.pdf

S4203-Monreal 1989.pdf

S4204-Leyvraz 1991.pdf

S4205-Haas 1987.pdf

S4206-Lassen 1988.pdf

S4207-Lassen 1989.pdf

S4209-Jaksch 1998.pdf

S4210-GRAMI (Rodriguez) 1998.pdf

S4211-Zwolle 5 (Suryapranata) 1998.pdf

S4212-stent-PAMI (Grines) 1999.pdf

S4213-PASTA (Saito) 1999.pdf

S4214-PRISAM (Kawashima) 1999.pdf

S4215-STENTIM-2 (Maillard) 2000.pdf

S4216-PSSAAMI (Scheller) 2001.pdf

S4217-Stone (CADILLAC) 2002.pdf

S4218-Gupta et al 1997.pdf

S4219-ACADEMIC 1999.pdf

S4220-WIZARD 2003.pdf

S4221-ACES 2005-NCT00000617.pdf

S4222-ROXIS 1999.pdf

S4223-CLARIFY 2001.pdf

S4224-Leowattana et al 2001.pdf

S4225-STAMINA (Azithromycin) 2002.pdf

S4226-ANTIBIO 2003.pdf

S4227-AZACS 2003.pdf

S4228-PROVE-IT 2005.pdf

S4229-MASS 2002.pdf

S4230-Western Australia Study 2004.pdf

S4231-Viborg County Study 2002.pdf

S4232-Chichester Study, Men 1995.pdf

S4233-Chichester Study, Women 1995.pdf

S4234-Study 541 3000.pdf

S4235-Chiasson et al 1994.pdf

S4236-Study 656 1994.pdf

S4237-Hasche et al 1999.pdf

S4238-Campbell et al 1998.pdf

S4239-Bachmann et al 1998.pdf

S4240-Josse et al 2003.pdf

S4257-British Doctor’s Trial 1988.pdf

S4258-Physicians Health Study 1989-NCT00000500.pdf

S4259-Thrombosis Prevention Trial 1998-NCT00000614.pdf

S4260-HOT 1998.pdf

S4261-Primary Prevention Project 2001.pdf

S4263-Yoo 1997.pdf

S4264-Samama 1997.pdf

S4265-Levine 1996.pdf

S4266-Kalodiki 1996.pdf

S4267-Warwick 1995.pdf

S4268-Sourmelis 1995.pdf

S4284-Kassis 1987.pdf

S4285-Liao 1998.pdf

S4286-DiDi 1996.pdf

S4287-Littler 1995.pdf

S4288-PRAISE II 2000.pdf

S4289-Belardinelli et al 1999.pdf

S4290-Dubach et al 1997.pdf

S4291-Giannuzzi et al 1997.pdf

S4292-Hambrecht et al 1995.pdf

S4293-Kiilavuori et al 2000.pdf

S4294-McKelvie et al 2002.pdf

S4295-Zanelli et al 1997.pdf

S4296-Wielenga et al 1999.pdf

S4297-Willenheimer et al 1998.pdf

S4298-IONA 2002.pdf

S4301-CLARICOR 2006-NCT00121550.pdf

S4313-US carvedilol pooling 1996.pdf

S4316-Muller 1984.pdf

S4317-Gordon 1984.pdf

S4318-Eisenberg 1985.pdf

S4319-Bradagan 1986.pdf

S4321-Jaffe 1987.pdf

S4322-Gottlieb 1988.pdf

S4323-Erbel 1988.pdf

S4324-SPRINT I 1988.pdf

S4325-SPRINT II 1993.pdf

S4326-Bussman 1984.pdf

S4327-DAVIT I 1984.pdf

S4328-Crea 1985.pdf

S4329-DAVIT II 1990.pdf

S4330-Gibson 1986.pdf

S4331-Machecourt 1986.pdf

S4332-MDPIT 1988.pdf

S4333-ECG ancillary EIS 1985.pdf

S4334-CARMEN (carvedilol+enalapril) 2004.pdf

S4336-Kassis 1990.pdf

S4337-Gaudron 1996.pdf

S4338-Gheorghiade 1991.pdf

S4339-Packer 1991.pdf

S4340-Abrams 1993.pdf

S4341-Smith 1994.pdf

S4342-Rousseau 1994.pdf

S4343-Van den Toren 1996.pdf

S4345-Udelson 1996.pdf

S4346-Binkley 1996.pdf

S4347-Ghali 1997.pdf

S4348-Schofer 1990.pdf

S4349-Dunselman 1990.pdf

S4350-De Vries 1995.pdf

S4351-WHI low fat 2005-NCT00000611.pdf

S4353-MI study group 1979.pdf

S4355-TNT 2005-NCT00327691.pdf

S4356-IDEAL 2005-NCT00159835.pdf

S4357-LIPS (sub groups) 2002.pdf

S4363-CRIS 1996.pdf

S4364-INTACT 1990.pdf

S4365-ACTION 2005.pdf

S4366-CAPRIE 1996.pdf

S4367-CHARISMA 2006-NCT00050817.pdf

S4368-HOPE 2 (doublon) 2006.pdf

S4370-NORVIT (vit B6) (Bonaa) 2006-NCT00266487.pdf

S4371-NORVIT (folic acid, B12 and vit B6) (Bonaa) 2006-NCT00266487.pdf

S4424-Almallah 1998.pdf

S4425-Bairati 1992.pdf

S4426-Bellamy 1992.pdf

S4427-Belluzzi 1996.pdf

S4428-Bemelmans 2002.pdf

S4429-Bonnema 1995.pdf

S4430-Borchgrevink 1966.pdf

S4431-Brox 2001.pdf

S4432-Burr (DART) 1989.pdf

S4433-Burr (DART 2) 2003.pdf

S4434-Connor 1993.pdf

S4435-Dehmer 1998.pdf

S4436-Dry 1991.pdf

S4437-Eritsland 1996.pdf

S4438-Franzen 1993.pdf

S4439-Geusens 1994.pdf

S4440-GISSI-P 1999.pdf

S4441-Greenfield 1993.pdf

S4442-Hawthorne 1992.pdf

S4443-Johansen 1999.pdf

S4444-Katan 1997.pdf

S4445-Kaul 1992.pdf

S4446-Lau 1993.pdf

S4447-Lau 1995.pdf

S4448-Leaf 1994.pdf

S4449-Loeschke 1996.pdf

S4450-Lorenz-Meyer 1996.pdf

S4451-Malaguarnera 1999.pdf

S4452-Maresta 2002.pdf

S4453-Mate-Jimenez 1991.pdf

S4454-Milner 1989.pdf

S4455-Natvig 1968.pdf

S4456-Nilsen 2001.pdf

S4457-Nye 1990.pdf

S4458-Reis 1991.pdf

S4459-Rossing 1996.pdf

S446-GUSTO tPA Hiv 1993.pdf

S447-ISAM 1986.pdf

S448-AIMS 1988.pdf

S449-ISIS-2 (SK) 1988.pdf

S450-ASSET 1988.pdf

S451-Western Washington Intravenous Trial 1988-NCT00000507.pdf

S452-German Multicenter Trial 1988.pdf

S4534-Tishler 2004.pdf

S4535-Sterner-Victorin 2004.pdf

S4538-Leibetseder 2004.pdf

S4548-Kristof 2000.pdf

S455-GISSI II 1990.pdf

S456-International Study Group 1990.pdf

S457-GISSI I 1986.pdf

S458.pdf

S459-COMPASS 1998.pdf

S460-GUSTO tPA-SK Hiv 1993.pdf

S461-GUSTO III 1997.pdf

S462-INJECT 1995.pdf

S464-PRIMI (vs SK) 1989.pdf

S465-Mathey 1985.pdf

S466-SESAM 1997.pdf

S467-COBALT 1997.pdf

S4670-CONSENSUS 2 1992.pdf

S4671-GISSI 3 1994.pdf

S4672-ISIS-4 1995.pdf

S4673-CCS-1 1995.pdf

S4674-SMILE 1995.pdf

S4679- OPTIMAAL 2002.pdf

S468-ASSENT-2 1999.pdf

S4680- VALIANT (valsartan alone) 2003.pdf

S4681- VALIANT (valsartan+capropril) 2003.pdf

S469-InTIME-II 2000.pdf

S470.pdf

S4721-ACTIVE W 2006-NCT00243178.pdf

S4722-Naylor 1998.pdf

S4723-WALLSTENT 2001.pdf

S4724-CAVATAS 2001.pdf

S4725-Brooks 2001.pdf

S4726-Link 2000.pdf

S4727-SPPHIRE 2003.pdf

S4728-ARGAMI-2 1998.pdf

S4729-HERO 1997.pdf

S4730-HIT-4 1999.pdf

S4731-TIMI 9B 1996.pdf

S4732-GUSTO IIB 1996.pdf

S4733-Klootwijk 1999.pdf

S4734-OASIS pilot 1997.pdf

S4735-TRIM 1997.pdf

S4736-BAT (Bittl) 1995.pdf

S4737-HELVETICA (Serruys) 1995.pdf

S4775-Toohill (MCW-2) 1987.pdf

S4776-Jortay (EORTC 24771) 1990.pdf

S4777-Lewin (SHNG-85) 1997.pdf

S4778-Martin (Créteil-86) 1994.pdf

S4779-Paccagnella (GSTTC-86 ) 1994.pdf

S4780-Domenge (GETTEC neo1) 1995.pdf

S4781-Domenge (GETTEC) 2000.pdf

S4782-Dalley (AHNTG) 1995.pdf

S4783-Tejedor (Las Palmas) 1992.pdf

S4784-Gedouin (Rennes-87) 1996.pdf

S4785-Di Blasio (Parma) 1994.pdf

S4786-Depondt (CFHNS) 1993.pdf

S4787-Volling (Cologne) 1994.pdf

S4788-Hasegawa (HNAP-02) 1996.pdf

S4789-BNH 003 0.pdf

S4790-Richard (IGR-65) 1974.pdf

S4791-Fazekas (RTOG 6801) 1980.pdf

S4793-Pearlman (Denver 77 ) 1985.pdf

S4794-HNCP 1987.pdf

S4795-Richard (EORTC 78-OCP) 1991.pdf

S4796-Holoye (MCW-1) 1985.pdf

S4797-Schuller (SWOG 8006) 1988.pdf

S4798-Szpirglas (Pitié-81 ) 1988.pdf

S4799-Carugati (Buenos Aires ) 1988.pdf

S4800-Mazeron (Créteil-82) 1992.pdf

S4801-Brunin (HNCGIC02) 1989.pdf

S4802-Salvajoli (AC Camargo) 1992.pdf

S4811-SENIORS 2005.pdf

S4814-RIO-North America 20 mg 2006-NCT00029861.pdf

S4818-RIO europe 5mg 2005.pdf

S4819-RIO europe (20 vs 5 mg) 2005.pdf

S4820-RIO-North America 5mg 2006.pdf

S4821-RIO-North America (20mg vs 5mg) 2006.pdf

S4822-Anderson 2002.pdf

S4823-Croft 2002.pdf

S4824-Jain 2002.pdf

S4825-Breum 1995.pdf

S4826-Connolly 1995.pdf

S4827-Darga 1991.pdf

S4828-Goldstein 1994.pdf

S4829-Gray 1992.pdf

S4830-Marcus 1990.pdf

S4831-Mendoza Espejo 1995.pdf

S4832-Michelson 50wk 1999.pdf

S4834-O’Kane 1994.pdf

S4835-Bakris 2002.pdf

S4836-Broom 2002.pdf

S4837-Broom, 2001.pdf

S4838-Davidson 1999.pdf

S4839-Deerochanawong, 2001.pdf

S4840-Derosa 2003.pdf

S4841-Gotfredsen 2001.pdf

S4842-Halpern 2003.pdf

S4843-Hanefeld 2002.pdf

S4844-Hauptman 2000.pdf

S4845-Hill 1999.pdf

S4846-Hollander 1998.pdf

S4847-Karhunen 2000.pdf

S4848-Kelley 2002.pdf

S4849-Krempf 2005.pdf

S4850-Lindgarde 2000.pdf

S4851-Lucas 2003.pdf

S4852-Micic 1999.pdf

S4853-Miles 2002.pdf

S4854-Muls 2001.pdf

S4855-Naumov 2002.pdf

S4856-Reaven 2001.pdf

S4857-Rissanen 2001.pdf

S4858-Rosenfalck 2002.pdf

S4859-Rossner 2000.pdf

S4860-Shi Yi 2001.pdf

S4861-Sjostrom 1998.pdf

S4862-Vidgren 1999.pdf

S4863-Bray 2003.pdf

S4864-Caterson 2003.pdf

S4865-Pud’homme 2003.pdf

S4866-Rissanen 2003.pdf

S4867-Stenlof 2003.pdf

S4868-Tonstad 2003.pdf

S4876-McMahon 2000.pdf

S4877-McMahon 2002.pdf

S4878-Smith 2001.pdf

S4974-MEGA 2006-NCT00211705.pdf

S4975-DREAM ramipril 2006-NCT00095654.pdf

S4976-DREAM rosiglitazone 2006-NCT00095654.pdf

S4977-DREAM 2005-NCT00421330.pdf

S4978-EVAR trial 2 2005-ISRCTN55703451.pdf

S4979-EVAR trial 1 2005-ISRCTN55703451.pdf

S4981-Powerlink 0.pdf

S4986-Jaulerry Trial 2 (Curie)(HNCGIC03) 1992.pdf

S4987-Maipang (Songkla) 1995.pdf

S4988-Prévost 2005.pdf

S4990-Fonseca 1997.pdf

S4991-Starr 1996.pdf

S4992-Vokes 1990.pdf

S4995-Chua 1998.pdf

S4996-RTOG 91-11 (I+RT vs RT alone) 2003.pdf

S5000-Hareyama 2002.pdf

S5005-GETTEC 1998.pdf

S5006-Veterans Affairs 1998.pdf

S5007-EORTC 24891 1996-EORTC 24891.pdf

S5024-DeCIDE (IRB 13362B, Chicago) 0-NCT00117572.pdf

S5025-National Health Research Institutes, Taiwan 0-NCT00201396.pdf

S5615-EORTC 24971 (TAX 323) 2006-NCT00003888.pdf

S5616-Posner (TAX324) 2007-NCT00273546.pdf

S5618-GORTEC 2000-01 0-NCT00169182.pdf

S5619-Hitt docetaxel 2005.pdf

S5623-Chauvergne 1988.pdf

S5712-Kohno 2000.pdf

S5716-Hitt paclitaxel 2005.pdf

S5717-Fonseca 2005.pdf

S5718-Le 2006.pdf

S5719-Olaz 2004.pdf

S5720-Caponigro 2002.pdf

S5721-Jiang 2001.pdf

S5724-De Andres 1995.pdf

S5728-BNP-CARDS 2007-NCT00186329.pdf

S5729-JUMBO-TIMI 26 2005.pdf

S5730-TRITON 0.pdf

S5732-COURAGE 2007-NCT00007657.pdf

S5733-EVEREST Clinical Status 2007-NCT00071331.pdf

S5734-EVEREST Outcome 2007.pdf

S5735-MASS II 2007.pdf

S5736-MASS II 2007.pdf

S5737-MASS II 2007.pdf

S5738-MERLIN TIMI 36 2007-NCT00099788.pdf

S5739-ERICA 2006-NCT00091429.pdf

S5740-CARISA 750mg 2004.pdf

S5741-ARISE 2007-NCT00066898.pdf

S5748-VALIDD 2007-NCT00170924.pdf

S5753-METEOR 2007-NCT00225589.pdf

S5754-ICTUS 2007-ISRCTN82153174.pdf

S5756-Katori 2005.pdf

S5762-Licitra 2003-NCT00002747.pdf

S5763-Clark (Dana farber cancer Institute 83-084) 1988.pdf

S5764-Hitt (PF) 2005.pdf

S5765-Hitt (TPF) 2005.pdf

S5768-Buffoli (Brescia) 1992.pdf

S5769-Merlano (INRC HN-7) 1991.pdf

S5771-Taylor (ICC-PCP) 1994.pdf

S5789-Pearlman (Denver 77 ) 1985.pdf

S5799-SECOG II 0.pdf

S5816-Merlano (INRC HN-7) 1990.pdf

S5817-Adelstein (CMGH-85) 1990.pdf

S5822-RTOG 91-11 (I+RT vs concurrent CRT) 2003.pdf

S5835-Pinnaro 1994.pdf

S5845-EORTC 24954 0-EORTC 24954.pdf

S587-VA-NHLBI 1977.pdf

S588-ANBPS (Australian ) 1980.pdf

S589-Oslo (Hegeland) 1980.pdf

S590-MCR 35-64 (diuretics vs pbo) 1985.pdf

S595-ABCD hypertension 1998.pdf

S596-FACET 1997.pdf

S597-MIDAS (diabetic sub group) 1997.pdf

S598-UKPDS 39 1998.pdf

S599-UKPDS 38 1998.pdf

S600-FRISC 2 1999.pdf

S601-TIMI 3B (PTCA) 1994.pdf

S602-VANQWISH 1998.pdf

S603-RITA 2 1997.pdf

S604-ACME 1992.pdf

S605-Sievers 1993.pdf

S606-MASS 1995.pdf

S607-BARI 1996-NCT00000462.pdf

S608-MASS 1995.pdf

S609-CABRI 1995.pdf

S610-EAST 1994-NCT00000465.pdf

S611-GABI 1994.pdf

S612-Lausanne 1994.pdf

S613-RITA 1993.pdf

S614-ERACI 1992.pdf

S615-Toulouse 1992.pdf

S617-SOLVD treatment 1991-NCT00000516.pdf

S619-SOLVD prevention 1992-NCT00000516.pdf

S620-Canadian study (CCSG) 1978.pdf

S621-Swedish study 1987.pdf

S622-UK-TIA low dose 1988.pdf

S623-UK-TIA high dose 1988.pdf

S624-SALT 1991.pdf

S625-Reuther 1976.pdf

S626-AITA 1975.pdf

S627-DCS 1980.pdf

S628-AICLA 1981.pdf

S629-Lindblad 1991.pdf

S630-Danish low-dose 1986.pdf

S631-ESPS 2 1996.pdf

S632-TRACE 1995.pdf

S633-AIRE 1993.pdf

S634-SAVE 1992.pdf

S635-SMILE 1995.pdf

S636-CCS 1 1995.pdf

S637-ISIS 4 1995.pdf

S638-GISSI 3 1994.pdf

S639-CONSENSUS II 1992.pdf

S640-WIN 0.pdf

S641-EPISTENT à effacer doublons 1998.pdf

S642-Serruys Benestent 2 1998.pdf

S643-TASC-I 1997.pdf

S644-Versaci 1997.pdf

S6443-Mateo à effacer 1984.pdf

S6446-Strauss 1982.pdf

S646-Fischman STRESS 1994.pdf

S647-Serruys Benestent 1994.pdf

S6472-Livesley 1973.pdf

S6473-Floris (SR 200mg od) 1982.pdf

S6474-Comerford 1976.pdf

S6475-Hammershoy 1982.pdf

S6476-DIRDURANG (Frances) 200mg 1995.pdf

S6477-DIRDURANG (Frances) 300mg 1995.pdf

S6478-Keyrilainen 1975.pdf

S6479-Uusitalo 1979.pdf

S6480-Frick 1976.pdf

S6481-Borer 1976.pdf

S6482-Ekelund 60mg 1976.pdf

S6483-Ekelund 150mg 1976.pdf

S6484-Thadani 1980.pdf

S6485-Klein 1990.pdf

S6486-Keyrilainen 1976.pdf

S6487-Uusitalo 1981.pdf

S6488-Oro 1981.pdf

S6489-Rousseau 2005.pdf

S6490-Comerford 1982.pdf

S6491-Boyle 200mg 1983.pdf

S6492-Petru 1983.pdf

S6493-Lindenberg 1983.pdf

S6494.pdf

S6495.pdf

S6496.pdf

S6497-Bala Subramanian 1983.pdf

S6498-De Backer 1982.pdf

S6499.pdf

S6500.pdf

S6501.pdf

S6502.pdf

S6503.pdf

S6504.pdf

S6505-Pool 1982.pdf

S6506-Strauss à supprimer 1982.pdf

S6507-Sandler 360mg 1968.pdf

S6508-Sandler 120mg 1968.pdf

S6509-Balasubramanian 1976.pdf

S6510-Andreasen 1975.pdf

S6511-Go 1984.pdf

S6512-Mehta 1981.pdf

S6513-TAX324 (Larynx preservation subset) 2007-NCT00273546.pdf

S6514-Barcelona (Quer) 0.pdf

S6526-Freedman 1987.pdf

S6527-Crea 1990.pdf

S6528-Shapiro 1985.pdf

S6530-Khurmi 1990.pdf

S6531-Carboni 1987.pdf

S6532-Chan 1982.pdf

S6533-Borer 5mg 2003.pdf

S6534-Borer 10mg 2003.pdf

S6535-Borer 20mg 2003.pdf

S6537-Ruzyllo 2007.pdf

S6538-INITIATIVE (Tardif) 15mg 2005.pdf

S6540-Hung 1983.pdf

S6543-SISR 2007-NCT00231257.pdf

S6544-Tomai 2008.pdf

S6545-Kochiadakis 2007.pdf

S6546-RAVEL 2002-NCT00233805.pdf

S6547-SIRIUS 2003-NCT00232765.pdf

S6548-C-SIRIUS 2004-NCT00381420.pdf

S6549-E-SIRIUS 2003-NCT00235144.pdf

S6550-TAXUS I 2003.pdf

S6551-TAXUS II 2003-NCT00299026.pdf

S6552-TAXUS IV 2004-NCT00292474.pdf

S6553-ASPECT 2003-NCT00196079.pdf

S6554-ELUTES 2004.pdf

S6555-DELIVER 2004.pdf

S6556-PATENCY 2002.pdf

S6557-SCORE 2004.pdf

S6558-ACTION 2004.pdf

S6559-FUTURE I 2004.pdf

S6560-FUTURE II 2006.pdf

S6562-TAXUS V (all patients) 2005-NCT00301522.pdf

S6563-TAXUS VI 2005-NCT00297804.pdf

S6564-PASSION 2006-ISRCTN65027270.pdf

S6565-HAAMU-STENT 2006.pdf

S6568-SES-SMART 2004.pdf

S6569-DIABETES 2005.pdf

S6570-Pache et al 2005.pdf

S6571-PRISON II 2006-NCT00258596.pdf

S6572-SCANDSTENT 2006-NCT00151658.pdf

S6573-TYPHOON 2006-NCT00232830.pdf

S6574-SESAMI 2007-NCT00288210.pdf

S6575-DECODE 2005-NCT00489164.pdf

S6576-SCORPIUS 2007-NCT00495898.pdf

S6577-RRISC 2006-NCT00263263.pdf

S6578-MISSION 2008-ISRCTN62825862.pdf

S6580-TAXi 2005.pdf

S6581-ISAR-DESIRE (SES vs PES) 2005.pdf

S6582-ISAR-DIABETES 2005.pdf

S6583-SIRTAX (Windecker) 2005.pdf

S6584-CORPAL 2005.pdf

S6585-REALITY 2006-NCT00235092.pdf

S6586-ISAR-SMART 3 2006-NCT00146575.pdf

S6587-Zhang (SES vs PES) 2006.pdf

S6588-LONG DES II 2006.pdf

S6589-PROSIT 2006.pdf

S6590-SORT OUT II 2008-NCT00388934.pdf

S6591-Cervinka 2006.pdf

S6592-Petronio et al 2007.pdf

S6594-Han 2006.pdf

S6596-BASKET (vs paclitaxel) 2005.pdf

S6597-Di Lorenzo et al. 2005.pdf

S6599-Stone pooled analysis sirolimus 2007.pdf

S6600-Stone pooled analysis TAXUS studies 2007.pdf

S6601-Spaulding pooled analysis Ravel Sirius studies 2007-NCT00232765.pdf

S6604-ENDEAVOR II 2006.pdf

S6608-ABSORB 0-NCT00300131.pdf

S6610-Pasceri 2003.pdf

S6611-STRATEGY 2005-NCT00229515.pdf

S6615-Ravel (diabetics) 2004.pdf

S6619-SES-SMARt (diabetics) 2005.pdf

S6620-TAXUS II (diabetics) 2003.pdf

S6622-TAXUS IV (diabetics) 2005-NCT00292474.pdf

S6623-TAXUS V (diabetics) 2005.pdf

S6624-TAXUS VI (diabetics) 2005-NCT00297804.pdf

S6625-pooled SIRIUS (diabetics) 0.pdf

S6627-ISAR-CABG 0-NCT00611910.pdf

S6628-SPIRIT I 2005-NCT00180453.pdf

S6629-CRISTAL 0-NCT00323895.pdf

S6630-RES-I 2010-NCT00606333.pdf

S6631-PERSEUS Workhorse 2010-NCT00484315.pdf

S6632-DEFER-DES 0-NCT00592228.pdf

S6633-BASKET-SAVAGE 0-NCT00595647.pdf

S6634-EK-12006 0-NCT00279006.pdf

S6635-LEADERS 2008-NCT00389220.pdf

S6636-DES-ISR 0-NCT00485030.pdf

S6637-GISSOC II 2010-NCT00220558.pdf

S6638-FRE-RACE 0-NCT00130546.pdf

S6639-DIABEDES IV 0-NCT00552994.pdf

S6640-SPIRIT II 2006-NCT00180310.pdf

S6641-SYNTAX 2009-NCT00114972.pdf

S6643-FOCUS 0-NCT00485004.pdf

S6644-Lipsia-Yukon-DM 0-NCT00368953.pdf

S6645-ENDEAVOR III 2006-NCT00217256.pdf

S6646-ENDEAVOR IV 2009-NCT00217269.pdf

S6647-Nordic Bifurcation Study 0-NCT00376571.pdf

S6648-SPIRIT IV 2010-NCT00307047.pdf

S6649-SPIRIT III 2008-NCT00180479.pdf

S6650-LEFT-MAIN-2 0-NCT00598637.pdf

S6651-VELETI 0-NCT00289835.pdf

S6652-ISAR-TEST-1 2006-NCT00140530.pdf

S6653-Leipzig 0-NCT00176397.pdf

S6654-ISAR-DESIRE-2 2010-NCT00598715.pdf

S6655-ISAR-LEFT-MAIN 2009-NCT00133237.pdf

S6656-ZoMaxx phase 2 0-NCT00140101.pdf

S6657-ZoMaxx phase 3 2007-NCT00148356.pdf

S6658-PEPCAD IV 0-NCT00462631.pdf

S6659-Nordic Bifurcation Stent Technique Study 0-NCT00292305.pdf

S6661-RESEARCH à effacer 2004.pdf

S6662-PROTECT 2012-NCT00476957.pdf

S6663-PEPCAD III 0-NCT00473499.pdf

S6664-MIDCAB Versus DES in Proximal LAD Lesions 0-NCT00299429.pdf

S6665-PRISON III 2007-NCT00428454.pdf

S6666-SORT OUT IV 2012-NCT00552877.pdf

S6667-FEMH-93005 0-NCT00190099.pdf

S6669-GENESIS Trial CP-01 0-NCT00322569.pdf

S6672-Fonseca 2005.pdf

S6673-- Prévost 2005.pdf

S6674-Fonseca 1997.pdf

S6675-Starr 1996.pdf

S6676-Vokes 1990.pdf

S6677-EORTC 24971 (TAX 323) 2006-NCT00003888.pdf

S6678-Posner (TAX324) 2007-NCT00273546.pdf

S6679-GORTEC 2000-01 0-NCT00169182.pdf

S6680-Hitt docetaxel 2005.pdf

S6681-- Chauvergne 1988.pdf

S6682-Le 2006.pdf

S6683-Olaz 2004.pdf

S6684-Caponigro 2002.pdf

S6685-Jiang 2001.pdf

S6686-De Andres 1995.pdf

S6687-Katori 2005.pdf

S6688-- Clark (Dana farber cancer Institute 83-084) 1988.pdf

S6689-Vokes 1992.pdf

S6690-Laccourreye 1983.pdf

S6691.pdf

S6692-Yau 2006.pdf

S6695-Barcelona (Quer) 0.pdf

S6697-Toohill (MCW-2) 1987.pdf

S6699-Lewin (SHNG-85) 1997.pdf

S6700-Paccagnella (GSTTC-86 ) 1994.pdf

S6701-Domenge (GETTEC neo1) 1995.pdf

S6702-Domenge (GETTEC) 2000.pdf

S6703-Dalley (AHNTG) 1995.pdf

S6704-Tejedor (Las Palmas) 1992.pdf

S6705-Gedouin (Rennes-87) 1996.pdf

S6706-Di Blasio (Parma) 1994.pdf

S6707-Depondt (CFHNS) 1993.pdf

S6708-Volling (Cologne) 1994.pdf

S6709-Hasegawa (HNAP-02) 1996.pdf

S6710-BNH 003 0.pdf

S6711-Hareyama 2002.pdf

S6712-Licitra 2003-NCT00002747.pdf

S6713-Hitt (PF) 2005.pdf

S6714-EORTC 24844 0-EORTC-24844.pdf

S6715-Hitt (TPF) 0.pdf

S6716-ASPEN 2006.pdf

S6718-ZEST (vs SES) 2009-NCT00418067.pdf

S6719-ZEST AMI (vs PES) 2009-NCT00422565.pdf

S6720-phase II 10mg 0.pdf

S6721-phase II 15mg 0.pdf

S6722-Kirtane (pooled Taxus diabetic patients) 2008.pdf

S6723-ACCORD 2008-NCT00000620.pdf

S6725-ADVANCE 2008-NCT00145925.pdf

S6726-ADVANCE 2007-NCT00145925.pdf

S6727-RE-MOBILIZE (220mg) 2008.pdf

S6728-RE-MODEL (220mg) 2007.pdf

S6729-RE-NOVATE (220mg) 2007-NCT00168818.pdf

S6730-ISAR 2005.pdf

S6731-Neumann 1966.pdf

S6732-Nouvel essai 1987.pdf

S6733-Khurmi 1987.pdf

S6736-ISAR-REACT 3 2008-NCT00262054.pdf

S6739-STEEPLE 2006-NCT00077844.pdf

S6740-Enhance 2008.pdf

S6741-ONTARGET (telmisartan alone) 2008-NCT00153101.pdf

S6743-ONTARGET (association vs ramipril) 2008-NCT00153101.pdf

S6744-PERISCOPE 2008-NCT00225277.pdf

S6745-STRADIVARIUS 2008-NCT00124332.pdf

S6746-AUDITOR 0.pdf

S6747-CRESCENDO 2010-NCT00263042.pdf

S6748-taranabant phase 3 0.pdf

S6749-IMPROVE-IT 2014-NCT00202878.pdf

S6750-HYVET 2008.pdf

S6751-JUPITER 2008-NCT00239681.pdf

S6752-TOMIIS 1994.pdf

S6753-Horie et al 1998.pdf

S6754-TOAT 2002.pdf

S6755-DECOPI 2004.pdf

S6756-Silva et al 2005.pdf

S6757-OAT 2006.pdf

S6758-TOSCA-2 2006-NCT00025766.pdf

S6761-Dakik 1998.pdf

S6762-ALKK 2003.pdf

S6763-Hambrecht 2004.pdf

S6764-Bech 2001.pdf

S6766-Nouvel essai 0.pdf

S6769-TRUCS 2000.pdf

S6770-ISAR-COOL 2003.pdf

S6772-OASIS 2 1999.pdf

S6774-Nicklas 1989.pdf

S6775-Gold 1987.pdf

S6776-Williams 1990.pdf

S6777-Freeman 1992.pdf

S6779-van der Brand 1991.pdf

S6780-charbonnier 1992.pdf

S6781-Ardissino 1990.pdf

S6782-TIMI 3B 1995.pdf

S6783-TAUSA 1994.pdf

S6786-CORONA 2007-NCT00206310.pdf

S6788-VA cooperative 1987.pdf

S6789-ATACS main 1994.pdf

S6790-ATACS pilot 1990.pdf

S6791-APRICOT-2 2002.pdf

S6792-ASPECT-2 (coumadin alone) 2002.pdf

S6793-Huynh 2001.pdf

S6794-OASIS main 2001.pdf

S6795-OASIS pilot 1998.pdf

S6796-WARIS II (warfarin alone) 2002.pdf

S6797-Williams 1997.pdf

S6798-Zibaeenezhad 2004.pdf

S6807-ARTS 2001.pdf

S6808-Cisowski 0.pdf

S6809-Diegeler 2002.pdf

S6810-Drenth 2002.pdf

S6811-ERACI II 2003.pdf

S6812-Grip 2001.pdf

S6813-OCTOSTENT 2003-NCT00975858.pdf

S6814-SIMA 2000.pdf

S6815-SOS 2002-NCT00475449.pdf

S6818-CARDia (PCI) 2008-ISRCTN19872154.pdf

S6819-FREEDOM 2012-NCT00086450.pdf

S6821-AMIST (Reeves) 2004.pdf

S6822-Hong 2005.pdf

S6823-Kim 2005.pdf

S6825-Atlanta (Sbar) 1967.pdf

S6826-Becker 1967.pdf

S6827-Mayo-B (Chesebro) 1983.pdf

S6828-Berglund 1985.pdf

S6829-Wirecki 1967.pdf

S6830-SAPAT 1992.pdf

S6831-VA bypass IV-B (aspirin 325 od) 1989.pdf

S6849-Dutch-aspirin 1990.pdf

S6850-Gent-AMI 1968.pdf

S6851-ISIS-pilot 1987.pdf

S6852-ISIS-2 1988.pdf

S6853-French 1993.pdf

S6854-Dutch sulphinpyrazone 1986.pdf

S6855-Huddinge 1988.pdf

S6856-Jones 1987.pdf

S6857-Knudsen-A 1985.pdf

S6858-Johannessen 1989.pdf

S6859-Wilcox 1980.pdf

S6860-GRAND 1987.pdf

S6861-Frankfurt 1976.pdf

S6862-Louvain sulphinpyrazone 1983.pdf

S6863-APRICOT 1993.pdf

S6866-TACT 1990.pdf

S6867-Schwartz (Toronto) 1988.pdf

S6868-White (aspirin+dipiridamol) 1991.pdf

S6869-Finci 1989.pdf

S6870-Taylor (Perth) 1991.pdf

S6871-Nye (Dunedin) 1990.pdf

S6872-Mayo-PTCA 1989.pdf

S6873-Oriol 1995.pdf

S6874-M-HEART II (aspirin) 1995.pdf

S6876-McEnany 1982.pdf

S6877-Brooks 1985.pdf

S6878-Mayo-A 1984.pdf

S6879-Liège-I 1984.pdf

S6880-Liège-II 1987.pdf

S6881-Pantely 1979.pdf

S6882-Wadsworth 1985.pdf

S6883-Lorenz 1984.pdf

S6884-VA Co-op CABG 1988.pdf

S6885-CABG .pdf

S6886-Brussels 1987.pdf

S6887-GESIC (aspirin) 1990.pdf

S6888-Basel 1989.pdf

S6890-Leeds-B 1985.pdf

S6891-Czech 1986.pdf

S6892-Thaulow 1987.pdf

S6893-Guiteras 1989.pdf

S6894-Sydney 1991.pdf

S6895-Des Moines 1980.pdf

S6896-Zurich 1982.pdf

S6897-Knudsen-B 1983.pdf

S6898-Romeo 1983.pdf

S6899-Baur 1982.pdf

S6900-Kohn 1990.pdf

S6901-Toronto dipyridamole 1987.pdf

S6902-Hockings 1993.pdf

S6903-Ekestrom 1990.pdf

S6904-German sulotroban 1989.pdf

S6906-PNFP-010 .pdf

S6907-PNFP-014 .pdf

S6908-PNFP-027 .pdf

S6909-PNFP-026 .pdf

S6910-OPI-502 .pdf

S6911-PNFP-012 .pdf

S6912-OPI-504 -NCT00521820.pdf

S6913-GLAI -NCT00331487.pdf

S6914-PNFP-001 .pdf

S6915-EC405 .pdf

S6916-OPI-501 .pdf

S6917-EC404 .pdf

S6918-EC409 .pdf

S6919-EC410 .pdf

S692-OMS clofibrate 1978.pdf

S6920-OPI-520 -NCT00521742.pdf

S6921-GLAT .pdf

S6922-CHICAGO .pdf

S6924-OPI-506 0-NCT00494312.pdf

S6926.pdf

S6927.pdf

S6928.pdf

S6929.pdf

S6930.pdf

S6931-100684 -NCT01045590.pdf

S6932.pdf

S6933.pdf

S6934.pdf

S6935.pdf

S6936-AVM100264 -NCT00359112.pdf

S6937.pdf

S6938.pdf

S6939.pdf

S6940.pdf

S6941.pdf

S6942.pdf

S6943.pdf

S6944.pdf

S6945.pdf

S6946.pdf

S6948.pdf

S6949.pdf

S6950.pdf

S6951.pdf

S6952.pdf

S6953.pdf

S6954.pdf

S6955.pdf

S6956.pdf

S6957.pdf

S6958.pdf

S6959.pdf

S696-LIPID 1998.pdf

S6960.pdf

S6961.pdf

S6962.pdf

S6963.pdf

S6964.pdf

S6965.pdf

S6966-AVA100193 .pdf

S6967-DREAM -NCT00095654.pdf

S6968-ADOPT 2006-NCT00279045.pdf

S6969-OASIS 6 2007-NCT00064428.pdf

S697-CARE 1996.pdf

S6970-CREATE-ECLA 2006.pdf

S6971-Glucose-insulin-potassium study II 2007.pdf

S6972-Krljanac 2005.pdf

S6973-Bucciarelli-Ducci 2006.pdf

S6975-A to Z 2004-NCT00251576.pdf

S6976-Vascular basis 2005.pdf

S6977-SAGE 2007.pdf

S6979-Costar II 2008-NCT00165035.pdf

S698-4S 1994.pdf

S6980-ASTEROID 0.pdf

S6983-Excel 1991.pdf

S6984-Weintraub 1994.pdf

S699.pdf

S700-Newcastle 1971.pdf

S701-Scottish 1971.pdf

S702-VA-HIT 1999-NCT00283335.pdf

S703-BIP 2000.pdf

S7039-SHEP (diabetic subgroup) 1996.pdf

S704-Carlson 1977.pdf

S7040-Syst-Eur (diabetic subgroup) 1999.pdf

S7041-HOPE (diabetic subgroup) 2000.pdf

S7042-RENAAL 2001.pdf

S7043-IPDM 150mg 2001.pdf

S7044-CAPP (diabetic subgroup) 1999.pdf

S7045-NORDIL (diabetic subgroup) 2000.pdf

S7046-INSIGHT (diabetic subgroup) 2000.pdf

S7047-STOP-2 CCB (diabetic subgroup) 2000.pdf

S7048-STOP-2 ACEI (diabetic subgroup) 2000.pdf

S7049-IDNT irbesartan 2001.pdf

S705.pdf

S7050-IDNT amlodipine 2001.pdf

S7051-IDNT (irbesartan vs amlodipine) 2001.pdf

S7052-Coope (subgroup ) 1986.pdf

S7053-EWPHE (subgroup ) 1985.pdf

S7054-SHEP-P (subgroup ) 1989.pdf

S7055-SHEP (subgroup ) 1991.pdf

S7056-STOP (subgroup ) 1991.pdf

S7057-Syst-Eur (subgroup ) 1997.pdf

S7058-CASTEL (subgroup ) 1994.pdf

S706-Woodhill 1966.pdf

S7061-Syst-China 1998.pdf

S7066-MRC2 1992.pdf

S7067-CONVINCE 2003.pdf

S7068-STOP-2 1999.pdf

S7069-AASK (vs metoprolol) 2002.pdf

S707-MRC Soya 1968.pdf

S7070-ALLHAT (vs chlorthalidone) 2002.pdf

S7071-ANBP2 2003.pdf

S7073-AASK (vs amlodipine) 2002.pdf

S7074-ABCD (N) 2002.pdf

S7075-ALLHAT (vs amlodipine) 2002.pdf

S7076-JMIC-B 2002.pdf

S7077-IDNT 2001.pdf

S7078-NICOLE 2001.pdf

S7079-AASK (vs metoprolol) 2002.pdf

S708-Oslo 1966.pdf

S7080-ALLHAT (CCB vs diu) 2002.pdf

S7081-ELSA 2002.pdf

S7082-SHELL 2003.pdf

S7083-IDNT (vs placebo) 2001.pdf

S7084-RENAAL 2001.pdf

S709-Rose 1965.pdf

S7094-ACCOMPLISH 2008-NCT00170950.pdf

S7095-CARE-HF 2005.pdf

S7096-COMPANION (CRT vs MT) 2004.pdf

S7097-MIRACLE 2002.pdf

S7098-MUSTIC-SR 2001.pdf

S7099-MUSTIC AF 2002.pdf

S710-MRC low fat 1965.pdf

S7100-HAPPY 1987.pdf

S7101-HYVET 2008-NCT00122811.pdf

S7102-ALLHAT (CCB vs ACEI) 2002.pdf

S7104-No trial available for MK-0524A 0.pdf

S7105-AASK (vs ramipril) 2002.pdf

S7106-ABCD 0.pdf

S7107-FACET 0.pdf

S7108-Castel 1994.pdf

S7109-MRC (diu vs BB) 1985.pdf

S7111-VALUE 2004-NCT00129233.pdf

S7112-SCOPE 2003.pdf

S7113-LIFE 2002.pdf

S7114-IDNT (vs amlodipine) 2001.pdf

S7116-RE-MODEL (150mg) 2007.pdf

S7117-RE-NOVATE (150mg) 2007-NCT00168818.pdf

S7118-RE-MOBILIZE (150mg) 2008.pdf

S7119-BISTRO II (225mg bid) 2005.pdf

S712-No trial available for aaa 0.pdf

S7120-PENTAMAKS (Bauer) 2001.pdf

S7121-PENTHIFRA–PLUS (Eriksson) 2003.pdf

S7122-PENTHIFRA (Eriksson) 2001.pdf

S7123-PENTATHLON (Turpie) 2002.pdf

S7124-EPHESUS (Lassen) 2002.pdf

S7125-Phase II (Heit) 2001.pdf

S7126-Platinum (Colwell) 2003.pdf

S7127-METHRO I 2002.pdf

S7128-METHRO II 2002.pdf

S7129-METHRO III 2002.pdf

S713-COMET 2003.pdf

S7130-EXPRESS 2003.pdf

S7131-Stockholm-I 1975.pdf

S7132-Lyon-I 1975.pdf

S7133-Massachusetts-II 1976.pdf

S7134-Pasteyer 1977.pdf

S7135-Harris-I 1977.pdf

S7136-McKenna-I 1980.pdf

S7137-Sautter 1983.pdf

S7138-Cooke 1977.pdf

S7139-Rocha 1986.pdf

S7140-McKenna-II 1983.pdf

S7141-McBride 1983.pdf

S7142-Hume-A 1977.pdf

S7143-Lyon-II 3000.pdf

S7144-Gardecki 3000.pdf

S7145-Stockholm-II 1981.pdf

S7146-Hamburg 1976.pdf

S7147-Anderson 1985.pdf

S7148-Paolisso 1992.pdf

S7149-Waagstein 1993.pdf

S7150-Hull 1993.pdf

S7151-RD Heparin 1994.pdf

S7152-Hamulyak 1994.pdf

S7153-Leclerc 1996.pdf

S7154-Francis 1997.pdf

S7155-Heit 1997.pdf

S7156-Colwell 1999.pdf

S7157-Hull 2000.pdf

S7158-Fitzgerald 2001.pdf

S7159-Samama 2001.pdf

S7160-Borsgtrom 1965.pdf

S7161-Eskeland 1966.pdf

S7162-Myrhe 1969.pdf

S7163-Hamilton 1970.pdf

S7164-Pinto 1970.pdf

S7165-Hume 1973.pdf

S7166-Morris 1976.pdf

S7167-Powers 1989.pdf

S7168-Myrhe 1969.pdf

S7169-Harris 1972.pdf

S7170-Barber 1977.pdf

S7171-Francis 1983.pdf

S7172-Hume 1973.pdf

S7173-Powers 1989.pdf

S7174-Lotke 1997.pdf

S7175-Paiement 1987.pdf

S7176-Bailey 1991.pdf

S7177-Kaempffe 1991.pdf

S7178-Francis 1992.pdf

S7179-Hume 1973.pdf

S7180-Barber 1977.pdf

S7181-Gerhart 1991.pdf

S7182-van Comp 1998.pdf

S7183-van Geloven 1977.pdf

S7184-TRIAS-HR 2008-ISRCTN74297220.pdf

S7185-TRIAS-High-Risk à effacer 0.pdf

S7186-TRIAS-Low-Risk 0.pdf

S7187-Hamer 1989.pdf

S7188-Nicklas 1991.pdf

S7189-EPAMSA 1985.pdf

S7190-GESICA 1994.pdf

S7191-STATCHF 1995.pdf

S7192-ATHENA à effacer 0.pdf

S7193-EURIDIS 2007-NCT00259428.pdf

S7194-ADONIS 2007-NCT00259376.pdf

S7195-the Italian Elderly ACS study 0-NCT00510185.pdf

S7196-Williams 1978.pdf

S7197-Abraham-Inpijn 1975.pdf

S7198-Lowe 1981.pdf

S7199-Morris 1974.pdf

S7200-Welin-Berger 1982.pdf

S7201-Bergqvist 1979.pdf

S7202-Hampson 1974.pdf

S7203-Moskovitz 1978.pdf

S7204-Gallus 1973.pdf

S7205-VTCSG 1975.pdf

S7206-Mannucci 1976.pdf

S7207-Dechavanne 1974.pdf

S7208-Dechavanne 1975.pdf

S7209-Lahnborg 1980.pdf

S7210-Xabregas 1977.pdf

S7211-Bergqvist 1979.pdf

S7212-Galasko 1976.pdf

S7213-Moskovitz 1978.pdf

S7214-Svend-Hansen 1981.pdf

S7215-Gallus 1973.pdf

S7216-Morris 1977.pdf

S7217-PETRO (150mg) 2007.pdf

S7218-RE-LY (150mg) 2009-NCT00262600.pdf

S7219- Weitz (edoxaban phase 2) 0-NCT00504556.pdf

S7221-idraparinux BOREALIS-AF 0-NCT00580216.pdf

S7222-ROCKET-AF 2010-NCT00403767.pdf

S7223-AMADEUS 2008-NCT00070655.pdf

S7224-ODIXa-HIP 10mg 2006.pdf

S7225-ODIXa-KNEE 2005.pdf

S7226-APROPOS 2.5mg 2007-NCT00097357.pdf

S7228-Turpie 2001.pdf

S7229-DRIVE 2008-NCT00338897.pdf

S7230-PENTUA 2004.pdf

S7231-OASIS 5 2006-NCT00139815.pdf

S7233-INTERACT 2006.pdf

S7234-EVET 2005.pdf

S7235-Gurfinkel (LMWH+asp vs UFH+asp) 1995.pdf

S7236-OASIS 1997.pdf

S7238-Holdright 1994.pdf

S7240-Cohen (ATACS pilot) (heparin+aspirin vs asp) 1990.pdf

S7241-RISC (heparin+aspirin vs ASP) 1990.pdf

S7242-Theroux (heparin+aspirin vs PBO) 1988.pdf

S7243-Gurfinkel (UFH+aspririn vs aspirin) 1995.pdf

S7244-Christenson 1999.pdf

S7245-Chello et al. 2006.pdf

S7246-Patti et al. 2006.pdf

S7247-Leicester (Naylor) 1998.pdf

S7248-WALLSTENT (Alberts) 2001.pdf

S7249-CAVATAS-CEA 2001-ISRCTN01425573.pdf

S7250-Kentucky A (Brooks) 2001.pdf

S7251-Link 2000.pdf

S7252-SPACE 2000.pdf

S7253-EVA-3S (Mas) 2000.pdf

S7256-Theroux (heparin vs PBO) 1988.pdf

S7257-RISC (heparin vs PBO) 1990.pdf

S7258-Cohen (ATACS pilot) (heparin vs asp) 1990.pdf

S7259-Gurfinkel (LMWH+asp vs asp) 1995.pdf

S7260-FRIC prolonged treatment phase (LWMH vs PBO) 1997.pdf

S7261-CLARITY 0.pdf

S7262-TRITON-TIMI 38 2007-NCT00097591.pdf

S7263-CURE PCI importé 2001.pdf

S7264-Niitani 1992.pdf

S7265-Magnani 1990.pdf

S7266-CMRG 1983.pdf

S7267-Rieger 1991.pdf

S7268-Dosseger 1993.pdf

S7269-Gundersen 1994.pdf

S7270-Brown 1995.pdf

S7271-Cilazapril-Captopril Multi-centre Group 1995.pdf

S7272-FEST (Erhardt) 1996.pdf

S7273-Hampton 1998.pdf

S7274-Sharpe 1984.pdf

S7275-McGrath 1985.pdf

S7276-Chrysant 1985.pdf

S7278-Lough 1998.pdf

S7279-Acanfora 1997.pdf

S728-ATACS (Cohen) 1994.pdf

S7280-beynon 1997.pdf

S7281-Nussberger 1994.pdf

S7282-Quinapril Heart Failure Trial Investigators 1993.pdf

S7283-Yasumura 2004.pdf

S7284-I-PRESERVE (McMurray) 2008-NCT00095238.pdf

S7285-Gremmler 2007.pdf

S7286-Kum 2008.pdf

S7287-White 2007.pdf

S7288-CL3-018 10mg 0.pdf

S7289-CL3-018 15mg 0.pdf

S729-FRISC (long term) 1996.pdf

S7290-Harvey 1950.pdf

S7291-Anderson 0.pdf

S7292-Griffith 1952.pdf

S7293-HELAS (warfarin vs placebo) 2006.pdf

S7294-WATCH (warfarin vs aspirin) 2009-NCT00007683.pdf

S7295-Losartan phase II S 1996.pdf

S7296-losartan phase II US 1996.pdf

S7297-PEP CHF 2006.pdf

S7298-Sumukadas 2007-ISRCTN676795.pdf

S7299-Hutcheon 2002.pdf

S730-FRIC (acute phase LMWH vs UFH) 1997.pdf

S7301-Cilazapril-Captopril Multi-centre Group (capt vs pbo) 1995.pdf

S7302-Cilazapril-Captopril Multi-centre Group (cila vs capt) 1995.pdf

S7303-packer 1986.pdf

S7304-WATCH (clopidogrel vs aspirin) 0.pdf

S7305-WASH (aspirin) 2004.pdf

S7306-Barzizza (ASA) 1993.pdf

S7307-Boccanelli 1986.pdf

S7308-Burr 1977.pdf

S7309-Cheitlin 1991.pdf

S731-FRAXIS (6days) 1998.pdf

S7310-Cowley 1986.pdf

S7311-Dalhstrom 1986.pdf

S7312-De jong 1994.pdf

S7313-Haerer 1989.pdf

S7314-Myers 1982.pdf

S7315-Nordrehaug 1992.pdf

S7316-Richardson 1987.pdf

S7317-Sherman 1986.pdf

S7318-Sievert 1989.pdf

S7319-Walma 1997.pdf

S732-ESSENCE 1997.pdf

S7320-Walma (copie de 7319) 1997.pdf

S7321-Myers (copie de 7314) 1982.pdf

S7322-De jong (copie de 7312) 1994.pdf

S7323-Burr (copie de 7308) 1977.pdf

S7324-Mathur 1984.pdf

S7325-Parker 1993.pdf

S7326-Andrews 1997.pdf

S7327-De Vries 1996.pdf

S733-TIMI 11 B (short term) 1998.pdf

S7330-RECORD 1 2008-NCT00329628.pdf

S7331-RECORD 2 2008-NCT00332020.pdf

S7332-RECORD 3 2008-NCT00361894.pdf

S7333-RECORD 4 2009-NCT00362232.pdf

S7334-FUSION 2 2008-NCT00091520.pdf

S7335-EVEREST 2008-NCT00071331.pdf

S7336-ACTIV in CHF 2004.pdf

S7337-ASCEND-HF 2011-NCT00475852.pdf

S7339-Krum 2007.pdf

S7340-Node 2003.pdf

S7341-Laufs 2004.pdf

S7342-Strey 2005.pdf

S7343-Tousoulis 2005.pdf

S7344-Hong 2005.pdf

S7345-Landmesser 2005.pdf

S7346-GISSI-HF rosuvastatine 2008-NCT00336336.pdf

S7347-V-HeFT II 1991.pdf

S7349-FIRST 1997.pdf

S7352-VERITAS I 2006-NCT00525707.pdf

S7353-VERITAS II 2007-NCT00525707.pdf

S7354-RITZ-5 2003.pdf

S7356-RITZ 4 importé 2003.pdf

S7357-Ghose (vs placebo) 1993.pdf

S7358-Ghose (vs captopril) 1993.pdf

S7359-VHeFT I (prazosin) 1986.pdf

S7360-NICE (Lewis) 1999.pdf

S7361-Chatterjee 1980.pdf

S7362-Colucci 1980.pdf

S7363-Franciosa 1982.pdf

S7364-Markham 1983.pdf

S7365-Higginbotham 1983.pdf

S7366-Conradson 1984.pdf

S7367-Franciosa 1978.pdf

S7368-Harper 1980.pdf

S7369-Furberg 1985.pdf

S7370-Magorien 1984.pdf

S7371-Horizons 2008-NCT00433966.pdf

S7372-REPLACE-2 2003.pdf

S7373-DCCT (secondary prevention of retinopathy) 1993.pdf

S7374-Steno 2 2003.pdf

S7375-UKPDS 33 1998.pdf

S7376-UKPDS 34 1998.pdf

S7377-Kumamoto (primary prev) 1995.pdf

S7378-VA CSDM 1997.pdf

S7379-DIGAMI 1995.pdf

S7380-DIGAMI 2 2005.pdf

S7381-UGDP (IVAR) 1996.pdf

S7382-Kumamoto (secondary prev) 1995.pdf

S7383-Holman 1983.pdf

S7384-Verrillo 1988.pdf

S7385-Lauritzen (STENO 1) 1991.pdf

S7386-Lauritzen (STENO 2) à effacer 1992.pdf

S7387-SDIS 1993.pdf

S7388-MCSG 1995.pdf

S7390-Post CABG (sub group) 1999.pdf

S7391.pdf

S7392-GISSI P (sub group) 2000.pdf

S7393-LIPS (sub group) 2002.pdf

S7394-ALLHAT-LLT (sub group) 2002.pdf

S7395-ALERT (sub group) 2003.pdf

S7396-CARDS 2004.pdf

S7397-PROVE IT TIMI 22 (diabetic sub group) 2006.pdf

S7398-TNT (sub group) 2006.pdf

S7399-FIELD 2005-ISRCTN64783481.pdf

S7400-ASPEN 2006.pdf

S7401-Dahan 1986.pdf

S7402-Samama 1999.pdf

S7403-Fraisse 2000.pdf

S7404-Leizorovicz 2004.pdf

S7405-Mahe 2005.pdf

S7406-Lederle 2006.pdf

S7407-ARTEMIS (Cohen) 2006.pdf

S7408-Blech 1981.pdf

S7409-Cade 0.pdf

S7410-Gardlund 1996.pdf

S7411-Díaz de la Llera 2007.pdf

S7412-MULTISTRATEGY 2008.pdf

S7413-SIRTAX (small vessels subgroup) 2005.pdf

S7414-Erglis 2007.pdf

S7415-COMBAT 0.pdf

S7416-Korean Randomized Study 0.pdf

S7418-Munich Study 0.pdf

S7419-REVASCULARIZE 0.pdf

S7420-ExTraMATCH 2004.pdf

S7421-European multicentre study 1991.pdf

S7422-ACTSG (Hull) sub-group 1992.pdf

S7423-Prandoni sub-group 1992.pdf

S7424-Thery 1992.pdf

S7425-Kuijer 1995.pdf

S7426-Meyer 1995.pdf

S7427-COLOMBUS sub group 1997.pdf

S7428-THESEE 1997.pdf

S7429-Campbell 1998.pdf

S7430-PREPIC 1998.pdf

S7431-Certoparin-Study Group sub group 1998.pdf

S7432-Merli sub group 2001.pdf

S7435-ASSENT-4 PCI (Van de Werf) 2006-NCT00168792.pdf

S7436-SAMI (O’Neill) 1992.pdf

S7437-PRAGUE (Widimisky) 2000.pdf

S7438-LIMI (Vermeer) 1999.pdf

S7439-PACT (Ross,) 1999.pdf

S7440-GRACIA (Fernandez-Aviles,) 2004.pdf

S7441-On-Time (van’t Hof) 2004.pdf

S7442-TIGER-PA (Lee) 2003.pdf

S7443-ERAMI (Mesquita Gabriel) 2003.pdf

S7444-REOMOBILE (Arntz) 2003.pdf

S7445-Zorman 2002.pdf

S7446-Cutlip 2003.pdf

S7447-ReoPro-BRIDGING (Gyongyosi) 2004.pdf

S7448-INTAMI (Zeymer) 2005.pdf

S7449-Bellandi 2006.pdf

S7450-ADVANCE-MI 2005.pdf

S7451-BRAVE (Kastrati) 2004.pdf

S7452-FINESSE (combination-facilitated PCI) 2008-NCT00046228.pdf

S7456-Marassi [41] .pdf

S7457-Bergqvist [42] .pdf

S7459-ANDROMEDA 2008-NCT00543699.pdf

S7460-Schmitz-Huebner 1984.pdf

S7461-ToÈrngren 1984.pdf

S7462-Kakkar and Murray 1985.pdf

S7463-Bergqvist 1986.pdf

S7464-Onarheim 1986.pdf

S7465-Sasahara 1986.pdf

S7466-Voigt 1986.pdf

S7468-Koller 1986.pdf

S7469-EFS 1988.pdf

S7470-Fricker 1988.pdf

S7471-Bergqvist 1988.pdf

S7472-Caen 1988.pdf

S7473-Borstad 1988.pdf

S7474-Samama 1 1988.pdf

S7475-Samama 2 1988.pdf

S7476-Samama 3 1988.pdf

S7477-Welzel 1988.pdf

S7478-Briel 1988.pdf

S7482-Kakkar 1989.pdf

S7483-Adolf 1989.pdf

S7484-Heilmann 1989.pdf

S7485-Baumgartner 1989.pdf

S7486-Dahan 1989.pdf

S7487-Verardi 1989.pdf

S7488-Creperio 1990.pdf

S7489-Hartl 1990.pdf

S749-HINT (nifedipine vs metoprolol) 1988.pdf

S7491-Koppenhagen 1990.pdf

S7492-Barbui 1990.pdf

S7493-Leizorovicz 1991.pdf

S7494-Schielke 1991.pdf

S7495-Kaaja 1992.pdf

S7496-Koppenhagen 1992.pdf

S7497-Borstad 1992.pdf

S7498-Hoffmann and Largiader 1992.pdf

S7499-Garcea 1992.pdf

S750-Göbel (Dutch study) 1995.pdf

S7500-Kakkar 1993.pdf

S7501-Kakkar 1993.pdf

S7502-Godwin 1993.pdf

S7503-Gazzaniga (ISG) 1993.pdf

S7504-Limmer 1994.pdf

S7505-Eurin 1994.pdf

S7506-Nurmohamed 1995.pdf

S7507-McLeod (Canadian) 1995.pdf

S7508-Gonzalez 1996.pdf

S7509-ENOXACAN 1997.pdf

S751-DRS 1986.pdf

S7510-Heilmann 1997.pdf

S7511-Haas 1999.pdf

S7513-Westrich GH 2006.pdf

S7514-Stone 1996.pdf

S7515-Warwick 1998.pdf

S7516-Norgren 1998.pdf

S7517-Warwick à exclure 2002.pdf

S7518-Gelfer 2006.pdf

S7519-Planes 1999.pdf

S7520-TIFDED 1999.pdf

S7521-Navarro-Quilis A 2003.pdf

S7522-FX140, Simonneau G 2006.pdf

S7523-Planes A 1998.pdf

S753-RALES 1998.pdf

S7530-Faunø importé 1994.pdf

S7531-Rader importé 1997.pdf

S7532-Senaran importé 2006.pdf

S7533-Kakkar (IMT) 0.pdf

S7534-Gruber 0.pdf

S7535-Kakkar 1972.pdf

S7536-Kiil 1978.pdf

S7537-Torngren 1978.pdf

S7538-Torngren 0.pdf

S7539-Lahnborg 1975.pdf

S754-No trial available for Other diuretics 0.pdf

S7540-Lahnborg 1976.pdf

S7541-Covey 1975.pdf

S7542-Belch 1980.pdf

S7543-Taberner 1978.pdf

S7544-Strand 1975.pdf

S7545-Roberts 1975.pdf

S7546-Ribaudo 1975.pdf

S7547-Wu 1977.pdf

S7548-Lawrence 1977.pdf

S7549-Muiticentre 1984.pdf

S755-VHeFT I (hydralazine ISDN) 1986.pdf

S7550-Muiticentre 53,S4 1984.pdf

S7551-Muiticentre 1984.pdf

S7552-Jourdan 1984.pdf

S7553-van Geloven 1977.pdf

S7554-Loew 1977.pdf

S7555-Vinazzer 1980.pdf

S7556-Gordon-Smith 1972.pdf

S7557-Nicolaides 1972.pdf

S7558-Multiunit 1974.pdf

S7559-Abernethy 1974.pdf

S7560-Clarke-Pearson 1983.pdf

S7561-Plante 1979.pdf

S7562-Abraham-Inpijn 1979.pdf

S7563-Spebar 1981.pdf

S7564-Sagar 1974.pdf

S7565-Koppenhagen 1982.pdf

S7566-Bergqvist 1980.pdf

S7567-Torngren 1978.pdf

S7568-Kruse-Blinkenberg 1980.pdf

S7569-Kraytman 1977.pdf

S757-PRAISE 1996.pdf

S7570-Marchetti 1982.pdf

S7571-Gallus 1973.pdf

S7572-Gallus 1976.pdf

S7573-Groote Schuur 1979.pdf

S7574-Kraytman 1976.pdf

S7575-Kraytman 1977.pdf

S7576-Kettunen 1974.pdf

S7577-Caloghera 1984.pdf

S7578-Marchelli 1983.pdf

S7579-Ziemski 1979.pdf

S7581-Bejjani 1983.pdf

S7582-Coe 1978.pdf

S7583-Sebeseri 1975.pdf

S7584-Allen 1978.pdf

S7585-Hedlund 1979.pdf

S7586-Kutnowski 1977.pdf

S7587-Vandendris 1980.pdf

S7588-Bergqvist 1996.pdf

S7589-Planes 1996.pdf

S759-VHeFT III 1997.pdf

S7590-Dahl 1997.pdf

S7591-Lassen 1998.pdf

S7592-Manganelli 1998.pdf

S7593-NPHDO 1998.pdf

S7594-Heit 2000.pdf

S7595-Hull 2000.pdf

S7596-Comp 2001.pdf

S7598-Agnelli 1998.pdf

S7599-Nurmohamed 1996.pdf

S760-MACH 1 2000.pdf

S7600-Melon 1987.pdf

S7601-Cerrato 1978.pdf

S7602-Arneson 1978.pdf

S7603-Common 1976.pdf

S7604-Elsharawy 2002.pdf

S7605-Goldhaber (tPA alone) 1990.pdf

S7606-Kiil 1981.pdf

S7607-Schulman 1986.pdf

S7608-Schweizer tPA 1998.pdf

S7609-Schweizer (local tPA) 2000.pdf

S761-HELAS (warfarin vs aspirin) 2006.pdf

S7610-Tsapogas 1973.pdf

S7611-Turpie 1990.pdf

S7612-Verhaeghe (high dose) 1989.pdf

S7613-Goldhaber (tPA+heparin) 1990.pdf

S7614-Schweizer (urokinase) 1998.pdf

S7615-Verhaeghe (low dose) 1989.pdf

S7616-Kakkar (streptokinase) 1969.pdf

S7617-Kakkar (arvin) 1969.pdf

S7618-Schweizer (local urokinase) 2000.pdf

S7619-Schweizer (systemic SK) 2000.pdf

S7620-Schweizer (systemic urokinase) 2000.pdf

S7623-Charbonnier 1998.pdf

S7624-Holmström 1992.pdf

S7625-Merli 2001.pdf

S7626-Partsch 1996.pdf

S7627-Siegbahn 1989.pdf

S7629-Cohen (L8405) 2007.pdf

S7630-APOLLO (Turpie) 2007.pdf

S7632-PEGASUS 2005.pdf

S7634-UPET 1973.pdf

S7635-Tibbutt 1974.pdf

S7636-Ly 1978.pdf

S7637-Marini 1988.pdf

S7638-PIOPED 1990.pdf

S7639-Levine 1990.pdf

S7640-PAIMS 2 1992.pdf

S7641-Goldhaber 1993.pdf

S7642-Jerjes-Sanchez 1995.pdf

S7644-Cesarone 2003.pdf

S7645-Deitcher 2006.pdf

S7646-Hull 2006.pdf

S7647-Lee 2003.pdf

S7648-Lopez Beret 2001.pdf

S7649-Meyer 2002.pdf

S7650-Schulman (subgroup) 2003.pdf

S7651-Wells (subgroup) 2005.pdf

S7652-O’Sullivan 1972 .pdf

S7653-Holmgren 1985 .pdf

S7654-Schulman 3 vs 1.5 1985 .pdf

S7655-Schulman 6 vs 3 1985 .pdf

S7656-Fennerty 1987 .pdf

S7657-British Thoracic Society 1992 .pdf

S7658-Belcaro 1993 .pdf

S7659-Levine 1995.pdf

S7660-Schulman 1995.pdf

S7661-LAFIT (Kearon) 1999.pdf

S7662-Agnelli 2001.pdf

S7663-Pinede 2001.pdf

S7664-Agnelli 2003.pdf

S7665-PREVENT (Ridker) 2003.pdf

S7666-Schulman 2003 .pdf

S7667-ELAET (Kearon) 2004.pdf

S7672-CONTAK-CD 2003.pdf

S7673-MIRACLE-ICD-I 2003.pdf

S7674-MIRACLE-ICD-II 2004.pdf

S7675-AMIOVIRT 2003.pdf

S7676-CAT 2002.pdf

S7677-DEFINITE 2004.pdf

S7678-MADIT-II 2002.pdf

S7679-SCD-HeFT (ICD vs placebo) 2005-NCT00000609.pdf

S7680-COMPANION (CRT+ICD vs MT) 2004.pdf

S7681-COMPANION (CRT+ICD vs CRT) 2004.pdf

S7682-AMIOVIRT 2003.pdf

S7683-AVID 1997-NCT00000531.pdf

S7684-CASH 2000.pdf

S7685-CIDS 2000.pdf

S7686-MADIT 1996.pdf

S7687-CABG-patch 1997-NCT00000540.pdf

S7689-DINAMIT 2004.pdf

S7690-MUSIT 1999.pdf

S7691-SCD-HeFT (ICD vs amiodarone) 2005-NCT00000609.pdf

S7692-Garrigue 2002.pdf

S7693-PATH-CHF 2002.pdf

S7694-RD-CHF 2003.pdf

S7695-Leclercq (Doublon CR-RD) 2003.pdf

S7696-Dutch trial 1995.pdf

S7697-Konstantinides 2002.pdf

S7698-Andreozzi (200 vs 100) 1996.pdf

S7699-Anonymous 1970.pdf

S7700-Archer 1977.pdf

S7701-Belcaro 1989.pdf

S7702-Belcaro 1990.pdf

S7703-Belcaro (LMWH vs low dose hep) 1999.pdf

S7704-ACTIV 2001.pdf

S7705-Ferrari 1992.pdf

S7706-Gorski 2005.pdf

S7707-Holzgreve 1989.pdf

S7708-Incandela 2001.pdf

S7709-Katzenschlager 2003.pdf

S771-WESG 1991.pdf

S7710-Koshkin 2001.pdf

S7711-Kuhlwein 1985.pdf

S7712-Lozano 2003.pdf

S7713-Marchiori 2002.pdf

S7714-Marshall 2001.pdf

S7715-Messa 1997.pdf

S7716-Nocker (diclofenac) 1991.pdf

S7717-Nusser 1991.pdf

S7718-Pinto 1992.pdf

S7719-Stenox (enoxaparin 40mg) 2003.pdf

S772-PROMISE 1991.pdf

S7720-Titon (nadroparin 0.6ml vs naproxen) 1994.pdf

S7721-Vesalio 2005.pdf

S7722-Boccalon 2000.pdf

S7723-Chong 2005.pdf

S7724-Daskalopoulos 2005.pdf

S7725-Koopman 1996.pdf

S7726-Levine 1996.pdf

S7727-Ramacciotti 2004.pdf

S7728-Merli (once daily vs UFH) 2001.pdf

S7729-Merli 2001.pdf

S7730-Hot cafe 2004.pdf

S7731-RACE 2002.pdf

S7732-STAF 2003.pdf

S7733-J-RHYTHM 0.pdf

S7734-AFFIRM 2002-NCT00000556.pdf

S7735-PIAF 2000.pdf

S7736-AF-CHF 2002-NCT00597077.pdf

S7737-AFFIRM Substudy (amiodarone vs sotalol) 2003.pdf

S7738-AFIB 1997.pdf

S7739-ASAP 2003.pdf

S774-PRIME II 1997.pdf

S7740-Aliot 1996.pdf

S7741-Bellandi (propafenone vs placebo) 2001.pdf

S7742-Benditt 1999.pdf

S7744-Carunchio (flecainide vs placebo) 1995.pdf

S7745-Channer 2004.pdf

S7746-DAFNE 2003.pdf

S7747-DIAMOND 2001.pdf

S7748-Dogan 2004.pdf

S7749-EURIDIS ADONIS (pooled analysis) 2009.pdf

S7750-FAPIS 1996.pdf

S7751-GEFACA 2001.pdf

S7752-Hillestad 1971.pdf

S7753-Hohnloser 1995.pdf

S7754-Juul-Moller 1990.pdf

S7755-Kalusche 1994.pdf

S7756-Karlson 1998.pdf

S7757-Kochiadakis (amiodarone vs placebo) 2000.pdf

S7758-Kochiadakis a 2004.pdf

S7759-Kochiadakis b (propafenone vs placebo) 2004.pdf

S7760-Kuhlkamp 2000.pdf

S7761-Lloyd (quinidine vs placebo) 1984.pdf

S7762-Naccarelli 1996.pdf

S7763-Okishige 2000.pdf

S7764-PAFAC (quinidine vs placebo) 2004.pdf

S7765-PRODIS 1996.pdf

S7766-Plewan 2001.pdf

S7767-RAFT 2003.pdf

S7768-Reimold 1993.pdf

S7769-Richiardi 1992.pdf

S7770-SAFE-T (amiodarone vs placebo) 2005.pdf

S7771-SAFIRE-D 2000.pdf

S7772-SMART 2002.pdf

S7773-SOCESP 1999.pdf

S7774-SOPAT (quinidine vs placebo) 2004.pdf

S7775-Singh 1991.pdf

S7776-Sodermark 1975.pdf

S7777-Steinbeck (quinidine vs digoxin) 1988.pdf

S7778-Stroobandt 1997.pdf

S7779-Van Gelder 1989.pdf

S7780-Villani 1992.pdf

S7781-Vitolo 1981.pdf

S7782-Byrne Quinn 1979.pdf

S7783-AFFIRM Substudy (amiodarone vs class I drugs) 2003.pdf

S7784-Bellandi (sotalol vs placebo) 2001.pdf

S7785-Carunchio (sotalol vs placebo) 1995.pdf

S7786-Kochiadakis (sotalol vs placebo) 2000.pdf

S7787-Kochiadakis b (sotalol vs placebo) 2004.pdf

S7788-Lloyd (Disopyramide vs placebo) 1984.pdf

S7789-PAFAC (sotalol vs placebo) 2004.pdf

S7790-SAFE-T (sotalol vs placebo) 2005.pdf

S7791-SOPAT (sotalol vs placebo) 2004.pdf

S7792-Steinbeck (flecainide vs digoxin) 1988.pdf

S7794-Lloyd (Disopyramide vs quinidine) 1984.pdf

S7795-Steinbeck (quinidine vs flecainide) 1988.pdf

S7796-Lloyd (quinidine vs disopyramide) 1984.pdf

S7797-PAFAC (quinidine vs sotalol) 2004.pdf

S7798-SOPAT (quinidine vs sotalol) 2004.pdf

S7799-Kochiadakis (amiodarone vs sotalol) 2000.pdf

S7800-SAFE-T (amiodarone vs sotalol) 2005.pdf

S7801-Carunchio (sotalol vs flecianide) 1995.pdf

S7802-Kochiadakis b (sotalol vs propafenome) 2004.pdf

S7803-AFFIRM Substudy (sotalol vs class I drugs) 2003.pdf

S7804-Anderson 1994.pdf

S7805-Babuty 1999.pdf

S7806-Boissel 1981.pdf

S7807-CTAF 2002.pdf

S7808-Connolly 1989.pdf

S7809-ERAFT 2002.pdf

S7810-Frances 1985.pdf

S7811-Hartel 1974.pdf

S7812-Kanoupakis 2004.pdf

S7813-Lardoux 1996.pdf

S7814-Lau 1992.pdf

S7815-Manios 2003.pdf

S7816-Massacci 1991.pdf

S7817-PSVT 1995.pdf

S7818-Pietersen 1991.pdf

S7819-Piot 1998.pdf

S7820-Rasmussen 1981.pdf

S7821-Steeds 1999.pdf

S7822-Tonet 1986.pdf

S7823-Touboul 1995.pdf

S7824-VEPARAF 2003.pdf

S7825-Van Wijk 1989.pdf

S7826-Wanless 1997.pdf

S7827-Zehender 1992.pdf

S7828-Bonalumi 1986.pdf

S7829-Caramelli 1988.pdf

S7830-Castano 1999.pdf

S7831-Castano 2001.pdf

S7832-Castano 2003.pdf

S7833-Coccheri 2002.pdf

S7834-Cospite 1985.pdf

S7835-Gans 1990.pdf

S7836-Liguori 1993.pdf

S7837-Palmieri 1984.pdf

S7838-St Thomas’ Trial 1983.pdf

S7839-Avery 1994.pdf

S7840-Boon 1987.pdf

S7841-CTOPP 2000.pdf

S7842-Capucci 3000.pdf

S7843-Channon 1994.pdf

S7844-Davis 3000.pdf

S7845-Deharo 1996.pdf

S7846-Hargreaves 1995.pdf

S7847-Heldman 1990.pdf

S7848-Höijer 2002.pdf

S7849-Kamalvand 1997.pdf

S7850-Kenny 1986.pdf

S7851-Kristensson 1985.pdf

S7852-Lau (1) 1994.pdf

S7853-Lau (2) 1994.pdf

S7854-Linde-Edelstam 1992.pdf

S7855-Lukl 1994.pdf

S7856-MOST 2002-NCT00000561.pdf

S7857-Mattioli 1998.pdf

S7858-Menozzi 1990.pdf

S7859-Mitsuoka 1988.pdf

S786-MDC (Waagstein) 1993.pdf

S7860-Oldroyd 1991.pdf

S7861-PASE 1998.pdf

S7862-Perrins 1983.pdf

S7863-Rediker 1988.pdf

S7864-Saner and Fricker 3000.pdf

S7865-Sulke 1991.pdf

S7866-Sulke 1992.pdf

S7867-Sulke 1994.pdf

S7868-Wharton 1998.pdf

S7869-Yee 1984.pdf

S787-CIBIS 1994.pdf

S7870-EMOTE 2007.pdf

S7874-RECORD 2009-NCT00379769.pdf

S7875-Wessely 2008.pdf

S7881-CIBIS III 2005.pdf

S7882-BEST (elderly subgroup) 2001.pdf

S7883-Carvedilol U.S. Trials (elderly subgroup) 1996.pdf

S7884-CIBIS II (elderly subgroup) 1999.pdf

S7885-COPERNICUS (elderly subgroup) 2001.pdf

S7886-MERIT-HF (elderly subgroup) 1999.pdf

S7888-Auteri 1995.pdf

S7889-GEAIT 0.pdf

S789-ANZ-HeFT 1997.pdf

S7890-Matias-Guiu 1994.pdf

S7891-Smirne 1994.pdf

S7892-TACIP 0.pdf

S7893-TAPIRSS 2004.pdf

S7894-TIM 2000.pdf

S7895-Aberg 1989.pdf

S7896-Abingdon 1990.pdf

S7897-Applegate 1992.pdf

S7898-Blumenthal 2000.pdf

S7899-CELL 1995.pdf

S790-CIBIS II 1999.pdf

S7900-Change of Heart 1999.pdf

S7901-Connell 1995.pdf

S7902-FARIS 1997.pdf

S7903-Family Heart 1994.pdf

S7904-Finnish DPS 1999.pdf

S7905-Given 1984.pdf

S7906-Göteborg Study 1986.pdf

S7907-HDFP 1979-NCT00000498.pdf

S7908-Hellenius 1993.pdf

S7909-Iso 1994.pdf

S791-MERIT-HF 1999.pdf

S7910-Jalkanen 1991.pdf

S7911-Johns Hopkins 1983.pdf

S7912-Lin 1996.pdf

S7913-Lindahl 1999.pdf

S7914.pdf

S7915-Meland 1997.pdf

S7916-Nilsson 1992.pdf

S7917-Nilsson 2001.pdf

S7918-OXCHECK 1994.pdf

S7919-Oldroyd 2001.pdf

S792-BEST 2001-NCT00000560.pdf

S7920-Oslo Diet Exercise 0.pdf

S7921-Perez-Stabled 1995.pdf

S7922-Stamler 1989-NCT00000495.pdf

S7923-Stefanick 1998.pdf

S7924-Swedish RIS 1994.pdf

S7925-Take Heart 1995.pdf

S7926-Oslo 1981.pdf

S7927-Tromso 1991.pdf

S7928-Uusitupa 1993.pdf

S7929-WHLP  1995.pdf

S793-CARMEN (carvedilol alone) 2004.pdf

S7930-WHO Factories 1982.pdf

S7931-Wing 1998.pdf

S7932-Helsinki Businessmen Study 1985.pdf

S7933-CASCADE 2009-NCT00228423.pdf

S7934-CASPAR 0.pdf

S7935-AFFIRM 0.pdf

S7936-PREPIC 1998.pdf

S7937.pdf

S7938.pdf

S7939-Belcaro (coumadin vs low dose hep) 1999.pdf

S794-COPERNICUS 2002.pdf

S7940-Belcaro (ligation vs low dose hep) 1999.pdf

S7941-Belcaro (complete stripping vs low dose hep) 1999.pdf

S7942-De Sanctis 2001.pdf

S7943-STENOX (tenoxicam vs PBO) 2003.pdf

S7944-Katzenschlager (LMWH vs hep spraygel) 2003.pdf

S7945-Gorski (LMWH vs hep spraygel) 2005.pdf

S7946-STENOX (enox fixed dose vs NSAIDS) 2003.pdf

S7947-STENOX (prophylactic LMWH vs NSAIDs) 2003.pdf

S7948-Belcaro (prophylactic UFH vs no) 1999.pdf

S7949-Belcaro (hep vs no hep) 1989.pdf

S795-CAPRICORN 2001.pdf

S7950-Belcaro (hep vs defibrotide) 1990.pdf

S7951-Nocker (exhirud) 1991.pdf

S7952-Andreozzi (desmin SC vs 100) 1996.pdf

S7953-HIJ-CREATE 2009.pdf

S7954-ELITE 1997.pdf

S7955-ELITE-II 2000.pdf

S7956-OPTIMAAL 2001.pdf

S7957.pdf

S7958.pdf

S7959.pdf

S7960.pdf

S7961-DETAIL 2004.pdf

S7965-DURAC (Schulman) 1997.pdf

S798-Thrombosis Prevention trial (Warfarin) 1998-NCT00000614.pdf

S7984-SIRTAX diabetics 2005-NCT00297661.pdf

S7987-SIRIUS UA substudy 2007.pdf

S7992-Elliott 1999.pdf

S7993-Ginzburg 2003.pdf

S7994-Murakami 2003.pdf

S7995-Kurtoglu 2004.pdf

S7996-WACS vitamin C 2007-NCT00000541.pdf

S7999-DESSERT 2008.pdf

S800-Thrombosis Prevention trial (W plus A) 1998-NCT00000614.pdf

S8000-Tuttle 2008.pdf

S8001-Austin (Abergavenny) 2008.pdf

S8002-UKPDS (vs SU or INS) 0.pdf

S8003-UKPDS (v Conven) 0.pdf

S8004-DeFronzo (vs glyburide) 1995.pdf

S8005-Horton (vs PBO) 2000.pdf

S8006-Hallsten (vs PBO) 2002.pdf

S8007-Teupe 1991.pdf

S8008-DeFronzo (vs PBO) 1995.pdf

S8009-Horton (vs Nateglinide) 2000.pdf

S8010-UKPDS (vs insulin) 0.pdf

S8011-UKPDS (vs chlorpropamide) 0.pdf

S8012-UKPDS (vs glibenclamide) 0.pdf

S8013-MATISSE 2004.pdf

S8014-THRIVE III 2003.pdf

S8015-THRIVE I 2003.pdf

S8016-Ott importé 1998.pdf

S8017-Nielsen importé 1994.pdf

S8018-Fiessinger 2005.pdf

S8019-CLARITY-TIMI 28 hors sujet 2005.pdf

S8020-Pfisterer 1987.pdf

S8021-WARIS 1999.pdf

S8022-ASPECT 1994.pdf

S8023-CHAMP 2002.pdf

S8024-CARS (warafrin 3mg) 1997.pdf

S8025-LoWASA 2004.pdf

S8026-CARS (warfarin 1mg) 1997.pdf

S8027-ASPECT-2 (coumadin+ASA vs ASA) 2002.pdf

S8028-WARIS II (warfarin+ASA) 2002.pdf

S8029-ISIS-2 Pilot 1987.pdf

S8030-ECSG 1992.pdf

S8031-OSIRIS 1992.pdf

S8032-DUCCS 1994.pdf

S8033-ASSENT 3 2001.pdf

S8034-HART II 2001.pdf

S8035-Baird 2002.pdf

S8036-ENTIRE-TIMI 2 2002.pdf

S8037-ASSENT Plus 2003.pdf

S8038-ASSENT 3 Plus 2003.pdf

S8039-FRAMI 1997.pdf

S8040-BIOMACS II 1999.pdf

S8041-AMI-SK 2002.pdf

S8042-CREATE 2005.pdf

S8043-Castaigne 1989.pdf

S8044-Roth 1990.pdf

S8045-Schofer 1990.pdf

S8046-Barbash 1990.pdf

S8047-Castaigne 1987.pdf

S8048-Mcneill 1989.pdf

S8049-Abraham 1987.pdf

S8050-ISIS-4 1995.pdf

S8051-MAGIC 2000-NCT00000610.pdf

S8052-Bhargava 1995.pdf

S8053-Ceremuzynski 1989.pdf

S8054-Chen 1991.pdf

S8055-Feldstedt 1991.pdf

S8056-Gyamlani 2000.pdf

S8057-Ising 1990.pdf

S8058-Morton 1984.pdf

S8059-Nakashima 2004.pdf

S8060-Nameki 2004.pdf

S8061-Parikka 1990.pdf

S8062-Raghu 1999.pdf

S8063-Rasmussen 1986.pdf

S8064-Santoro 2000.pdf

S8065-Shechter 1990.pdf

S8066-Shechter 1991.pdf

S8067-Shechter 1995.pdf

S8068-Singh 1990.pdf

S8069-Smith 1986.pdf

S807-TEAHAT 1990.pdf

S8070-Thogersen 1995.pdf

S8071-Urek 1996.pdf

S8072-Woods 1992.pdf

S8073-Wu 1992.pdf

S8074-Zhu 2002.pdf

S8075-Abraham 1994.pdf

S8076-Balkin 1994.pdf

S8077-petri 1985.pdf

S8078-Smith 1985.pdf

S8079-Su 1997.pdf

S808-MITI 1993-NCT00000468.pdf

S8083-Centre Illinois 1993.pdf

S8084-Cherng 1992.pdf

S8085-ECSG 1985.pdf

S8086-PAIMS 1989.pdf

S8087-TIMI-1 1987-NCT00000505.pdf

S8088-White 1989.pdf

S8089-KAMIT 1991.pdf

S809-GREAT 1994.pdf

S8090-RAPID-2 1996.pdf

S8091-LATE 1993.pdf

S8093-EMERAS (all delay) 1993.pdf

S8094-USIM 1991.pdf

S8095-REACT (rescue PCI) 2005.pdf

S8096-MERLIN 2004.pdf

S8097-RESCUE II 2000.pdf

S8098-RESCUE 1994.pdf

S8099-TAMI 1994.pdf

S810-EMIP 1993.pdf

S8101-REACT (repeat fibrinolysis) 2005.pdf

S8102-Sarullo 2000.pdf

S8103-Mounsey 1995.pdf

S8110-CAIUS 1996.pdf

S8111-Sahni 1991.pdf

S8114-Harrold 1969.pdf

S8115-Begg 1971.pdf

S8116-Acheson 1972.pdf

S8117-VA Neurology Section 1974.pdf

S8118-Cullen 1974.pdf

S8119-Frick à effacer DOUBLON 1993.pdf

S8120-Gross 1973.pdf

S8121-Ryan 1974.pdf

S8122-Gundersen 1976.pdf

S8123-Ruoff 1978.pdf

S8125-HARP 1994-NCT00000461.pdf

S8127-POSCH 1990-NCT00000490.pdf

S8128-SCRIP 1994-NCT00000508.pdf

S8129-FATS Fukosawa (probucol) 2002.pdf

S8133-Marmorstein 1962.pdf

S8134-Stamler 1963.pdf

S8135-VA Neurology Section (estrogen) 1966.pdf

S8136-CDP tyroxine 1975.pdf

S8137-CDP estrogen 5 1975.pdf

S8138-CDP estrogen 2.5 1975.pdf

S8139-VA drugs (Estrogen or thyroxine) 1968.pdf

S8142-Singh 1992.pdf

S8145-GREACE 2002.pdf

S8147-ALERT 2003.pdf

S8149-LCAS 1997.pdf

S8150-Riegger et al. 1999.pdf

S8151-BCAPS 2001.pdf

S8152-FLARE 1999.pdf

S8161-CLAPT 1999.pdf

S8163-SENDCAP 1998.pdf

S8164-LEADER 2002.pdf

S8174-DAIS 2001.pdf

S8175-HHS (Frick)(secondary prev subgroup) 1993.pdf

S8178-STARS (cholestyramine) 1992.pdf

S8186-McCaughan 1981.pdf

S8188-Tardif 1997.pdf

S8189-Más 1999.pdf

S8190-Batista 1996.pdf

S8191-Castano 2001.pdf

S8192-STARS (St Thomas, diet) 1992.pdf

S8193-Los Angeles VA (Dayton) 1969.pdf

S8197-Minnesota 1989.pdf

S8198-Ornish 1990.pdf

S8199-Kallio 1979.pdf

S8200-MRFIT 1982.pdf

S8201-Hjermann 1981.pdf

S8202-Finnish Mental Hospital (Miettinen) 1985.pdf

S8203-WHO Collaborative 1986.pdf

S8204-Göteborg (Wilhelmsen) 1986.pdf

S8205-Black 1994.pdf

S8206-VA drugs 1968.pdf

S8207-Goteborg 1986.pdf

S8208-4S (subgroup) 1997.pdf

S8209-CARE (subgroup) 1998.pdf

S8210-LIPID (sub group) 2001.pdf

S8211-HPS (subgroup) 2002.pdf

S8212-PLAC I (sub group) 1995.pdf

S8213-REGRESS (subgroup) 1995.pdf

S8214-FLARE (subgroup) 1999.pdf

S8215-LIPS (subgroup) 2002.pdf

S8216-PROSPER (subgroup) 2002.pdf

S8217-CRISP 40mg 1994-NCT00000477.pdf

S8218-CASIS 1995.pdf

S8219-APSIS 1996.pdf

S8220-IMAGE 1990.pdf

S8221-TIBET (ass) 1996.pdf

S8222-FEMINA (Dunselman) 1997.pdf

S8223-Schofield 1999.pdf

S8224-Allen 1999.pdf

S8225-Frazier 1999.pdf

S8226-ATLANTIC (Burkhoff) 1999.pdf

S8227-Aaberge 2000.pdf

S8228-Huikeshoven 2003.pdf

S8229-Jones (doublons Frazier) 1999.pdf

S8230-PACIFIC 2000.pdf

S8231-Galiñanes 2004.pdf

S8232-Stone 2002.pdf

S8233-Allen 2000.pdf

S8234-Salem 2004.pdf

S8236-Loubani 2003.pdf

S8237-van der Sloot 2004.pdf

S8238-March 1999.pdf

S8239-Leon (high dose) 2005.pdf

S824-TAMI 1 pilot 1987.pdf

S825-ECSG 1988.pdf

S8255-Sixty Plus reinfarction Study 1980.pdf

S8256-EPSIM 1982.pdf

S8257-German-Austrian Study Group (oac vs asp) 1980.pdf

S8258-OASIS pilot phase 2 0.pdf

S826-SWIFT 1991.pdf

S8260-Loogna 1985.pdf

S8261-TRENT (Wilcox) 1986.pdf

S8262-Walker 1988.pdf

S8263-Zannad 1988.pdf

S8264-Eichler 1985.pdf

S8265-Danish study 1984.pdf

S8266-Sirnes 1984.pdf

S8267-Hockings 1981.pdf

S8268-Durrer 1982.pdf

S8269-Cohn 1982.pdf

S827-SIAM 1992.pdf

S8270-Chiche 1979.pdf

S8271-Bussman 1981.pdf

S8272-Flaherty 1983.pdf

S8273-Nelson 1983.pdf

S8274-Jaffe 1983.pdf

S8275-Lis 1984.pdf

S8276-Jugdutt 1983.pdf

S8277-ISIS 2 pilot 1987.pdf

S8278-EMERAS (7-12h) 1993.pdf

S8279-PRIMI (vs UK) 1989.pdf

S828-TIMI 2 1989.pdf

S8286-French 1999.pdf

S8287-CATS 1996.pdf

S8288-FAMIS 1998.pdf

S8289-PRACTICAL (captopril) 1994.pdf

S829-Guerci 1987.pdf

S8290-ECCE 1997.pdf

S8291-Sharpe 1991.pdf

S8292-Ray 1993.pdf

S8293-Schulman 1995.pdf

S8294-Nabel 1991.pdf

S830-Van den Brand 1991.pdf

S831-TOPS 1992.pdf

S8316-Kostuk and Beanlands 0.pdf

S8317-Bennett 1970.pdf

S8318-Baker 1971.pdf

S8319-Chopra 1971.pdf

S8320-Pitt 1971.pdf

S8321-Darby 1972.pdf

S8322-O 0.pdf

S8323-Lie (IV) 1974.pdf

S8324-Wyse 1988.pdf

S8325-Sandlar 0.pdf

S8326-Singh and Kocot 1976.pdf

S8327-Lie (IM) 1978.pdf

S8328-Dunn 1985.pdf

S8329-Koster and Dunning 1985.pdf

S8332-BASIS 1990.pdf

S8333-CAMIAT 1991.pdf

S8334-Ceremuzynski 1992.pdf

S8335-Navarro-Lopez 1993.pdf

S8336-Hockings 1987.pdf

S8337-Rodriguez 1992.pdf

S8338-Strasberg 1990.pdf

S8341-Krahenbuhl 1979.pdf

S8342-Bentley 1980.pdf

S8343-Andersson 1982.pdf

S8344-Hull 1986.pdf

S8345-Doyle 1987.pdf

S8346-Walker 1987.pdf

S8347-Lopaciuk 3000.pdf

S8348-Pini 1990.pdf

S8349-Pini 1994.pdf

S8350-Das 1996.pdf

S8351-Gonzalez-Fajardo 1999.pdf

S8352-Lopaciuk 1999.pdf

S8353-Veiga 2000.pdf

S8354-Lopez-Beret 2001.pdf

S8355-Meyer 2002.pdf

S8356-Hull 2002.pdf

S8357-Deitcher 2003.pdf

S8358-Kakkar 2003.pdf

S8359-Lee 2003.pdf

S8360-Canata 2003.pdf

S8361-Michot 2002.pdf

S8362-Roth 1995.pdf

S8363-Wirth 2001.pdf

S8364-FANTASTIC 1998.pdf

S8365-ISAR 1996.pdf

S8366-Foussas 2000.pdf

S8367-MATTIS 1998.pdf

S8368-STARS (vs coumadin+asp) 1998.pdf

S8369-STARS (vs aspirin) 1998.pdf

S8370-Hall 1996.pdf

S8371-Müller 2000.pdf

S8372-CLASSICS 2000.pdf

S8373-TOPPS 2001.pdf

S8374-Piamsomboon 2001.pdf

S8375-Kozuma 2001.pdf

S8376-Ochiai 1999.pdf

S8377-Park 1999.pdf

S8378-Yoon 1999.pdf

S8379-Kamishirado 2002.pdf

S8380-Sekiya 1998.pdf

S8381-Kunishima 1997.pdf

S8382-White (ticlopidine) 1991.pdf

S8383-M-HEART II (sulotroban) 1995.pdf

S8384-HORIZONS-AMI (Stone) 2008-NCT00433966.pdf

S8385-HORIZONS-AMI (Stone) doublons à effacer 2008.pdf

S8386-ACUITY (sub groups, bivalirudin alone) 2007.pdf

S8387-ACUITY (Stone) (bivalirudin alone) 2006-NCT00093158.pdf

S8388-REPLACE-1 2004.pdf

S8389-CACHET (without abciximab) 2002.pdf

S8390-Kleiman 2002.pdf

S8391-BAT (Bittl) 1995.pdf

S8392-DANAMI-2 1997.pdf

S8394-Steward 2008.pdf

S8396-HPS (sub groups) 2004.pdf

S8397-Lindholt 1999.pdf

S8398-PATI 2002.pdf

S8399-Wilmink 2000.pdf

S8400-Mosorin 2001.pdf

S8401-Vammen 2001.pdf

S8402-ONTARGET (association vs telmisartan) 2008-NCT00153101.pdf

S8403-Aksoyek 1996.pdf

S8404-Bermudez-HT (normotensive) 1995.pdf

S8405-Bermudez-NT (hypertensive) 1995.pdf

S8406-Brochier 1986.pdf

S8407-Brodbin 1968.pdf

S8408-Brottier 1990.pdf

S8409-Butina 2002.pdf

S8410-Chutz 1984.pdf

S8411-Dalla-Volta 1990.pdf

S8412-Detry 1994.pdf

S8413-Grosgogeat 1987.pdf

S8414-ETTIC (Hanania) 2002.pdf

S8415-Kunjara 1990.pdf

S8416-Levy 1995.pdf

S8417-Lu 1998.pdf

S8418-Manchanda 1997.pdf

S8419-Manchanda 2003.pdf

S8420-Mehrotra 1967.pdf

S8421-Michaelidis 1997.pdf

S8422-Passeron 1986.pdf

S8423-Prasad 1989.pdf

S8424-Sellier 1986.pdf

S8425-TRIMPOL II (Szwed) 2001.pdf

S8426-Zaslavskaia 1999.pdf

S8427-ATHENA 2009-NCT00174785.pdf

S8428-DIONISOS 2007-NCT00489736.pdf

S8429-Lausen 1998.pdf

S8430-ENOXACAN II (Bergqvist) 2002.pdf

S8431-FAME (Rasmussen) 2006.pdf

S8432-Igloe 1970.pdf

S8433-Zion 1961.pdf

S8434-Kinsella 1962.pdf

S8435-Leiberman 1964.pdf

S8436-Dewar 1961.pdf

S8437-Neumann 1964.pdf

S8438-Foulds 1960.pdf

S8439.pdf

S8440-Holford 1976.pdf

S8441-Turner 1984.pdf

S8442-Turpie (GCS vs crtl) 1989.pdf

S8443-Allan 1983.pdf

S8444.pdf

S8445-Wille-Jorgensen 1991.pdf

S8446-Wille-Jorgensen 1985.pdf

S8447.pdf

S8448-Scurr (GCS+IPC vs IPC) 1987.pdf

S8449.pdf

S8450-Fredin 1989.pdf

S8451.pdf

S8452.pdf

S8453-Barnes 1978.pdf

S8454.pdf

S8455.pdf

S8456.pdf

S8457.pdf

S8458.pdf

S8460-Porteous 1989.pdf

S8461-Williams 1988.pdf

S8462-Hui THR 1996.pdf

S8463-Hui TKR 1996.pdf

S8464-Howard 2004.pdf

S8465-William 1996.pdf

S8466.pdf

S8469.pdf

S8472.pdf

S8473.pdf

S8476-Benko 2001.pdf

S8480-REDUCE 1996.pdf

S8481-Rabah 1999.pdf

S8482-CRUISE 2003.pdf

S8483-Galeote 2001.pdf

S8484-Dudek 2000.pdf

S8485-Dudek b (enox alone) 2000.pdf

S8486-Drozd 2001.pdf

S8487-Natarajan (without antiGp2b3a) 2003.pdf

S8488-Dubek b (+abciximal) 2001.pdf

S8489-Natarajan (+ antiGp2b3a) 2003.pdf

S8526-ACUITY (sub groups, bivalirudin +aGP2b3a) 2007.pdf

S8527-Topol 1993.pdf

S8528-Leon 1998.pdf

S8530-ACAS 1995.pdf

S8531-ACST 1994.pdf

S8532-VA 1993.pdf

S8533-BACASS (Hoffman) 2006.pdf

S8534-Beijing 2003.pdf

S8535-CAVATAS-MED 2007.pdf

S8536-Kentucky B (Brooks) 2004.pdf

S8538-SAPPHIRE (yadav) 2004.pdf

S8539-TESCAS-C (Ling) 2006.pdf

S8540-ACST-2 0-NCT00883402.pdf

S8541-ACT I 0-NCT00106938.pdf

S8542-Agostoni 0.pdf

S8543-CREST 2010-NCT00004732.pdf

S8544-ICSS 2010-ISRCTN25337470.pdf

S8545-Link 0.pdf

S8546-TACTICS-TIMI 18 elderly (sub group) 2001.pdf

S8547-Topol 1988.pdf

S8548-NQWMI (Eisenberg) 2005.pdf

S8550-Doucet 2000.pdf

S8551-ATACS (pilot study) (warfarin vs control) 1990.pdf

S8552-ATACS 1994.pdf

S8553-Williams 1997.pdf

S8554-CARS 1997.pdf

S8555-OASIS Pilot (phase 1) 1998.pdf

S8556-OASIS Pilot (phase 2) 1998.pdf

S8557-Huyhn 2001.pdf

S8558-OASIS-2 Warfarin Substudy 2001.pdf

S8559-ASPECT-2 (coumadin+asp vs asp) 2002.pdf

S8560-APRICOT-2 2002.pdf

S8561-CHAMP 2002.pdf

S8562-WARIS 2002.pdf

S8563-LoWASA 2004.pdf

S8564-Zibaeenezhad 2004.pdf

S8565-Canadian (Aspirin vs PBO) 1985.pdf

S8566-Canadian (sulfinpyrazone alone) 1985.pdf

S8567-Theroux (heparin+ASP vs ASP) 1988.pdf

S8568-RISC (ASP+ heparin vs PBO) 1990.pdf

S8569-FRAXIS (14 days) 1998.pdf

S8570-TIMI 11 B (long term) 1998.pdf

S8571-FRISC (short term) 1996.pdf

S8573-TRITON-TIMI 38 2007-NCT00097591.pdf

S8574-TRITON-TIMI 38 2007-NCT00097591.pdf

S8575-Doucet 2000.pdf

S8576-Karlberg 1998.pdf

S8577-TRIM 1997.pdf

S8579-Huynh (warfarin vs aspirin) 2001.pdf

S8580-ASPECT-2 (coumadin vs aspirin) 2002.pdf

S8581-ATACS (pilot study) warfarin vs aspirin 1990.pdf

S8582-LoWASA (copie de 8025) 0.pdf

S8583-German-Austrian Study Group (oac vs pbo) 1980.pdf

S8584-Miyazaki 1995.pdf

S8585-ADVANCE-1 2008-NCT00371683.pdf

S8586-APPRAISE-1 (10mg od) 2009-NCT00313300.pdf

S8589-ACUITY (biva alone vs hep+aGP2b3a) 2006-NCT00093158.pdf

S8590-ACUITY (biva+aGP2b3a vs hep+aGP2b3a) 2006-NCT00093158.pdf

S8591-ACUITY (sub groups PCI, bivalirudin +aGP2b3a) importé 2007.pdf

S8592-ACUITY (sub groups PCI, bivalirudin alone) importé 2007.pdf

S8594-BEAUTIFUL 2008-NCT00143507.pdf

S8595-TRANSCEND 2008-NCT00153101.pdf

S8596-GISSI HF fatty acid 2008-NCT00336336..pdf

S8597-Wojnicz 2006.pdf

S8598-Sola 2006.pdf

S8599-Yamada 2007.pdf

S8600-ERATO 2008-18760136.pdf

S8601-VA CARDS 0-NCT00326196.pdf

S8602-PIHRATE 0-NCT00377650.pdf

S8603-TAPAS 2008-ISRCTN16716833.pdf

S8606-DIAMOND MI 1997.pdf

S8607-CAST I 1991-NCT00000526.pdf

S8608-CAST II (early treatment) 1992.pdf

S8609-BASIS 1990.pdf

S8610-Julian 1982.pdf

S8611-ALIVE 2004.pdf

S8612-ARREST 1999.pdf

S8613-ALIVE 2002.pdf

S8614-APPRAISE-1 (2.5 mg bid) 2009-NCT00313300 .pdf

S8616-TRANSFER-AMI 2008-NCT00164190.pdf

S8617-CARESS 2008.pdf

S8620-CAPITAL AMI 2005.pdf

S8621-SPEED (Phase A) 2000.pdf

S8623-PROFESS 2008.pdf

S8624-UKPDS Sulfonyurea–insulin 10 year 2008-ISRCTN75451837.pdf

S8626-UKPDS Metformin10 year 2008-ISRCTN75451837.pdf

S8627-UKPDS 38 10 years 2008-ISRCTN75451837.pdf

S8628-BASKET-PROVE 2008.pdf

S8629-Kim 2008.pdf

S8630-TAxi (diabetics) 3000.pdf

S8631-REALITY (diabetics) 2006.pdf

S8632-SIRIUS (diabetics) 2003.pdf

S8633-ISAR-test (diabetics) 2006.pdf

S8635-ISAR-DESIRE (SES vs PTCA) 2005.pdf

S8636-ISAR-DESIRE (PES vs PTCA) 2005.pdf

S8639-TAXUS V ISR 2006-NCT00287573.pdf

S8640-SCRIPPS 1997.pdf

S8641-PREVENT 2000.pdf

S8642-WRIST 2001.pdf

S8643-GAMMA-ONE 2001.pdf

S8644-Schühlen 2001.pdf

S8645-INHIBIT 2002.pdf

S8646-START 2000.pdf

S8647-SVG-WRIST 2002.pdf

S8648-ECRIS 2003.pdf

S8649-Long-WRIST 2003.pdf

S8650-SPARE 2004.pdf

S8657-Pan 2007.pdf

S8658-DEDICATION 2008-NCT00192868.pdf

S8659-Cohen (copie de 7407) 2006.pdf

S8660-Cohen (30 mg) à effacer 2006.pdf

S8662-BARI 2D 2009-NCT00006305.pdf

S8663-TAXUS V small vessels sub groups 0.pdf

S8664-CARDIA (DES subgroups) 0.pdf

S8665-LEMANS 2002-NCT00375063.pdf

S8669-HORIZONS-AMI Stent 2008.pdf

S8670-ZEST AMI (vs SES) 2009-NCT00422565.pdf

S8671-FAME 2008-NCT00267774.pdf

S8672-DEFER 2001.pdf

S8772-CAST II (late treatment) 1992.pdf

S8773-ISAR TEST 2 (vs SES) 2009-NCT00332397.pdf

S8774-ISAR TEST 2 (vs ZES) 2009-NCT00332397.pdf

S8775-SORT-OUT-3 2010-NCT00660478.pdf

S8781-ASCEND (aspirin) 0-NCT00135226.pdf

S8782-POPADAD aspirin 2008-ISRCTN53295293.pdf

S8784-SOS 2008-NCT00247208.pdf

S8804-Murphy 2003.pdf

S8805-Einstein-DVT Dose-Ranging Study 2008.pdf

S8806-RIBS-II 2008.pdf

S8809-HF-ACTION 2008-NCT00047437.pdf

S8811-PHS II vitamin C 2008-NCT00270647.pdf

S8812-PHS II beta carotene 2003-NCT00270647.pdf

S8813-WAFACS 2008-NCT00000541.pdf

S8814-WACS vitamin E 2007-NCT00000541.pdf

S8816-WACS beta-caroten 2007-NCT00000541.pdf

S8820-APPROACH 2008-NCT00116831.pdf

S8822-JPAD DOUBLON à effacer 2008-NCT00110448.pdf

S8824-ZoMaxx I 2008.pdf

S8829-PHS II vitamin E 2008-NCT00270647.pdf

S8830-ACCEPT-D 0-ISRCTN48110081.pdf

S8831-MacMillan 1960.pdf

S8832-Borchegrevink 1960.pdf

S8833-Clausen 1961.pdf

S8834-Harvald 1961.pdf

S8835-Apenstrom and Korsan-Bengtsen 1964.pdf

S8836-Conrad 1964.pdf

S8837-Wasserman 1966.pdf

S8838-Loeliger 1967.pdf

S8839-Lovell 1967.pdf

S8840-Seaman 1969.pdf

S8841-Sorensen 1969.pdf

S8842-Sixty Plus Reinfarction 1980.pdf

S8843-WARIS 1990.pdf

S8844-ASPECT 1994.pdf

S8845-Meuwisse, 1969.pdf

S8846-Drapkin and Merskey 1972.pdf

S8847-Breddin 1980.pdf

S8848-CHARM preserved 2003.pdf

S8849-TOPCAT 0-NCT00094302.pdf

S8850-Barzizza (warfarin) 1993.pdf

S8851-Barzizza (A+D) 1993.pdf

S8853-TIMACS 2009-NCT00552513.pdf

S8854-JPAD 2008-NCT00110448.pdf

S8855-SEARCH 2010-NCT00124072.pdf

S8856-HOPE-2 (Lonn) 2006-NCT00106886.pdf

S8857-VISP (Toole) 2004.pdf

S8858-WENBIT (folic ac,B12,B6) 2008-NCT00354081.pdf

S8863-CASSIS (enalapril) 1995.pdf

S8864-CASSIS (spirapril) 1995.pdf

S8866-International Study Group (Lewis) 1989.pdf

S8867-NETWORK (2.5 bid vs 10 bid) 1998.pdf

S8868-ATLAS 1999.pdf

S8869-V-HeFT II 1991.pdf

S8870-NETWORK (5 bid vs 10 bid) 1998.pdf

S8872-OVERTURE 2002.pdf

S8873-IMPRESS 2000.pdf

S8874-OCTAVE 0.pdf

S8884-Astrup 0.pdf

S8885-A4 (Jais) 2008-NCT00540787.pdf

S8887-Wazni 2005.pdf

S8901-SANDS 2008-NCT00047424.pdf

S8904-TROICA 2008-NCT00157261.pdf

S8906-Abu-Laban 2002.pdf

S8907-TICA 2004.pdf

S8908-VADT 2008-NCT00032487.pdf

S8909-Mohler 2003.pdf

S8910-HYRIM 2005.pdf

S8911-FAST Fukuoka pravastatin 2002.pdf

S8912-KLIS 2000.pdf

S8913-PHYLLIS 2004.pdf

S8914-PREVEND IT 2004.pdf

S8918-Assmann 1991.pdf

S8919-Banning 1996.pdf

S8920-DiBianco 1984.pdf

S8924-Udelson 2008-NCT00132886.pdf

S8927-COSTAR II diabetic (sub group) 2008.pdf

S8928-Botticelli DVT 2008-NCT00252005.pdf

S8929-González-Fajardo 2008.pdf

S8936-WEST 2006.pdf

S8937-CAPITAL AMI 2005.pdf

S8938-GRACIA-1 2004.pdf

S8939-SIAM III 2002.pdf

S8940-PRAGUE 2000.pdf

S8941-TIMI II-A (defered) 0.pdf

S8942-TAMI-5 (Califf) 1991.pdf

S8943-SHOCK (Hochman) 1999-NCT00000552.pdf

S8944-Topol 1987.pdf

S8946-Ellis 1994.pdf

S8947-Vermeer 1999.pdf

S8948-SPEED (GUSTO-4 pilot) Hermann 2000.pdf

S8949-Kurihara à effacer 2004.pdf

S8950-PACT (Ross) 1999.pdf

S8951-combined TIMI 10B–TIMI 14 (Schweiger) 2001.pdf

S8954-Erbel 1989.pdf

S8956-O'neill 1992.pdf

S8957-MERLIN (Sutton) 2004.pdf

S8958-LIMI (Vermeer) 1999.pdf

S8959-SWISS-SMASH 1999.pdf

S8960-Heng .pdf

S8961-Stanley .pdf

S8962-Rogers .pdf

S8963-Satler .pdf

S8964-Mittra .pdf

S8965-Pitcher .pdf

S8966-Pentecost .pdf

S8967-MRC .pdf

S8968-Hjermann .pdf

S8969-ACIP 1997.pdf

S8970-DANAMI 2007.pdf

S8971-INSPIRE 2006.pdf

S8972-SWISSI II 2007-NCT00387231.pdf

S8974-FRESCO 1998.pdf

S8976-CADILLAC abciximab. 2002.pdf

S8977-CADILLAC (no abciximab) 2002.pdf

S8978-ZWOLLE 6 2005.pdf

S8979-STOPAMI 3 2004.pdf

S8980-STOPAMI 4 0.pdf

S8981-STOPAMI 4 2004.pdf

S8983-MASS II 2007.pdf

S8984-VA 1984.pdf

S8985-ECSS (European) 1988.pdf

S8986-CASS 1983-NCT00000489.pdf

S8987-Texas 1977.pdf

S8988-Oregon 1979.pdf

S8989-New zealand 1 1981.pdf

S8990-New Zealand 2 0.pdf

S8991-Coronary Artery Bypass Graft Surgery Trialists Collaboration 1994.pdf

S8992-CABG Trialists Collaboration - one vessel subgroups 1994.pdf

S8993-CABG Trialists Collaboration - two vessels subgroups 1994.pdf

S8994-CABG Trialists Collaboration - three vessels subgroups 1994.pdf

S8995-CABG Trialists Collaboration -left main artery subgroups 1994.pdf

S8996-CABG Trialists Collaboration - normal LV function subgroups 1994.pdf

S8997-CABG Trialists Collaboration -abnormal LV function subgroups 1994.pdf

S8998-TIMI 2A 1988.pdf

S8999-Belenkie 1991.pdf

S9000-Topol 1987.pdf

S9001-TAMI 6 1992.pdf

S9002-Barbash 1990.pdf

S9007-Vermeer 1999.pdf

S9008-DANAMI 1997.pdf

S9010-MAASTRICHT (Vermeer) 1999.pdf

S9011-PRAGUE-1 2000.pdf

S9012-AIR-PAMI 2002.pdf

S9013-CAPTIM 2002.pdf

S9014-DANAMI-2 2003.pdf

S9015-PRAGUE-2 2003.pdf

S9016-PRAGUE-1 (thrombolysis+PTCA) 2000.pdf

S9017-Zijlstra 1993.pdf

S9018-Akhras 1997.pdf

S9019-Kedev 1997.pdf

S9020-O'Neill 1986.pdf

S9021-AIR-PAMI 2002.pdf

S9022-DANAMI-2 2003.pdf

S9023-PRAGUE-2 2003.pdf

S9025-STAT 2001.pdf

S9026-STOPAMI 1 2000.pdf

S9027-C-PORT 2002.pdf

S9028-STOPAMI 2 2002.pdf

S9029-HIS 2006.pdf

S9032-Kimura 2001.pdf

S9033-CARESS-in-AMI 2008.pdf

S9034-Belenkie 1992.pdf

S9035-APSIM 1989.pdf

S9036-TAMI 6 1992.pdf

S9037-TAMI 5 (t-PA vs uroK) 1991.pdf

S9038-TEAM 2 1991.pdf

S9039-TEAM 3 1992.pdf

S9040-TAPS 1992.pdf

S9041-RAAMI 1992.pdf

S9042-TIMI 4 1994.pdf

S9043-TAMI 5 (t-PA+uroK vs tPA) 1991.pdf

S9044-TAXUS ATLAS 0.pdf

S9047-Mehta 1981.pdf

S9048-Hoberg 1994.pdf

S9049-MARIZA 2004.pdf

S9050-RAN080 2005.pdf

S9051-Leon (low dose) 2005.pdf

S9052-STAR 1995.pdf

S9053-RAPID 1 1995.pdf

S9054-TIMI 10B 1998.pdf

S9055-ASSENT-1 1999.pdf

S9056-inTIME 1 1998.pdf

S9057-Bassand 1991.pdf

S9058-duteplase 1 1993.pdf

S9059-duteplase 2 1993.pdf

S9060-duteplase 3 1993.pdf

S9063-UNASEM 1992.pdf

S9064-TRIC 1992.pdf

S9065-TIMI 3A 1993.pdf

S9066-EXPIRA 0.pdf

S9067-CARISA 1000mg 2004.pdf

S9069-DEAR-MI 2006-NCT00257153.pdf

S9070-De Luca 2006.pdf

S9071-Kaltoft 2006.pdf

S9072-REMEDIA 2005.pdf

S9073-Dudek 2004.pdf

S9074-PIHRATE 2004.pdf

S9075-VAMPIRE 2004.pdf

S9076-Noel 2005.pdf

S9077-EXPIRA 2005.pdf

S9078-Sardella 2005.pdf

S9079-NONSTOP 2004.pdf

S9080-Export (Chevalier) 2008.pdf

S9081-AiMI 2006.pdf

S9082-X AMINE ST 2005.pdf

S9083-Florence 2004.pdf

S9084-Napodano 2003.pdf

S9085-Beran 2002.pdf

S9086-DEDICATION 2008.pdf

S9087-Tahk 2008.pdf

S9088-MICADO 2007.pdf

S9089-UpFlow MI 2007.pdf

S9090-PREMIAR 2007.pdf

S9091-Ochala 2007.pdf

S9092-PROMISE 2005.pdf

S9093-EMERALD 2005.pdf

S9094-DIPLOMATE 2004.pdf

S9124-VanGogh DVT 2007-NCT00067093.pdf

S9125-VanGogh extension 2007-NCT00071279.pdf

S9127-HEAAL 2009-NCT00090259.pdf

S9129-TIME CHF 2009.pdf

S9130-TITAX AMI 2009-NCT00495664.pdf

S9134-ISAR TEST 3 (BP) 2009.pdf

S9135-PROPHESS 2008-NCT00153062.pdf

S9137-Lindner 1997.pdf

S9138-Li 1999.pdf

S9139-Lee 2000.pdf

S9140-Stiell 2001.pdf

S9141-Wenzel 2004.pdf

S9143-ECST 1998.pdf

S9144-NASCET 1998.pdf

S9145-VA309 1991.pdf

S9146-GISSI Prevenzione 2000.pdf

S9147-HHS (sub group) 1987.pdf

S9148-DAIS 2001.pdf

S9149-VA-HIT (sub group) 1999.pdf

S9151-DES-DIABETES 2008.pdf

S9156-ISAR TEST 3 (PF) 2009.pdf

S9158-BARI 2D à effacer -NCT00006305.pdf

S9159-Birmingham-A 1979.pdf

S9160-London diabetes 1983.pdf

S9162-Dutch 1980.pdf

S9163-DAMAD 1989.pdf

S9164-TIMAD 1984.pdf

S9165-BTRS 1992.pdf

S9166-Nyberg 1984.pdf

S9167-ETDRS 1992.pdf

S9168-Cocozza 1995.pdf

S9171-CLIPS 2007.pdf

S9175-DAVID II 2009-NCT00187187.pdf

S9176-DAVID 2002.pdf

S9224-TRA-PCI 2009-NCT00132912.pdf

S9225-Nouvel essai .pdf

S9295-KLIPS 2000.pdf

S9313-Cice et al 2003.pdf

S9314-Li et al 2003.pdf

S9315-Cice et al 2006.pdf

S9316-Takahashi et al 2006.pdf

S9317-Zannad et al 2006.pdf

S9318-Nakao et al 2007.pdf

S9319-Suzuki et al 2008.pdf

S9320-Tepel et al 2008-NCT00124969.pdf

S9321-Han 2009-NCT00404716.pdf

S9322-GENIUS-STEMI 2009.pdf

S9323-ZEST (vs PES) 2009-NCT00418067.pdf

S9325-STICH (ventricular reconstruction) 2009-NCT00023595.pdf

S9327-NAPLES II (Briguori) 2009.pdf

S9328-Nouvel essai .pdf

S9329-ABOARD 2009-NCT00442949.pdf

S9330-TIPS 2009.pdf

S9331-OMEGA 2009-NCT00251134.pdf

S9332-AURORA 2009.pdf

S9333-IRIS 2009.pdf

S9345-ACTIVE A 2009-NCT00249873.pdf

S9349-Romera 2009.pdf

S9353-DIAD 2009-NCT00769275.pdf

S9354-DYNAMIT 2010-NCT00627783.pdf

S9355-GISSI-AF (Disertori) 2009-NCT00376272.pdf

S9356-PRIMA 0.pdf

S9357-CAPTIVATE 2009-NCT00151788.pdf

S9358-ACCELERATE 2017-NCT01687998.pdf

S9360-RADIANCE 1 2007-NCT00136981.pdf

S9361-ACTIVATE 2006-NCT00185042.pdf

S9362-ILLUMINATE 2007-NCT00134264.pdf

S9363-RADIANCE 2 2007.pdf

S9364-ILLUSTRATE 2007-NCT00134173.pdf

S9365-Kastelein à effacer 2007-NCT00136981.pdf

S9385-POST CABG 0-NCT00000463.pdf

S9388-PEPI 1995-NCT00000466.pdf

S9389-Becker 0-NCT00000486.pdf

S9390-MILIS 0-NCT00000493.pdf

S9391-MERCATOR 0-NCT00000496.pdf

S9394-NCT00000527 0-NCT00000527.pdf

S9395-TOHP 0-NCT00000528.pdf

S9396-ERA (estrogen alone ) 2000-NCT00000549.pdf

S9397-HATS à effacer doublon 0-NCT00000553.pdf

S9398-WAVE 2002-NCT00000555.pdf

S9399-WELL-HART (estrogen alone) 2003-NCT00000559.pdf

S9400-Schulman (NHLBI) (estrogen alone) 2002-NCT00000601.pdf

S9401-EAGAR 2006-NCT00000605.pdf

S9403-ESCAPE 0-NCT00000619.pdf

S9404-Raitt 0-NCT00004558.pdf

S9410-NCT00032370 0-NCT00032370.pdf

S9411-THINRS 0-NCT00032591.pdf

S9412-ROOBY 0-NCT00032630.pdf

S9413-DITPA 0-NCT00032643.pdf

S9415-Cuenca 0-NCT00035451.pdf

S9416-Phillips 0-NCT00035464.pdf

S9418-NCT00040612 0-NCT00040612.pdf

S9419-VMAC (intravenous neseritide) 2002-NCT00083772.pdf

S9420-NSGET (comparative trial) 2000.pdf

S9421-FUSION 1 2004-NCT00270361.pdf

S9422-RECOVER -NCT00881777.pdf

S9423-NCT00887237 .pdf

S9424-Pre-RELAX-AHF 2009-NCT00520806.pdf

S9425-Gao -NCT00887211.pdf

S9426-Ranucci 0-NCT00881192.pdf

S9427-Christenson 2003.pdf

S9428-PROTECT (fundaparinux) -NCT00881088.pdf

S9429-PROTECT (nadroparin) -NCT00881088.pdf

S9430-STREAM -NCT00882635.pdf

S9431-ROBUST -NCT00888758.pdf

S9432-Schacky -NCT00886704.pdf

S9433-Seiler -NCT00886509.pdf

S9434-SUPRIM -NCT00888485.pdf

S9435-Kumar -NCT00883727.pdf

S9436-WARCEF 2012-NCT00041938.pdf

S9437-NCT00043628 0-NCT00043628.pdf

S9439-Udelson 2007-NCT00043758.pdf

S9441-Kooy (HOME) 2009.pdf

S9442-HAT -NCT00047411.pdf

S9444-REVIVE II 2013-NCT00048425.pdf

S9445-STAMINA-HeFT (Ghali) 2008-NCT00049985.pdf

S9446-ARISE 2008-NCT00066898.pdf

S9447-Meybohm -NCT00882622.pdf

S9448-Seoul -NCT00889811.pdf

S9449-Ali 2007.pdf

S9450-Cheung 2006.pdf

S9451-Gunaydin 2000.pdf

S9452-Hausenloy 2007-NCT00397163.pdf

S9453-FREEDOM-C2 -NCT00887978.pdf

S9455-RESCUE -NCT00077818.pdf

S9456-REMODEL -NCT00082589.pdf

S9457-Losordo 2007-NCT00081913.pdf

S9458-van Veldhuisen 2007-NCT00086086.pdf

S9460-AGENT-1 (Grines) 2002.pdf

S9461-AGENT-2 (Grines) 2003.pdf

S9462-AGENT-3 0-NCT00346437.pdf

S9463-AGENT-4 0-NCT00185263.pdf

S9464-AWARE 0-NCT00438867.pdf

S9465-AGENT 3 and 4 pooled 0.pdf

S9466-FIRST (Simons) 2002.pdf

S9467-VIVA (Henry) 2003.pdf

S9468-REVASC (Stewart) 2006.pdf

S9469-EUROINJECT-ONE (Gyöngyösi) 2005.pdf

S9470-ISAR-SAFE 2009-NCT00661206.pdf

S9472-JELIS 2009-NCT00231738.pdf

S9473-APEX-AMI 2007-NCT00091637.pdf

S9474-TRIUMPH 2007-NCT00112281.pdf

S9475-COMMA 2003.pdf

S9476-EVOLVE 2005.pdf

S9477-COMPLY 2003.pdf

S9478-Phase II CABG .pdf

S9479-PRIMO-CABG -NCT00088179.pdf

S9480-Genzyme SMC00202 à effacer .pdf

S9481-Genzyme SMC00202 -NCT00102128.pdf

S9482-ANTIPAF -NCT00098137.pdf

S9483-HEARTS .pdf

S9484-IMMEDIATE -NCT00091507.pdf

S9485-SOFA transferé à effacer -NCT00110838.pdf

S9486-Raitt transféré à effacer 0-NCT00004558.pdf

S9488-Raitt 2006-NCT00004558.pdf

S9489-SOFA 2006-NCT00110838.pdf

S9490-Leaf 2005.pdf

S9492-NCT00090714 -NCT00090714.pdf

S9493-ExTRACT-TIMI25 2006-NCT00077792.pdf

S9494-EMPOWER -NCT00077948.pdf

S9496-EARLY ACS -NCT00089895.pdf

S9497-NCT00090259 -NCT00090259.pdf

S9498-RESOLVE-AF -NCT00111488.pdf

S9499-Schmieder (vs HCTZ) 2009.pdf

S9500-AVOID 2008-NCT00097955.pdf

S9501-ALLAY 2009.pdf

S9502-Andersen 2008.pdf

S9503-ATMOSPHERE -NCT00853658.pdf

S9504-ACCLAIM 2008-NCT00111969.pdf

S9505-PROVIDENCE -NCT00116792.pdf

S9506-Ponikowski 2007-NCT00117234.pdf

S9508-REVIVAL-2 (Zohlnhöfer ) 2006-NCT00126100.pdf

S9509-STEMMI (Ripa) 2006.pdf

S9510-G-CSF-STEMI (Engelmann) 2006.pdf

S9511-FIRSTLINE-AMI (Ince) 2005.pdf

S9512-MAGIC Cell-3-DES (Kang) 2006.pdf

S9513-MAGIC (G-CSF) (Kang) 2004.pdf

S9514-MAGIC 1 (Kang) 2007.pdf

S9515-Valgimigli 2005.pdf

S9516-Ellis 2006-NCT00215124.pdf

S9517-Takano 2007.pdf

S9518-RIGENERA (Leone) 2007.pdf

S9519-Suarez de Lezo (G-CSF) 2007.pdf

S9520-PAD (Hallstrom) 2004.pdf

S9521-van Alem 2003.pdf

S9522-Kellermann 1993.pdf

S9523-BBS (Moller) 2010-NCT00120991.pdf

S9524-PIE II -NCT00123955.pdf

S9525-DOORS 2009-NCT00123981.pdf

S9526-UNLOAD -NCT00124137.pdf

S9527-Nouvel essai -NCT00125437.pdf

S9529-GLOBAL -NCT00125645.pdf

S9530-BASEL -NCT00130611.pdf

S9531-CAPRAF (Tveit) 2007-NCT00130975.pdf

S9532-Weir -NCT00132093.pdf

S9533-RethinQ 2007-NCT00132977.pdf

S9534-MANTRA-PAF -NCT00133211.pdf

S9535-Jikei Heart DOUBLON 2007-NCT00133328.pdf

S9536-APRICOT-3 -NCT00138034.pdf

S9537-APAF (Pappone) 2006.pdf

S9538-CAFCOAF (Stabile) 2006.pdf

S9539-Krittayaphong 2003.pdf

S9540-Brown -NCT00141778.pdf

S9541-senior PAMI 2005-NCT00136929.pdf

S9543-CRIT Pilot -NCT00126334.pdf

S9544-n3-PUFA-HF -NCT00149409.pdf

S9545-van Kraaij -NCT00149422.pdf

S9547-Parissis 2008.pdf

S9548-Palazzuoli 2006.pdf

S9549-Parissis 2009.pdf

S9550-Kourea 2008.pdf

S9551-TRANSFER-AMI à effacer -NCT00164190.pdf

S9554-NORDISTEMI 2009-NCT00161005.pdf

S9556-RAPS (Desai) 2004-NCT00187356.pdf

S9557-RSVP 2008-NCT00139399.pdf

S9558-Czech trial -NCT00171275.pdf

S9559-Hayward (Younger) 2008.pdf

S9560-Gaudino (radial A) 2005.pdf

S9561-PRAGUE 4 (Widimsky) 2004.pdf

S9562-BHACAS I (Ascione) 1999.pdf

S9563-BHACAS II (Angelini) 2002.pdf

S9564-OCTOPUS (van Dijk) 2002.pdf

S9565-SMART (Staton) 2003.pdf

S9566-Al-Ruzzeh b 2006.pdf

S9567-Gu 1998.pdf

S9568-Diegeler 2000.pdf

S9569-Gulielmos 1999.pdf

S9570-Matata 2000.pdf

S9571-Covino 2001.pdf

S9572-Penttila 2001.pdf

S9573-Caputo 2002.pdf

S9574-Zamvar 2002.pdf

S9575-Carrier 2003.pdf

S9576-Raja b 2003.pdf

S9577-Alwan 2004.pdf

S9578-Gerola 2001.pdf

S9579-Khan 2004.pdf

S9580-Legare 2004-NCT00216957.pdf

S9581-Lingaas 2003.pdf

S9582-Motallebzadeh 2004.pdf

S9583-PRAGUE-4 DOUBLON 2004.pdf

S9584-Selvanayagam 2004.pdf

S9585-Ascionee 2005.pdf

S9586-Kobayashi 2005.pdf

S9587-Ascione 2006.pdf

S9588-Michaux 2006.pdf

S9589-Motallebzadeh b 2006.pdf

S9590-Niranjan 2006.pdf

S9591-Paparella 2006.pdf

S9592-Tatoulis 2006.pdf

S9593-Jares 2006.pdf

S9594-Kunes 2007.pdf

S9595-Ozkara 2007.pdf

S9596-ROOBY (Shroyer) 2009-NCT00032630.pdf

S9597-OCTOPUS II .pdf

S9598-CADUCEUS -NCT00893360.pdf

S9599-Corcos 1985.pdf

S9600-Whitworth 1986.pdf

S9601-Hoberg 1994.pdf

S9602-O’Keefe 1991.pdf

S9603-Unverdorben 1996.pdf

S9604-Dens (CAPARES) 2000.pdf

S9605-Jorgensen (NICOLE) 2001.pdf

S9677-OPTIMAAL .pdf

S9678-ASTRONAUT 2013-NCT00894387.pdf

S9682-PPAR -NCT00212004.pdf

S9683-ASSOCIATE - CL3-16257-057 DOUBLON -NCT00202566.pdf

S9685-ASCET -NCT00222261.pdf

S9687-Tebbe 2009.pdf

S9688-ACTIVE I 2009-NCT00249795.pdf

S9689-EMPHASIS-HF 2010-NCT00232180.pdf

S9690-STOP-AF -NCT00252967.pdf

S9691-TRIANA 2009-NCT00257309.pdf

S9694-EARTH -NCT00900549.pdf

S9696-PLATO 2009-NCT00391872.pdf

S9697-DISPERSE-2 (90mg) 2007.pdf

S9698-CHAMPION-PLATFORM 2009-NCT00385138.pdf

S9699-CHAMPION-PCI 2009-NCT00305162.pdf

S9700-Bridge -NCT00767507.pdf

S9707-MAGIC (cell infusion ) 2004.pdf

S9708-Suarez de Lezo (cell) 2007.pdf

S9710-PROactive 2005-NCT00174993.pdf

S9711-TCT-STAMI (Ge) 2006.pdf

S9712-Huang 2006.pdf

S9713-Janssens 2006.pdf

S9714-MAGIC Cell-3-DES (Kang) 2006.pdf

S9715-Karpov 2005.pdf

S9716-Li 2007.pdf

S9717-ASTAMi (Lunde) 2006.pdf

S9718-Meluzin LD 2006.pdf

S9719-Meluzin HD 2006.pdf

S9720-BOOSt (Meyer) 2004.pdf

S9721-Penicka 2007.pdf

S9722-Ruan 2005.pdf

S9723-REPAIR-AMI (Schachinger) 2006-NCT00279175.pdf

S9725-Suzuki 2006.pdf

S9726-Deng 2006.pdf

S9727-NEVO RES-ELUTION I 0-NCT00714883.pdf

S9728-Nouvel essai .pdf

S9729-TRIGGER-PCI -NCT00910299.pdf

S9737-PROTECT-TIMI 30 2006-NCT00250471.pdf

S9740-PRECEDENT 2002-NCT00270400.pdf

S9741-Ontario -NCT00259493.pdf

S9742-ACCESS -NCT00252317.pdf

S9743-INTAMI 2005-NCT00251823.pdf

S9745-Nouvel essai .pdf

S9752-Almroth 2009.pdf

S9754-AIM-HIGH 2011-NCT00120289.pdf

S9755-HPS 2-Thrive -NCT00461630.pdf

S9756-BALANCE 2009.pdf

S9757-Nouvel essai .pdf

S9758-Imperial College -NCT00285454.pdf

S9761-COREA TAXUS -NCT00292721.pdf

S9762-HERS 1998-NCT00319566.pdf

S9763-CARACCASS -NCT00317265.pdf

S9764-REGENT (Wojakowski) -NCT00316381.pdf

S9767-Thiele 2009-NCT00299429.pdf

S9768-ATLAS ACS-TIMI 46 (DOUBLONS) 2009-NCT00402597.pdf

S9769-PROTECT (Dierner) .pdf

S9770-PREVAIL (Sherman) .pdf

S9771-Hillborn 2002.pdf

S9772-PASEO 2009.pdf

S9773-Tveit 2004.pdf

S9774-MIRACL (sub-group) (Schwartz) 2004.pdf

S9776-Ozaydin 2006.pdf

S9778-Dernellis 2006.pdf

S9780-MDRD 1994.pdf

S9781-HOT 1994.pdf

S9782-ABCD (H) 2000.pdf

S9783-AASK 2002.pdf

S9784-REIN-2 2005.pdf

S9786-Patwala 2009.pdf

S9787-REACT (rescue PCI vs repeat fibrinolysis) 2005.pdf

S9788-ASPEN (primary prevention sub group) 2006.pdf

S9789-HPS (diabetic primary prevention sub group) 2003.pdf

S9790-PROSPER (primary prevention subgroup) 2002.pdf

S9791-ARMYDA-3 (AF ancillary study) 2006.pdf

S9792-Chello 2006.pdf

S9793-MIRACL (AF ancillary study) 2001.pdf

S980-Engelmeier 1985.pdf

S981-Pollock 1990.pdf

S982-Lechat 1991.pdf

S983-Woodley 1991.pdf

S9831-Ogawa -NCT00265239.pdf

S984-Wisenbaugh 1993.pdf

S985-Fisher 1994.pdf

S986-Bristow 1994.pdf

S987-Eichhorn 1994.pdf

S988-Metra 1994.pdf

S9885-TRIANA -NCT00257309.pdf

S989-Olsen 1995.pdf

S990-Krum 1995.pdf

S9902-Thiele 2005.pdf

S9903-Burkhoff 2006.pdf

S9904-Seyfarth 2008.pdf

S991-Bristow (MOCHA) 1996.pdf

S9911-NCT00975234 -NCT00975234.pdf

S9912-RECOVER 2 2009-NCT00972270.pdf

S9913-Wang 2003.pdf

S9914-ASPARAGUS 2008.pdf

S9915-Nanasato 2004.pdf

S992-Parker 1996.pdf

S993-Colucci 1996.pdf

S994-Cohn 1997.pdf

S9946-Export study .pdf

S9969-MARVEL .pdf

S9973-COGENT 2009-NCT00557921.pdf

S9974-OCLA 2008-NCT00349661.pdf

S9975-PACA 2009.pdf

S9976-COMPARE 2009-NCT01016041.pdf

S9977-Nordic-Baltic Bifurcation Study III 2009-NCT00914199.pdf

S9978-DEBATER (SES vs BMS) 2009.pdf

S9979-PAINT (sirolimus) 2009-NCT00752362.pdf

S9981-CASPER 2009.pdf

S9986-PAD DOUBLONS A EFFACER 2007.pdf

S9987-IRIS 2009-NCT00157768.pdf

S9988-CHAOS-2 2002.pdf

S9989-FOLARDA (Liem) 2004.pdf

S9990-GOES (Liem) 2003.pdf

S9991-WENBIT (folic ac,B12) 2008-NCT00354081.pdf

S9992-WENBIT (vit B6) 2008-NCT00354081.pdf

S9993-CARRPO 2009-NCT00159991.pdf

S9994-TIME .pdf

S9997-OVER 2009-NCT00094575.pdf

S9999-Chen 2004.pdf